
<html lang="en"     class="pb-page"  data-request-id="830ff2ff-bfee-4005-acb4-a45d7ced63d5"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/jm100665z;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2010.53.issue-24"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Novel Chimeric Histone Deacetylase Inhibitors: A Series of Lapatinib Hybrides as Potent Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), and Histone Deacetylase Activity" /></meta><meta name="dc.Creator" content="Siavosh  Mahboobi" /></meta><meta name="dc.Creator" content="Andreas  Sellmer" /></meta><meta name="dc.Creator" content="Matthias  Winkler" /></meta><meta name="dc.Creator" content="Emerich  Eichhorn" /></meta><meta name="dc.Creator" content="Herwig  Pongratz" /></meta><meta name="dc.Creator" content="Thomas  Ciossek" /></meta><meta name="dc.Creator" content="Thomas  Baer" /></meta><meta name="dc.Creator" content="Thomas  Maier" /></meta><meta name="dc.Creator" content="Thomas  Beckers" /></meta><meta name="dc.Description" content="Reversible lysine-specific acetylation has been described as an important posttranslational modification, regulating chromatin structure and transcriptional activity in the case of core histone pro..." /></meta><meta name="Description" content="Reversible lysine-specific acetylation has been described as an important posttranslational modification, regulating chromatin structure and transcriptional activity in the case of core histone pro..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 16, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm100665z" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm100665z" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm100665z" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm100665z" /></link>
        
    
    

<title>Novel Chimeric Histone Deacetylase Inhibitors: A Series of Lapatinib Hybrides as Potent Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), and Histone Deacetylase Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm100665z" /></meta><meta property="og:title" content="Novel Chimeric Histone Deacetylase Inhibitors: A Series of Lapatinib Hybrides as Potent Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), and Histone Deacetylase Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/large/jm-2010-00665z_0006.jpeg" /></meta><meta property="og:description" content="Reversible lysine-specific acetylation has been described as an important posttranslational modification, regulating chromatin structure and transcriptional activity in the case of core histone proteins. Histone deacetylases (HDAC) are considered as a promising target for anticancer drug development, with 2a as pan-HDAC inhibitor approved for cutanous T-cell lymphoma therapy and several other HDAC inhibitors currently in preclinical and clinical development. Protein kinases are a well-established target for cancer therapy with the EGFR/HER2 inhibitor 5 approved for treatment of advanced, HER2 positive breast cancer as a prominent example. In the present report, we present a novel strategy for cancer drug development by combination of EGFR/HER2 kinase and HDAC inhibitory activity in one molecule. By combining the structural features of 5 with an (E)-3-(aryl)-N-hydroxyacrylamide motif known from HDAC inhibitors like 1 or 3, we obtained selective inhibitors for both targets with potent cellular activity (target inhibition and cytotoxicity) of selected compounds 6a and 6c. By combining two distinct pharmacologically properties in one molecule, we postulate a broader activity spectrum and less likelihood of drug resistance in cancer patients." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm100665z"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm100665z">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm100665z&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm100665z&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm100665z&amp;href=/doi/10.1021/jm100665z" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 8546-8555</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm100941j" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm100786g" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel Chimeric Histone Deacetylase Inhibitors: A Series of Lapatinib Hybrides as Potent Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), and Histone Deacetylase Activity</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Siavosh++Mahboobi">Siavosh Mahboobi</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andreas++Sellmer">Andreas Sellmer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthias++Winkler">Matthias Winkler</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Emerich++Eichhorn">Emerich Eichhorn</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Herwig++Pongratz">Herwig Pongratz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Ciossek">Thomas Ciossek</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Baer">Thomas Baer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Maier">Thomas Maier</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Beckers">Thomas Beckers</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">â </span> <span class="aff-text">Department of Pharmaceutical Chemistry I, University of Regensburg, D-93040 Regensburg, Germany</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">â¡</span> <span class="aff-text">Nycomed GmbH, Therapeutic Area Oncology, Byk-Gulden Strasse 2, D-78467 Konstanz, Germany</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">Â§</span> <span class="aff-text">Oncotest GmbH, Institute for Experimental Oncology, Am Flughafen 12-14, D-79108 Freiburg, Germany</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. For medicinal chemistry (S.M.): phone, (+49) (0) 941 943 4824; fax, (+49) (0) 941-9431737; E-mail, <a href="/cdn-cgi/l/email-protection#0d7e646c7b627e6523606c656f62626f644d6e656860646823786364207f686a68637e6f787f6a236968"><span class="__cf_email__" data-cfemail="e99a80889f869a81c78488818b86868b80a98a818c84808cc79c8780c49b8c8e8c879a8b9c9b8ec78d8c">[emailÂ protected]</span></a>. For pharmacology (T.B.): phone, (+49) (0) 761 5155916; fax, (+49) (0) 761 5155955; E-mail, <a href="/cdn-cgi/l/email-protection#eeba8681838f9dc0ac8b8d858b9c9dae81808d819a8b9d9ac08a8b"><span class="__cf_email__" data-cfemail="bbefd3d4d6dac895f9ded8d0dec9c8fbd4d5d8d4cfdec8cf95dfde">[emailÂ protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm100665z&amp;href=/doi/10.1021%2Fjm100665z" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 8546â8555</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 16, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 June 2010</li><li><span class="item_label"><b>Published</b> online</span>16 November 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 December 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm100665z" title="DOI URL">https://doi.org/10.1021/jm100665z</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8546%26pageCount%3D10%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSiavosh%2BMahboobi%252C%2BAndreas%2BSellmer%252C%2BMatthias%2BWinkler%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D24%26contentID%3Djm100665z%26title%3DNovel%2BChimeric%2BHistone%2BDeacetylase%2BInhibitors%253A%2BA%2BSeries%2Bof%2BLapatinib%2BHybrides%2Bas%2BPotent%2BInhibitors%2Bof%2BEpidermal%2BGrowth%2BFactor%2BReceptor%2B%2528EGFR%2529%252C%2BHuman%2BEpidermal%2BGrowth%2BFactor%2BReceptor%2B2%2B%2528HER2%2529%252C%2Band%2BHistone%2BDeacetylase%2BActivity%26numPages%3D10%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8555%26publicationDate%3DDecember%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm100665z"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3870</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">65</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm100665z" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel Chimeric Histone Deacetylase Inhibitors: A Series of Lapatinib Hybrides as Potent Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), and Histone Deacetylase Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Siavosh&quot;,&quot;last_name&quot;:&quot;Mahboobi&quot;},{&quot;first_name&quot;:&quot;Andreas&quot;,&quot;last_name&quot;:&quot;Sellmer&quot;},{&quot;first_name&quot;:&quot;Matthias&quot;,&quot;last_name&quot;:&quot;Winkler&quot;},{&quot;first_name&quot;:&quot;Emerich&quot;,&quot;last_name&quot;:&quot;Eichhorn&quot;},{&quot;first_name&quot;:&quot;Herwig&quot;,&quot;last_name&quot;:&quot;Pongratz&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Ciossek&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Baer&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Maier&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Beckers&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;8546-8555&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm100665z&quot;},&quot;abstract&quot;:&quot;Reversible lysine-specific acetylation has been described as an important posttranslational modification, regulating chromatin structure and transcriptional activity in the case of core histone proteins. Histone deacetylases (HDAC) are considered as a promising target for anticancer drug development, with 2a as pan-HDAC inhibitor approved for cutanous T-cell lymphoma therapy and several other HDAC inhibitors currently in preclinical and clinical development. Protein kinases are a well-established target for cancer therapy with the EGFR/HER2 inhibitor 5 approved for treatment of advanced, HER2 positive breast cancer as a prominent example. In the present report, we present a novel strategy for cancer drug development by combination of EGFR/HER2 kinase and HDAC inhibitory activity in one molecule. By combining the structural features of 5 with an (E)-3-(aryl)-N-hydroxyacrylamide motif known from HDAC inhibitors like 1 or 3, we obtained selective inhibitors for both targets with potent cellular activity (target &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100665z&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100665z" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100665z&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100665z" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100665z&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100665z" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm100665z&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100665z&amp;href=/doi/10.1021/jm100665z" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm100665z" /></input><a href="/doi/pdf/10.1021/jm100665z" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm100665z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm100665z%26sid%3Dliteratum%253Aachs%26pmid%3D21080629%26genre%3Darticle%26aulast%3DMahboobi%26date%3D2010%26atitle%3DNovel%2BChimeric%2BHistone%2BDeacetylase%2BInhibitors%253A%2BA%2BSeries%2Bof%2BLapatinib%2BHybrides%2Bas%2BPotent%2BInhibitors%2Bof%2BEpidermal%2BGrowth%2BFactor%2BReceptor%2B%2528EGFR%2529%252C%2BHuman%2BEpidermal%2BGrowth%2BFactor%2BReceptor%2B2%2B%2528HER2%2529%252C%2Band%2BHistone%2BDeacetylase%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D24%26spage%3D8546%26epage%3D8555%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/24" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jmcmar.2010.53.issue-24/production/jmcmar.2010.53.issue-24.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/medium/jm-2010-00665z_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/large/jm-2010-00665z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100665z&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Reversible lysine-specific acetylation has been described as an important posttranslational modification, regulating chromatin structure and transcriptional activity in the case of core histone proteins. Histone deacetylases (HDAC) are considered as a promising target for anticancer drug development, with <b>2a</b> as pan-HDAC inhibitor approved for cutanous T-cell lymphoma therapy and several other HDAC inhibitors currently in preclinical and clinical development. Protein kinases are a well-established target for cancer therapy with the EGFR/HER2 inhibitor <b>5</b> approved for treatment of advanced, HER2 positive breast cancer as a prominent example. In the present report, we present a novel strategy for cancer drug development by combination of EGFR/HER2 kinase and HDAC inhibitory activity in one molecule. By combining the structural features of <b>5</b> with an (<i>E</i>)-3-(aryl)-<i>N</i>-hydroxyacrylamide motif known from HDAC inhibitors like <b>1</b> or <b>3</b>, we obtained selective inhibitors for both targets with potent cellular activity (target inhibition and cytotoxicity) of selected compounds <b>6a</b> and <b>6c</b>. By combining two distinct pharmacologically properties in one molecule, we postulate a broader activity spectrum and less likelihood of drug resistance in cancer patients.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16622" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16622" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Carcinogenesis and tumor suppression are controlled by genetic as well as epigenetic events. Unlike genetic aberrations, epigenetic changes in cancer cells such as DNA hypermethylation and histone deacetylation are largely reversible alterations. Histone deacetylase (HDAC<a class="ref internalNav" href="#fn2" aria-label="a">a</a><div class="NLM_fn" id="fn2">a<p class="last">Abbreviations: AMC, 7-amino-4-methylcoumarin; ATCC, American Type Culture Collection; BOP, 1-benzotriazolyloxy-tris-(dimethylamino)phosphonium hexafluorophosphate; CDK, cell division kinase; CML, chronic myeloid leukemia; HDACi, histone deacetylase inhibitor; HDAC, histone deacetylase; nd, not determined; InsR, insulin receptor; NSCLC, nonsmall cell lung cancer; PDGFR, platelet derived growth factor receptor; Plk1, polo-like kinase 1; PKA, protein kinase A; rHDAC, recombinant HDAC; SAHA, suberoylanilide hydroxamic acid; SDS, sodium dodecylsulfate; SDS-PAGE, SDS polyacrylamide gel electrophoresis; SMI, small molecule inhibitor; TSA, trichostatin A.</p></div>) class 1 and 2 enzymes with 11 isoforms are considered as promising targets for anticancer drug development.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Various inhibitors of HDAC class 1 and/or class 2 enzymes (HDACi) are currently evaluated in clinical phase 1 and 2 trials.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6">(2-6)</a></div><div class="NLM_p">Substrates of HDAC enzymes are core histone proteins H2A/B, H3, and H4, highly conserved proteins complexed with DNA and building up chromatin. Histone proteins are post-translationally modified by various means, including methylation and acetylation of N-terminal lysine residues. The reversible lysine-specific acetylation of core histone proteins has been well described as a mechanism to regulate chromatin structure, transcription factor accessibility, and finally transcriptional activity. Negatively charged DNA binds to positively charged lysine residues in the amino-terminal tails of histones, which is abrogated by lysine N-terminal acetylation.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> HDAC isoenzymes are essential for deacetylating histone proteins, allowing tight binding of DNA and formation of a closed, transcriptionally inactive chromatin conformation. Inhibitors of HDAC reactivate gene expression but also affect acetylation of nonhistone targets which have been described.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> On a cellular level, HDACiâs reactivate tumor suppressor genes exhibit cell cycle arresting and pro-apoptotic properties.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Several HDACiâs exhibiting the hydroxamic acid or benzamide motif as a Zn<sup>2+</sup> complexing headgroup are currently in preclinical and clinical development (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, compounds 1â4) as represented by the hydroxamic acid analogues â<b>1</b> (PXD101)â,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a><b>2a</b> (phase II), â<b>2b</b> (PCI(CRA)-24781)â<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> (phase II), â3 (LBH589),â<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a>or the benzamide analogue â<b>4</b> (SNDX/MS 275)â (phase II),<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> to name just a few.</div><div class="NLM_p">Inhibitors of protein tyrosine or serine/threonine kinases are another well described drug class. The human epidermal growth factor receptor (EGFR, HER1) and the family member HER2 (c-erbB2) have been linked to various human malignancies like breast, head and neck, pancreatic, colon, gastric, and nonsmall cell lung cancer. Small synthetic inhibitors (SMI) as well as monoclonal antibodies have been developed for cancer therapy. The SMI <b>5</b> is one example approved for treatment of HER2 positive advanced breast cancer in combination with Capecitabine.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><div class="NLM_p">In this report, we present a novel strategy for cancer drug development, combining the pharmacological activity of EGFR/HER2 kinase inhibition with inhibition of HDAC class 1/2 enzymes. As a scaffold, <b>5</b> was selected to include a HDAC inhibitory headgroup (âwarheadâ) in order to combine, in general, the antiproliferative activity of EGFR/HER2 inhibition with the pro-apoptotic, transcriptional reprogramming activity of a HDACi. Of the various HDAC inhibitory headgroups, we choose the hydroxamic acid and benzamide motifs for combination with the [3-chloro-4-(3-fluorobenzyloxy)phenyl]quinazolin-4-yl-amine core structure of <b>5</b> to obtain chimerically designed compounds.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/medium/jm-2010-00665z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/large/jm-2010-00665z_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of selected HDACiâs in preclinical and clinical developments (<b>1</b>â<b>4</b>), <b>5</b>, and novel chimerically designed compounds (<b>6</b>â<b>8</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/large/jm-2010-00665z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100665z&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32572" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32572" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthetic route to obtain the desired target compounds is given in the following (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>): ring closure of 2-amino-5-iodo benzoic acid (<b>9</b>) according to Ninishino<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> formed the 1<i>H</i>-quinazolin-4-one system <b>10</b>. Chlorination with phosphorus oxychloride and one-pot S<sub>N</sub>-reaction<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> by 3-chloro-4-(3-fluoro-benzyloxy)phenylamine (<b>15</b>), yielded the desired [3-chloro-4-(3-fluorobenzyloxy)phenyl]-(6-iodo quinazolin-4-yl)amine (<b>16</b>) as a central intermediate. The aniline derivative <b>15</b> was easily accessible from its nitro-precursor <b>14</b><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> by catalytic reduction with hydrogen over sulfided platinum.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The nitro-precursor <b>14</b> itself was prepared according to Wallace et al.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> by S<sub>NAr</sub>-reaction of 2-chloro-1-fluoro-4-nitrobenzene and (3-fluorophenyl)methanol in DMF solution.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/medium/jm-2010-00665z_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/large/jm-2010-00665z_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of [3-Chloro-4-(3-fluorobenzyloxy)phenyl]-(6-iodoquinazolin-4-yl)amine (<b>16</b>) As a Central Intermediate</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/large/jm-2010-00665z_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100665z&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The desired furanyl- and thiophenyl- and phenyl-<i>N</i>-hydroxy-acrylamides <b>6a</b>â<b>6d</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) were obtained from <b>16</b> by Suzuki coupling with the respective formylboronic acids <b>17a</b>â<b>17d</b> analogous to Hosoya,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Wittig olefination,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and deprotection of the resulting acrylic acid <i>tert</i>-butyl esters (<b>19a</b>â<b>19d</b>) with trifluoroacetic acid. Amidation of the acrylic acids <b>20a</b>â<b>20d</b> with commercially available NH<sub>2</sub>OTHP (<i>O</i>-(tetrahydropyran-2-yl)hydroxylamine) by use of BOP (1-benzotriazolyloxy-tris-(dimethylamino)phosphoniumhexafluorophosphat) as coupling reagent<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and cleavage of the tetrahydro-pyran-2-yl protected acrylamides <b>21a</b>â<b>21d</b> led to the <i>N</i>-hydroxy-acrylamides <b>6a</b>â<b>6d</b>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/medium/jm-2010-00665z_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/large/jm-2010-00665z_0010.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <i>N</i>-Hydroxyacrylamides <b>6a</b>â<b>6d</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/large/jm-2010-00665z_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100665z&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Analogously, the carboxylic acid (2-aminophenyl)amides <b>7a</b> and <b>7b</b> as well as the carboxylic acid hydroxyamides <b>8a</b> and <b>8b</b> were prepared as shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> by amidation of the carboxylic acids with NH<sub>2</sub>OTHP or the mono protected phenylendiamine <b>25</b>, followed by deprotection with trifluoroacetic acid (for details, see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>). The mono protected phenylendiamine <b>25</b> itself was easily accessible by reaction of <i>o</i>-phenylendiamine (<b>24</b>) with BOC<sub>2</sub>O in THF solution.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/medium/jm-2010-00665z_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/large/jm-2010-00665z_0011.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Carboxylic Acid (2-Aminophenyl)amides (<b>7a</b>, <b>7b</b>) and Carboxylic Acid Hydroxyamides (<b>8a</b>, <b>8b</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/large/jm-2010-00665z_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100665z&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/medium/jm-2010-00665z_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/large/jm-2010-00665z_0001.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Phenylaminoacrylamides (<b>7c</b>â<b>7e</b>) and of <i>N</i>-(2-Aminophenyl)-3-(4-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-yl)phenyl)propanamide (<b>7f</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/large/jm-2010-00665z_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100665z&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The (<i>E</i>)-<i>N</i>-(2-aminophenyl)-3-(furan-2-yl)acrylamide <b>7c</b> as well as the <i>N</i>-(2-aminophenyl)cinnamamides <b>7d</b> and <b>7e</b> were obtained in a similar manner by amidation<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> of the acrylic acids <b>20a</b>â<b>20d</b> with the mono protected phenylendiamine <b>25</b><a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and deprotection of the <i>tert</i>-butyl carbamates (<b>28a</b>, <b>28c</b>, and <b>28d</b>) with trifluoroacetic acid (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Selective catalytic hydrogenation in presence of a benzyloxy- and a chloroaryl-group by use of PtO<sub>2</sub> yielded the <i>N</i>-(2-aminophenyl)-3-phenylpropanamide <b>7f</b> without additional cleavage.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11756" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11756" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesized chimeric compounds were characterized in biochemical assays for HDAC as well as protein-kinase inhibitory activity. In addition, cellular target specific activity was assessed in respective cancer cell lines. Finally, the cytotoxic activity was determined in EGFR or HER2 overexpressing cancer cell lines for selected analogues.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Pharmacological Profile in Biochemical and Cellular, Target-Specific Assays</h3><div class="NLM_p">The in vitro data for inhibition of HeLa nuclear extract HDAC activity, a mixture of HDAC isoenzymes 1, 2, 3, 5, and 8, recombinant rHDAC 1, 3, and 6 as well as cellular data for induction of histone H3 hyperacetylation are compiled in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. As references, <b>5</b> as well as <b>2a</b> and <b>4</b> are included as representatives for hydroxamate and benzamide analogues. Combining the structural features a [3-chloro-4-(3-fluorobenzyloxy)phenyl]quinazolin-4-yl-amine (substructure of <b>5</b> in Figure.<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) with an (<i>E</i>)-3-(aryl)-<i>N</i>-hydroxyacrylamide motif taken from <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>; compounds <b>6a</b>â<b>6c</b>) leads to inhibition of nuclear extract HDAC, rHDAC1 and rHDAC6 in the submicromolar (<b>6a</b>) or even nanomolar range (<b>6c</b>) as well as cellular histone H3 hyperacetylation. Compounds <b>6a</b> to <b>6c</b> also display very potent and specific inhibition of EGFR and HER2 kinase activity in biochemical assays, with <b>6c</b> being only 2- to 5-fold less potent as Lapatinib (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The protein kinases PDGFRÎ², InsR, Abl, CDK2, PKA, and Plk1 were chosen to evaluate kinase target selectivity.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. IC<sub>50</sub>/EC<sub>50</sub> Values for Chimeric Lapatinib-HDAC Inhibitors As Tested for Inhibition of HeLa Nuclear Extract HDAC Activity, Recombinant HDAC Isoenzymes, and Induction of Cellular Histone H3 K<sup>9+14</sup> Hyperacetylation <a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/medium/jm-2010-00665z_0002.gif" alt="" id="fx1" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/medium/jm-2010-00665z_0003.gif" alt="" id="fx2" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">In general, experiments were done in replicate and mean values are shown (data for <b>4</b> and <b>2a</b> from ref <a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">22</a>).</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibition of Selected Recombinant Protein Tyrosine and Serine/Threonine Kinases in Biochemical Assays, Namely Epidermal Growth Factor Receptor (EGFR), Human EGFR-Like Receptor 2 (HER2), Platelet-Derived Growth Factor Receptor Î² (PDGF-RÎ²), Insulin Receptor (InsR), Abl1, Cell Division Kinase 2 (CDK2), Protein Kinase A (PKA), and Polo-Like Kinase 1 (PlK1)<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left">no.</th><th class="colsep0 rowsep0" align="char" char=".">EGFR IC<sub>50</sub> [Î¼M]</th><th class="colsep0 rowsep0" align="char" char=".">HER2 IC<sub>50</sub> [Î¼M]</th><th class="colsep0 rowsep0" align="left" char=".">PDGF-RÎ² IC<sub>50</sub> [Î¼M]</th><th class="colsep0 rowsep0" align="char" char=".">InsR IC<sub>50</sub> [Î¼M]</th><th class="colsep0 rowsep0" align="char" char=".">Abl1 IC<sub>50</sub> [Î¼M]</th><th class="colsep0 rowsep0" align="char" char=".">CDK2 IC<sub>50</sub> [Î¼M]</th><th class="colsep0 rowsep0" align="char" char=".">PKA IC<sub>50</sub> [Î¼M]</th><th class="colsep0 rowsep0" align="char" char=".">PlK1 IC<sub>50</sub> [Î¼M]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b></td><td class="colsep0 rowsep0" align="char" char=".">0.0025</td><td class="colsep0 rowsep0" align="char" char=".">0.0041</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">7.34</td><td class="colsep0 rowsep0" align="char" char=".">7.7</td><td class="colsep0 rowsep0" align="char" char=".">0.44</td><td class="colsep0 rowsep0" align="char" char=".">120</td><td class="colsep0 rowsep0" align="char" char=".">12.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6b</b></td><td class="colsep0 rowsep0" align="char" char=".">0.0048</td><td class="colsep0 rowsep0" align="char" char=".">0.0035</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">0.44</td><td class="colsep0 rowsep0" align="char" char=".">35</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6c</b></td><td class="colsep0 rowsep0" align="char" char=".">0.018</td><td class="colsep0 rowsep0" align="char" char=".">0.011</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">5.3</td><td class="colsep0 rowsep0" align="char" char=".">0.92</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">6.80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6d</b></td><td class="colsep0 rowsep0" align="char" char=".">0.018</td><td class="colsep0 rowsep0" align="char" char=".">0.012</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">3.7</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td><td class="colsep0 rowsep0" align="char" char=".">0.85</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">9.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7a</b></td><td class="colsep0 rowsep0" align="char" char=".">0.0029</td><td class="colsep0 rowsep0" align="char" char=".">0.0057</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td><td class="colsep0 rowsep0" align="char" char=".">15.0</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7b</b></td><td class="colsep0 rowsep0" align="char" char=".">0.0028</td><td class="colsep0 rowsep0" align="char" char=".">0.0049</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">6.0</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7c</b></td><td class="colsep0 rowsep0" align="char" char=".">0.026</td><td class="colsep0 rowsep0" align="char" char=".">0.0087</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">8.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7d</b></td><td class="colsep0 rowsep0" align="char" char=".">0.049</td><td class="colsep0 rowsep0" align="char" char=".">0.014</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td><td class="colsep0 rowsep0" align="char" char=".">0.85</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7e</b></td><td class="colsep0 rowsep0" align="char" char=".">0.029</td><td class="colsep0 rowsep0" align="char" char=".">0.015</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">6.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7f</b></td><td class="colsep0 rowsep0" align="char" char=".">0.015</td><td class="colsep0 rowsep0" align="char" char=".">0.0047</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="char" char=".">7.1</td><td class="colsep0 rowsep0" align="char" char=".">6.9</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8a</b></td><td class="colsep0 rowsep0" align="char" char=".">0.0039</td><td class="colsep0 rowsep0" align="char" char=".">0.0020</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">0.46</td><td class="colsep0 rowsep0" align="char" char=".">85</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8b</b></td><td class="colsep0 rowsep0" align="char" char=".">0.0022</td><td class="colsep0 rowsep0" align="char" char=".">0.0035</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">0.0029</td><td class="colsep0 rowsep0" align="char" char=".">0.0045</td><td class="colsep0 rowsep0" align="char" char=".">8.50</td><td class="colsep0 rowsep0" align="char" char=".">17.0</td><td class="colsep0 rowsep0" align="char" char=".">23.0</td><td class="colsep0 rowsep0" align="char" char=".">11.0</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">In general, experiments were done in replicate and mean IC<sub>50</sub> values are shown.</p></div></div></div><div class="NLM_p">A change of the substitution patterns from meta (<b>6c</b>) to para substitution drastically reduced HDAC inhibitory potency, as seen for <b>6d</b> and the bioisosteric built up thiophene derivative <b>6b</b>, while inhibition of EGFR and HER2 kinases was not affected. In modifications bearing the <i>N</i>-(2-aminophenyl)-benzamide substituent as a HDACi motif taken from <b>4</b>, the potent inhibition of EGFR and HER2 kinase activity and selectivity are conserved. However, no significant HDAC inhibitory activity is evident for benzamide analogues <b>7a</b> and <b>7b</b>, structurally related to <b>8a</b> and <b>8b</b>.</div><div class="NLM_p">To investigate the effect of the system vinylogous to benzamides, included in the HDAC-inhibitory structures <b>6a</b> and <b>6c</b>, we extended the study to the vinylogous benzamides <b>7c</b>â<b>7e</b> as well as to benzamide <b>7f</b> and the arylhydroxamates <b>8a</b> and <b>8b</b>. In the resulting benzamide and arylhydroxamate series, EGFR and HER2 kinases were strongly inhibited (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Regarding inhibition of HDAC enzymes, no activity is exhibited by benzamides <b>7a</b>â<b>7f</b>, independent from the substitution patterns (ortho or para), the nature of the A-ring system (Figure.<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) in the substructure of <b>5</b>, or from the linker between the benzamide structure and the A-ring system. This result is in contrast to our findings, published earlier, where combination of a benzamide motif with the imatinib pharmacophore led to chimeric HDAC class I inhibitors.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Weak inhibition of HeLa nuclear extract HDAC, rHDAC 1, 3, and 8 class I enzymes activity with stronger inhibition of rHDAC6 as a class 2 representative was observed for the hydroxamate <b>8b</b>. These compounds were potent inhibitors of EGFR and HER2 with presumably less selectivity (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/medium/jm-2010-00665z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/large/jm-2010-00665z_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Western blot analysis of Cal27 head and neck cancer cells treated for 16 h with compounds <b>5</b> (A) and <b>6c</b> or <b>6a</b> (B). As a control, cells treated with 1 Î¼M <b>5</b>, <b>6a</b>, or <b>6c</b> were documented by phase contrast microscopy in (C).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/large/jm-2010-00665z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100665z&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Cytotoxic Properties toward EGFR and HER2 Expressing Cancer Cell Lines</h3><div class="NLM_p">All compounds were tested for cytoxicity toward cancer cell lines either with EGFR (A431, Cal27) or HER2 (SKBR3, SKOV3) overexpression or of relevance for HDAC inhibitor testing (HeLa, A549). The data are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, showing highly potent activity of <b>5</b> in the Cal27, SKBR3, and SKOV3 cell lines with a bottom plateau of the concentrationâeffect curve between 30% and 70%. In the EGFR overexpressing cal27 head and neck cancer cell line, <b>5</b> also strongly inhibited cellular EGF stimulated EGFR phosphorylation (IC<sub>50</sub> < 32 nM) with no effect on histone H3 acetylation (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B). <i>N</i>-hydroxyacrylamide analogues <b>6a</b> and <b>6c</b> were most interesting from the initial in vitro profiling experiments. Whereas <b>6a</b> potently inhibited EGF stimulated EGFR phosphorylation in Cal27 cells (IC<sub>50</sub> < 32nM), <b>6c</b> was less potent (IC<sub>50</sub> â 0.5 Î¼M) (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A). Nevertheless, <b>6c</b> was nicely inducing histone H3 hyperacetylation at 1 Î¼M, behaving as a cellularly active, pharmacologically bifunctional compound. In the cytotoxicity profile, <b>6c</b> was broadly active with IC<sub>50</sub> values â¤1 Î¼M (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) and a complete cell kill at higher concentrations.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Cytotoxicity of the Chimeric HDAC Inhibitors Towards Selected Cancer Cell Lines, Namely A549 NSCL and HeLa Cervical Cancer (Source for HDAC Nuclear Activity), A431 Epidermoid Carcinoma, and Cal27 Head and Neck Cancer (EGFR Overexpression) and SKOV3 Ovarian and SKBR3 Breast Cancer (HER2 Overexpression)<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/medium/jm-2010-00665z_0004.gif" alt="" id="_i13" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/medium/jm-2010-00665z_0005.gif" alt="" id="_i14" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">In general, experiments were done in replicate and mean IC<sub>50</sub> values are shown (data for <b>2a</b> from Beckers et al., 2007<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a>).</p></div></div></div></div></div><div id="sec99" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30011" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30011" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Transferring the (<i>E</i>)-3-(aryl)-<i>N</i>-hydroxyacrylamide motif of <b>5</b>, which is an EGFR/HER protein kinase inhibitor and a drug approved for treatment of advanced, HER2 positive breast cancer, leads to chimeric compounds with <b>6c</b> acting as truly pharmacologically chimeric compound. In biochemical assays, this prototypic analogue shows selective and potent inhibiton of EGFR/HER2 as well as HDAC enzymatic activity. In cellular assays exemplified by the head and neck cell line Cal27, EGFR phosphorylation and histone H3 acetylation are concentration dependently inhibited and induced, respectively. Between 0.1 and 1 Î¼M concentration, maximal target inhibitory effects are visible, correlating with an IC<sub>50</sub> of 0.59 Î¼M in the cytotoxicity assay. However, transferring the HDAC inhibitory benzamide motif so far resulted in compounds with conserved kinase but no HDAC inhibitory activity. By combination of two pharmacologically distinct properties in one molecule, we postulate a broader activity spectrum with less likelihood of drug resistance. Thus, chimeric HDAC-kinase inhibitors might constitute a new class of experimental cancer drugs worth to be studied in more detail.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20122" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20122" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Biological Methods</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Biochemical HDAC Assays</h4><div class="NLM_p">For rHDAC1 and rHDAC6 expression, a clonal HEK293 (ATCC CRL1573) human kidney cell line expressing the human rHDAC1 isoenzyme bearing a C-terminal Flag epitope was provided by E. Verdin, The Gladstone Institute/San Francisco, CA, USA. Human HDAC3-Flag was coexpressed with the SMRT DAD domain in Sf21 insect cells, whereas human HDAC8-Flag was expressed without cofactor in Sf21 cells. The rHDAC proteins were purified by M2-affinity gel chromatography according to the manufacture protocol (Sigma no. A2220). Purified protein samples were routinely analyzed by SDS-PAGE (12.5% or 10% Laemmli gels) followed by Coomassie stain and Western blotting using a FLAG-specific antibody (anti M2-POX antibody, Sigma no. A8592) followed by ECL-detection (GE Healthcare). In addition, protein batches were analyzed by Western blotting for various HDAC isoenzymes including HDAC1, 3, 6, and 8.</div><div class="NLM_p last">The biochemical HDAC activity assay was essentially done as described by Wegener et al.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Biochemical Protein Kinase Assays</h4><div class="NLM_p last">Active kinase proteins were either obtained from commercial suppliers (ProQinase, Freiburg/Germany; InvitroGen/Panvera, Carlsbad, CA, USA) or prepared in-house. Experimental details of the flash-plate based radioactive enzyme assay have been described previously.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Cellular Histone H3 Hyperacetylation Assay</h4><div class="NLM_p last">To assess the cellular efficacy of a histone deacetylase inhibition, an assay was set up for use on the Cellomics âArrayScan IIâ platform for a quantitative calculation of histone acetylation as described.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Cellular Proliferation Assay</h4><div class="NLM_p last">The antiproliferative activity of selected compounds was evaluated using the tumor cell lines HeLa (cervical carcinoma, ATCC CCL-2), A549 (NSCLC, ATCC CCL-185), SKBR-3 (breast carcinoma, ATCC HTB-30), SKOV-3 (ovarian carcinoma, ATCC HTB-77), Cal27 (tongue carcinoma, ATCC CRL-2095), and A-431 (vulva carcinoma, ATCC CRL-2592). For quantification of cellular proliferation/cytotoxicity, the Alamar Blue (Resazurin) cell viability assay was applied.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Western Blot Analysis</h4><div class="NLM_p last">For Western blot analysis, about 4 Ã 10<sup>5</sup> Cal27 cells/well in 6-well cell culture plates were treated with the test compounds for 16 h. Next, cells were stimulated with 100 ng/mL recombinant EGF for 5 min at room temperature before cell lysis. Cells were lysed in lysis buffer (50 mM Tris HCl pH8, 150 mM NaCl, 1v/v NP-40, 0.5% w/v sodium desoxycholate, 0.2% w/v disodium dodecylsulfate (SDS), 0.02% w/v NaN<sub>3</sub>, 1 mM sodium vanadate, 20 mM NaF, 100 Î¼g/mL PMSF, 10 mM sodium pyrophosphate, protease inhibitor mix/Roche and 50U/mL Benzonase) at 4 Â°C. Respective equal amounts of protein were separated by SDS-PAGE before transfer to polyvinylidendifluoride (PVDF) membrane (Biorad art. no. 162â0177) by semidry blotting. The following antibodies were used: monoclonal mouse antibody specific for Î²-actin (clone AC-12, Sigma art. no. A-5441), phosphorylated EGFR (Y1068, Cell Signaling), EGFR (Upstate), acetylated histone H3 (Cell Signaling), and histone H3 (Cell Signaling). As secondary antibodies, goat antirabbit IgG-HRP conjugated (Biorad: 170â6515), goat-antisheep (Santa Cruz) and goat-antimouse IgG-HRP conjugated (Biorad: 170-6516) were used.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Chemical Procedures</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> General</h4><div class="NLM_p last">NMR spectra were recorded with a Bruker Avance 300 MHz spectrometer at 300 K, using TMS as an internal standard. IR spectra (KBr or pure solid) were measured with a Bruker Tensor 27 spectrometer. Melting points were determined with a BÃ¼chi B-545. MS spectra were measured with a Finnigan MAT 95 (EI, 70 eV), or with a Finnigan Thermo Quest TSQ 7000 (ESI) (DCM/MeOH + 10 mmol/L NH<sub>4</sub>Ac), respectively. All reactions were carried out under nitrogen atmosphere. Elemental analyses were performed by the Analytical Laboratory of the University of Regensburg and are in a range of Â±0.4% of the calculated values if not given otherwise, ensuring a purity â¥95%. Chemical names were created using ChemBioDraw Ulta 11.0 software.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Procedures and Analytical Data</h4><div id="sec4_2_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> 3-Chloro-4-(3-fluorobenzyloxy)phenylamine (<b>15</b>)</h5><div class="NLM_p last">Preparation analogous lit.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> as follows: 2-chloro-1-(3-fluorobenzyloxy)-4-nitrobenzene (<b>14</b>) (20.0 g; 70.9 mmol) was dissolved in THF (300 mL), dry sulfided platinum on carbon (Aldrich) (4.00 g) were added and the mixture was stirred under a hydrogen atmosphere (10 atm) overnight. The platinum was filtered off over celite, washed with THF, the solvent removed under reduced pressure and the residue treated with light petrol to afford the title compound as an analytically pure solid. Yield (17.49 g; 98%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ (ppm) 4.98 (s, 2H, exchangeable), 5.04 (s, 2H), 6.54 (dd, 1H, <i>J</i> = 8.8 Hz, <sup>4</sup><i>J</i> = 2.6 Hz), 6.74 (d, 1H, <sup>4</sup><i>J</i> = 2.6 Hz), 6.92 (d, 1H, <i>J</i> = 8.8 Hz), 7.09â7.15 (m, 1H), 7.25â7.30 (m, 2H), 7.37â7.45 (m, 1H).</div></div><div id="sec4_2_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> [3-Chloro-4-(3-fluorobenzyloxy)phenyl]-(6-iodoquinazolin-4-yl)amine (<b>16</b>)<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></h5><div class="NLM_p last">Preparation analogous to lit.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> as follows: To a mixture of 6-iodo-1<i>H</i>-quinazolin-4-one (<b>10</b>) (6.80 g; 25.0 mmol), toluene (5.0 mL), and POCl<sub>3</sub> (27.5 mmol; 2.60 mL), triethylamine (27.5 mmol; 3.81 mL) was added carefully. The mixture was heated to 80 Â°C for 2 h, cooled to room temperature, a solution of 3-chloro-4-(3-fluorobenzyloxy)phenylamine (<b>15</b>) (27.50 mmol; 6.92 g) in 2-butanone (20.0 mL) added, and the mixture stirred at 80 Â°C for another hour. The mixture was cooled to 0 Â°C, and the yellow precipitate was filtered off and added to a NaOH solution (1N; 150 mL) by stirring. After 30 min, the yellow solid was filtered off, washed with water and a small amount of acetone, and dried in vacuo. Yield (8.38 g; 66%) analytical pure sample. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ (ppm) 5.26 (s, 2H), 7.15â7.22 (m, 1H), 7.27 (d, 1H, <i>J</i> = 9.1 Hz), 7.29â7.35 (m, 2H), 7.43â7.51 (m, 1H), 7.56 (d, 1H, <i>J</i> = 8.8 Hz), 7.74 (dd, 1H, <i>J</i> = 9.1 Hz, <sup>4</sup><i>J</i> = 2.5 Hz), 8.02 (d, 1H, <sup>4</sup><i>J</i> = 2.5 Hz), 8.12 (dd; 1H, <i>J</i> = 8.8 Hz, <sup>4</sup><i>J</i> = 1.7 Hz), 8.62 (s, 1H), 8.96 (d, <sup>4</sup><i>J</i> = 1.7 Hz), 9.90 (s, 1H, exchangeable).</div></div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> General Procedure for Suzuki Coupling</h4><div class="NLM_p last">Preparation analogous to Hosoya.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> A mixture of <b>16</b> (5.00 g; 9.88 mmol), the respective arylboronic acid (<b>17a</b>, <b>17b</b>, <b>22b</b> Aldrich; <b>17c</b>, <b>17d</b> Alfa Aesar; <b>22a</b> Rare Chemicals) (13.1 mmol), (PPh<sub>3</sub>)<sub>2</sub>PdCl<sub>2</sub> (0.35 g; 0.5 mmol), DME (30 mL), ethanol (20 mL), and 2 M aqueous Na<sub>2</sub>CO<sub>3</sub> (30 mL) was heated at 60 Â°C for 3 h. After cooling to room temperature, the crude product precipitated as a yellow solid. It was removed by filtration, washed with water, and dried in vacuo overnight. Crystallization from acetone afforded the title compound in sufficient purity for further synthesis. An analytical sample was obtained by column chromatography (SiO<sub>2</sub>; CH<sub>2</sub>Cl<sub>2</sub>/ethyl acetate = 4:1).</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Furane- and Benzene-carbaldehydes (<b>18a</b>, <b>18c</b>)</h4><div id="sec4_2_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> 5-{4-[3-Chloro-4-(3-fluorobenzyloxy)phenylamino]quinazolin-6-yl}furan-2-carbaldehyde (<b>18a</b>)<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></h5><div class="NLM_p last">Yield (3.65 g, 78%); mp 229.8â234.1 Â°C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ (ppm) 5.26 (s, 2H), 7.17 (dt, 1H, <i>J</i> = 2.5 Hz, <i>J</i> = 8.5), 7.26â7.34 (m, 3H), 7.40 (d, 1H, <i>J</i> = 3.6 Hz), 7.43â7.50 (m, 1H), 7.68â7.74 (m, 2H), 7.84 (d, 1H, <i>J</i> = 8.5 Hz), 7.98 (d, 1H, <i>J</i> = 2.5 Hz), 8.28 (dd, 1H, <i>J</i> = 1.1 Hz, <i>J</i> = 8.8 Hz), 8.58 (s, 1H), 8.95 (d, 1H, <i>J</i> = 0.8 Hz), 9.66 (s, 1H), 10.10 (s, 1H, exchangeable). +p ESI <i>m</i>/<i>z</i> (%): 476 [M + H<sup>+</sup>]<sup>+<b>Â·</b></sup> (37); 474 [M + H]<sup>+</sup> (100). âp ESI <i>m</i>/<i>z</i> (%): 474 [M â H<sup>+</sup>]<sup>â</sup> (37), 472 [M â H]<sup>â</sup> (100). IR (KBr): 3399, 1673 cm<sup>â1</sup> .</div></div><div id="sec4_2_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> 3-{4-[3-Chloro-4-(3-fluorobenzyloxy)phenylamino]quinazolin-6-yl}benzaldehyde (<b>18c</b>)</h5><div class="NLM_p last">Yield (2.73 g, 54%) yellow crystals; mp 243.2â247.5 Â°C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ (ppm) 5.25 (s, 2H), 7.18 (dt, 1H, <i>J</i> = 2.2 Hz, <i>J</i> = 8.3 Hz), 7.28 (d, 1H, <i>J</i> = 9.1 Hz), 7.33 (m, 2H), 7.47 (dt, 1H, <i>J</i> = 6.1 Hz, <i>J</i> = 8.0 Hz), 7.74 (dd, 1H, <i>J</i> = 2.2 Hz, <i>J</i> = 6.7 Hz), 7.78 (t, 1H, <i>J</i> = 5.4 Hz), 7.86 (d, 1H, <i>J</i> = 8.7 Hz), 7.97 (td, 1H, <i>J</i> = 1.2 Hz, <i>J</i> = 7.6 Hz), 8.01 (d, 1H, <i>J</i> = 2.6 Hz), 8.21 (m, 2H), 8.38 (t, 1H, <i>J</i> = 1.6 Hz), 8.60 (s, 1H), 8.85 (d, 1H, <i>J</i> = 1.6 Hz), 9.94 (s, 1H, exchangeable), 10.14 (s, 1H). EI-MS (70 eV) <i>m</i>/<i>z</i> (%): 483 (18) [M<sup>+Â·</sup>], 374 (100) [M-C<sub>7</sub>H<sub>6</sub>F<sup>Â·</sup>]<sup>+</sup>. IR (KBr): 3380, 2729, 1696 cm<sup>â1</sup>. Anal. (C<sub>28</sub>H<sub>19</sub>ClFN<sub>3</sub>O<sub>2</sub>Â·<sup>1</sup>/<sub>5</sub>H<sub>2</sub>O): C, H, N.</div></div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Acrylic Acid <i>tert</i>-Butyl Esters (<b>19a</b>â<b>d</b>)</h4><div class="NLM_p">A mixture of the respective aryl-2-carbaldehydes <b>18a</b>â<b>18d</b> (1.0 mmol), (<i>tert</i>-butoxycarbonylmethyl)triphenylphosphonium chloride (0.56 g; 1.02 mmol), NaOH (0.08 g; 2.04 mmol), and NEt<sub>3</sub> (0.3 g; 3.06 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (100 mL) and water (2.04 mL) was stirred at room temperature overnight. The organic layer was separated, subsequently washed with satd NH<sub>4</sub>Cl solution (3 Ã 50 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. The crude product was purified by column chromatography (DCM/EE = 1:1) and precipitated by addition of light petrol.</div><div id="sec4_2_5_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> 3-{5-[4-(3-Chloro-4-(3-fluorobenzyloxy)phenylamino]quinazolin-6-yl}furan-2-yl)acrylic Acid <i>tert</i>-Butyl Ester (<b>19a</b>)</h5><div class="NLM_p last">Yield (0.43 g, 76%) yellow crystals; mp 201.3â201.4 Â°C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ (ppm) 1.50 (s, 9H), 5.28 (s, 2H), 6.50 (d, 1H, <i>J</i><sub>trans</sub> = 15.6 Hz), 7.13 (d, 1H, <i>J</i> = 3.6 Hz), 7.19 (dt, 1H, <i>J</i> = 2.4 Hz, <i>J</i> = 8.6 Hz), 7.28â7.36 (m, 4H), 7.44 (d, 1H, <i>J</i><sub>trans</sub> = 15.6 Hz), 7.45â7.52 (m, 1H), 7.72 (dd, 1H, <i>J</i> = 2.5 Hz, <i>J</i> = 8.8 Hz), 7.82 (d, 1H, <i>J</i> = 8.8 Hz), 7.99 (d, 1H, <i>J</i> = 2.5 Hz), 8.29 (dd, 1H, <i>J</i> = 1.5 Hz, <i>J</i> = 8.6 Hz), 8.57 (s, 1H), 8.87 (d, 1H, <i>J</i> = 1.1 Hz), 9.97 (s, 1H, exchangeable). +p ESI <i>m</i>/<i>z</i> (%): 574 [M + H<sup>+</sup>] (39), 572 [M + H<sup>+</sup>] (100%). âp ESI <i>m</i>/<i>z</i> (%): 572 [M â H<sup>+</sup>]<sup>â</sup> (40), 570 [M â H<sup>+</sup>]<sup>â</sup>. IR (KBr): 2977, 1697 cm<sup>â1</sup>. Anal. (C<sub>32</sub>H<sub>27</sub>ClFN<sub>3</sub>O<sub>4</sub>): C, H, N.</div></div><div id="sec4_2_5_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> 3-{-[4-(3-Chloro-4-(3-fluorobenzyloxy)phenylamino]quinazolin-6-yl)phenyl)acrylic Acid <i>tert</i>-Butyl Ester (<b>19c</b>)</h5><div class="NLM_p last">Yield (2.30 g, 76%) colorless crystals; mp 202.9â203.0 Â°C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ (ppm) 1.51 (s, 9H), 5.27 (s, 2H), 6.73 (d, 1H, <i>J</i> = 16.0 Hz), 7.19 (dt, 1H, <i>J</i> = 2.2 Hz, <i>J</i> = 8.2 Hz), 7.32 (m, 3H), 7.48 (m, 1H), 7.60 (t, 1H, <i>J</i> = 7.7 Hz), 7.69 (d, 1H, <i>J</i> = 16.0 Hz), 7.76 (m, 2H), 7.87 (d, 1H, <i>J</i> = 8.7 Hz), 7.94 (d, 1H, <i>J</i> = 7.9 Hz), 8.03 (d, 1H, <i>J</i> = 2.6 Hz), 8.20 (m, 1H), 8.29 (dd, 1H, <i>J</i> = 1.7 Hz, <i>J</i> = 8.7 Hz), 8.60 (s, 1H), 8.83 (d, 1H, <i>J</i> = 1.5 Hz), 9.90 (s, 1H, exchangeable). EI-MS (70 eV) <i>m</i>/<i>z</i> (%): 581 (18) [M<sup>+Â·</sup>], 236 (100) [M-C<sub>11</sub>H<sub>14</sub>F<sup>Â·</sup>]<sup>+</sup>. IR (KBr): 3379, 2982, 1676 cm<sup>â1</sup>. Anal. (C<sub>34</sub>H<sub>29</sub>ClFN<sub>3</sub>O<sub>3</sub>) C, H, N.</div></div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Synthesis of Acrylic Acids (<b>20a</b>â<b>20d</b>) by Cleavage of the Acrylic Acid <i>tert</i>-Butyl Esters</h4><div class="NLM_p">The respective acrylic acid <i>tert</i>-butyl ester (3.50 mmol) was dissolved in 10 mL TFA. The mixture was stirred at 20 Â°C for 30 min, added to water (50 mL) by stirring, and the yellow precipitate filtered off, washed with water, and dried in vacuo.</div><div id="sec4_2_6_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> 3-{5-[4-(3-Chloro-4-(3-fluorobenzyloxy)phenylamino]quinazolin-6-yl}furan-2-yl)acrylic Acid (<b>20a</b>)</h5><div class="NLM_p last">Yield (0.18 g, 99%) yellow crystals; mp 268.8â268.9 Â°C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ (ppm) 5.27 (s, 2H), 6.53 (d, 1H, <i>J</i><sub>trans</sub> = 15.9 Hz), 7.11 (d, 1H, <i>J</i> = 0 3.6 Hz). 7.18 (dt, 1H, <i>J</i> = 2.0 Hz, <i>J</i> = 8.6 Hz), 7.26â7.35 (m, 4H, aromat), 7.41â7.50 (m, 1H), 7.46 (d, 1H, <i>J</i><sub>trans</sub> = 15.9 Hz), 7.73 (dd, 1H, <i>J</i> = 2.5 Hz, <i>J</i> = 8.9 Hz), 7.82 (d, 1H, <i>J</i> = 8.8 Hz), 8.00 (d, 1H, <i>J</i> = 2.5 Hz), 8.27 (dd, 1H, <i>J</i> = 1.6 Hz, <i>J</i> = 8.8 Hz), 8.57 (s, 1H), 8.86 (d, 1H, <i>J</i> = 1.4 Hz), 9.96 (s, 1H, exchangeable), 12.45 (s, 1H, exchangeable). +p ESI <i>m</i>/<i>z</i> (%): 518 [M + H<sup>+</sup>] (37), 516 [M + H<sup>+</sup>] (100). âp ESI <i>m</i>/<i>z</i> (%): 516 [M â H<sup>+</sup>]<sup>â</sup> (40), 514 [M + H<sup>+</sup>]<sup>+</sup> (100). IR (KBr): 3406, 1673 cm<sup>â1</sup>. Anal. (C<sub>28</sub>H<sub>19</sub>ClFN<sub>3</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_2_6_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> 3-{3-[4-(3-Chloro-4-(3-fluorobenzyloxy)phenylamino]quinazolin-6-yl}-phenyl)acrylic Acid (<b>20c</b>)</h5><div class="NLM_p last">Yield (0.78 g, 99%) orange crystals; mp 275.1â275.2 Â°C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ (ppm) 5.29 (s, 2H), 6.73 (d, 1H, <i>J</i> = 16.0 Hz), 7.19 (dt, 1H, <i>J</i> = 2.2 Hz, <i>J</i> = 8.3 Hz), 7.33 (m, 3H), 7.48 (m, 1H), 7.62 (t, 1H, <i>J</i> = 7.7 Hz), 7.71 (m, 2H), 7.80 (d, 1H, <i>J</i> = 7.8 Hz), 7.92 (m, 2H), 7.96 (d, 1H, <i>J</i> = 2.5 Hz), 8.19 (s, 1H), 8.42 (dd, 1H, <i>J</i> = 1.6 Hz, <i>J</i> = 8.8 Hz), 8.83 (s, 1H), 8.94 (d, 1H, <i>J</i> = 1.2 Hz), 10.88 (s, 1H, exchangeable), 12.58 (s, 1H, exchangeable). ES-MS (DCM/MeOH + 10 mmol/L NH<sub>4</sub>Ac) <i>m</i>/<i>z</i> (%): 526 (100) [M + H<sup>+</sup>]<sup>+</sup>. IR (KBr): 3442, 2934, 1671 cm<sup>â1</sup>. Anal. (C<sub>30</sub>H<sub>21</sub>ClFN<sub>3</sub>O<sub>3</sub>Â·<sup>3</sup>/<sub>4</sub>TFA) C, H, N.</div></div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> General Procedure for Amidation by Use of BOP as Coupling Reagent: Preparation of compounds <b>21a</b>â<b>21d</b>, <b>26a</b>â<b>26b</b> and <b>27a</b>â<b>27b</b></h4><div class="NLM_p">A mixture of the respective carboxylic acid (1.15 mmol), BOP (0.53 g; 1.20 mmol), the respective amine (2-aminophenyl)carbamic acid <i>tert</i>-butyl ester<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> (<b>25</b>) or <i>O</i>-tetrahydropyran-2-yl)hydroxylamine (Aldrich)) (1.15 mmol), and NEt<sub>3</sub> (0.24 g; 2.40 mmol) in DMF (10 mL) was stirred at room temperature for 12 h. The solution was added to water (50 mL) by stirring, the precipitating product filtered off, washed with water, and dried in vacuo. Crystallization from the respective solvent given afforded the pure compound as yellow crystals.</div><div id="sec4_2_7_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> (<i>E</i>)-3-(5-(4-(3-Chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-yl)furan-2-yl)-<i>N</i>-(tetrahydro-2<i>H</i>-pyran-2-yloxy)acrylamide (<b>21a</b>)</h5><div class="NLM_p last">Crystallization from acetone. Yield: (0.55 g, 78%); mp 232.8â232.9 Â°C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ (ppm) 1.54 (s, br., 3H), 1.70 (s, br, 3H), 3.54 (d, br., 1H, <i>J</i> = 11.0 Hz), 3.92â4.02 (m, br, 1H), 4.93 (s, 1H), 5.28 (s, 2H), 6.55 (d, 1H, <i>J</i><sub>trans</sub> = 15.6 Hz), 7.04 (d, 1H, <i>J</i> = 3.3 Hz), 7.16â7.52 (m, 7H), 7.74 (dd, 1H, <i>J</i> = 8.5 Hz, <i>J</i> = 1.4 Hz), 7.84 (d, 1H, <i>J</i> = 8.8 Hz), 8.01 (d, 1H, <i>J</i> = 2.5 Hz), 8.22 (dd, 1H, <i>J</i> = 8.8 Hz, <i>J</i> = 1.4 Hz), 8.58 (s, 1H), 8.86 (s, 1H), 9.98 (s, 1H,exchangeable), 11.30 (s, 1H, exchangeable). +p ESI <i>m</i>/<i>z</i> (%): 617 [M + H<sup>+</sup>] (39), 615 [M + H<sup>+</sup>] (100). âp ESI <i>m</i>/<i>z</i> (%): 615 [M â H<sup>+</sup>]<sup>â</sup> (37), 613 [M â H<sup>+</sup>]<sup>â</sup> (100). IR (KBr): 3295, 2950, 1651 cm<sup>â1</sup>. Anal. (C<sub>33</sub>H<sub>28</sub>ClFN<sub>4</sub>O<sub>5</sub>Â·<sup>1</sup>/<sub>2</sub>H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_2_7_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> (<i>E</i>)-3-(3-(4-(3-Chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-yl)phenyl)-<i>N</i>-(tetrahydro-2<i>H</i>-pyran-2-yloxy)acrylamide (<b>21c</b>)</h5><div class="NLM_p last">Yield (0.24 g, 67%) colorless crystals. Purification by cc (SiO<sub>2</sub>, ethyl acetate, CH<sub>2</sub>Cl<sub>2</sub> 1:1) and crystallization from ethyl acetate. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ (ppm) 1.55 (s, 3H), 1.71 (s, 3H), 3.54 (m, 1H), 3.96 (m, 1H), 4.94 (s, 1H), 5.27 (s, 2H), 6.68 (d, 1H, <i>J</i> = 15.8 Hz), 7.19 (dt, 1H, <i>J</i> = 2.2 Hz, <i>J</i> = 8.2 Hz), 7.32 (m, 3H), 7.48 (m, 1H), 7.64 (m, 3H), 7.76 (dd, 1H, <i>J</i> = 2.5 Hz, <i>J</i> = 8.9 Hz), 7.88 (d, 1H, <i>J</i> = 8.7 Hz), 7.92 (m, 1H), 8.03 (d, 1H, <i>J</i> = 2.5 Hz), 8.07 (s, 1H), 8.25 (dd, 1H, <i>J</i> = 1.7 Hz, <i>J</i> = 8.7 Hz), 8.61 (s, 1H), 8.85 (d, 1H, <i>J</i> = 1.1 Hz), 9.95 (s, 1H, exchangeable), 11.29 (s, 1H, exchangeable). ES-MS (DCM/MeOH + 10 mmol/L NH<sub>4</sub>Ac) <i>m</i>/<i>z</i> (%): 625 (100) [M + H<sup>+</sup>]. IR (KBr): 3444, 2872, 1668 cm<sup>â1</sup>. Anal. (C<sub>35</sub>H<sub>30</sub>ClFN<sub>4</sub>O<sub>4</sub>) C, H, N.</div></div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Synthesis of <i>N</i>-Hydroxyacrylamides (<b>6a</b>â<b>6d</b>, <b>8a</b>, and <b>8b</b> from the Respective (Tetrahydropyran-2-yloxy)amide: Precursors</h4><div class="NLM_p">To a stirred solution of the corresponding (tetrahydropyran-2-yloxy)amide (0.5 mmol) in MeOH (50 mL) was added 1N HCl (50 mL). The mixture was stirred at room temperature overnight. Half of the solvent was removed under reduced pressure, and the precipitating product was filtered off, crystallized from MeOH, and dried in vacuo.</div><div id="sec4_2_8_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> 3-{5-[4-(3-Chloro-4-(3-fluorobenzyloxy)phenylamino]quinazolin-6-yl}furan-2-yl)-<i>N</i>-hydroxy-acrylamide Hydrochloride Monohydrate (<b>6a</b>)</h5><div class="NLM_p last">Yield: (0.20 g, 60%) yellow crystals; mp 190.9â192.0 Â°C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ (ppm) 5.32 (s, 2H), 6.62 (d, 1H, <i>J</i><sub>trans</sub> = 15.6 Hz), 7.01 (d, 1H, <i>J</i> = 3.6 Hz), 7.19 (dt, 1H, <i>J</i> = 2.2 Hz, <i>J</i> = 8.9 Hz), 7.20â7.32 (m, 4H), 7.45â7.53 (m, 2H), 7.72 (dd, 1H, <i>J</i> = 2.5 Hz, <i>J</i> = 8.8 Hz), 7.95 (d, 1H, <i>J</i> = 2.5 Hz), 7.98 (d, 1H, <i>J</i> = 8.8 Hz), 8.40 (d, 1H, <i>J</i> = 0.8 Hz, <i>J</i> = 9.1 Hz), 8.91 (s, 1H), 9.40 (d, 1H, 0.8 Hz), 10.84 (s, 1H, exchangeable), 11,98 (s, 1H, exchangeable). +p ESI <i>m</i>/<i>z</i> (%): 533 [M + H<sup>+</sup>] (38), [M + H<sup>+</sup>] (531). âp ESI <i>m</i>/<i>z</i> (%): 589 [M + Ac<sup>â</sup>]<sup>â</sup> (91), 565 [M + Cl<sup>â</sup>]<sup>â</sup> (51), 592 [M â H<sup>+</sup>]<sup>â</sup> (100). IR (KBr): 3418, 2855, 1660 cm<sup>â1</sup>. Anal. (C<sub>28</sub>H<sub>20</sub>ClFN<sub>4</sub>O<sub>4</sub>Â·H<sub>2</sub>OÂ·HCl) C, H, N, Cl.</div></div><div id="sec4_2_8_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> (<i>E</i>)- 3-{3-[4-(3-Chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-yl)phenyl)-<i>N</i>-hydroxyacrylamide (<b>6c</b>)</h5><div class="NLM_p last">Yield (0.13 g, 88%) yellow crystals. NMR (DMSO-<i>d</i><sub>6</sub>) Î´ (ppm) 5.32 (s, 2H), 6.70 (d, 1H, <i>J</i> = 15.8 Hz), 7.20 (dt, 1H, <i>J</i> = 2.1 Hz, <i>J</i> = 8.3 Hz), 7.35 (m, 3H), 7.49 (dt, 1H, <i>J</i> = 6.1 Hz, <i>J</i> = 8.0 Hz), 7.61 (dd, 2H, <i>J</i> = 7.8 Hz, <i>J</i> = 15.5 Hz), 7.70 (m, 2H), 7.97 (m, 2H), 8.04 (d, 1H, <i>J</i> = 8.7 Hz), 8.15 (s, 1H), 8.51 (dd, 1H, <i>J</i> = 1.1 Hz, <i>J</i> = 8.8 Hz), 8.97 (s, 1H), 9.28 (d, 1H, <i>J</i> = 0.9 Hz, exchangeable), 10.85 (s, 1H, exchangeable), 11.89 (s, 1H, exchangeable). ES-MS (DCM/MeOH + 10 mmol/L NH<sub>4</sub>Ac) <i>m</i>/<i>z</i> (%): 541 (100) [M + H<sup>+</sup>]. IR (KBr): 3385, 2860, 1662 cm<sup>â1</sup>. Anal. (C<sub>30</sub>H<sub>22</sub>ClFN<sub>4</sub>O<sub>3</sub>Â·HClÂ·2H<sub>2</sub>O) C, H, N.</div></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45"><a href="/doi/suppl/10.1021/jm100665z">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42020" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42020" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Full experimental details for synthetically preparations, analytical data, and biological test systems. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm100665z/suppl_file/jm100665z_si_001.pdf">jm100665z_si_001.pdf (129.36 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm100665z" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63225" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63225" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Siavosh Mahboobi</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical Chemistry I, University of Regensburg, D-93040 Regensburg, Germany</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#295a40485f465a41074448414b46464b40694a414c44404c075c4740045b4c4e4c475a4b5c5b4e074d4c097d414644485a076b4c4a424c5b5a6946474a465d4c5a5d074d4c"><span class="__cf_email__" data-cfemail="aeddc7cfd8c1ddc680c3cfc6ccc1c1ccc7eecdc6cbc3c7cb80dbc0c783dccbc9cbc0ddccdbdcc980cacb">[emailÂ protected]</span> <span class="__cf_email__" data-cfemail="82d6eaedefe3f1acc0e7e1e9e7f0f1c2edece1edf6e7f1f6ace6e7">[emailÂ protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Beckers</span> - <span class="hlFld-Affiliation affiliation">Oncotest GmbH, Institute for Experimental Oncology, Am Flughafen 12-14, D-79108 Freiburg, Germany</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5d2e343c2b322e3573303c353f32323f341d3e353830343873283334702f383a38332e3f282f3a7339387d093532303c2e731f383e36382f2e1d32333e3229382e29733938"><span class="__cf_email__" data-cfemail="2d5e444c5b425e4503404c454f42424f446d4e454840444803584344005f484a48435e4f585f4a034948">[emailÂ protected]</span> <span class="__cf_email__" data-cfemail="0d596562606c7e234f686e66687f7e4d62636e6279687e79236968">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andreas Sellmer</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical Chemistry I, University of Regensburg, D-93040 Regensburg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthias Winkler</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical Chemistry I, University of Regensburg, D-93040 Regensburg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emerich Eichhorn</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical Chemistry I, University of Regensburg, D-93040 Regensburg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Herwig Pongratz</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical Chemistry I, University of Regensburg, D-93040 Regensburg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Ciossek</span> - <span class="hlFld-Affiliation affiliation">Nycomed GmbH, Therapeutic Area Oncology, Byk-Gulden Strasse 2, D-78467 Konstanz, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Baer</span> - <span class="hlFld-Affiliation affiliation">Nycomed GmbH, Therapeutic Area Oncology, Byk-Gulden Strasse 2, D-78467 Konstanz, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Maier</span> - <span class="hlFld-Affiliation affiliation">Nycomed GmbH, Therapeutic Area Oncology, Byk-Gulden Strasse 2, D-78467 Konstanz, Germany</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01108" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01108" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank E. Verdin, Gladstone Institute for Virology and Immunology, San Francisco, California, USA, for providing rHDAC1 and rHDAC6 expressing Hek293 cell lines. We also thank colleagues at ALTANAâNycomed Discovery Research, in particular U. Bosch and G. Quintini, for providing rHDAC and kinase protein preparations, and C. Burkhardt, H. Wieland, C. Engesser, and H. Julius for excellent technical assistance.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88851" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88851" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 26 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Lin, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weng, J.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.-S.</span><span> </span><span class="NLM_article-title">Targeting Histone Deacetylase in Cancer Therapy</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">397</span><span class="NLM_x">â</span> <span class="NLM_lpage">413</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm100665z&amp;key=10.1002%2Fmed.20056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm100665z&amp;key=16450343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm100665z&amp;key=1%3ACAS%3A528%3ADC%252BD28XntFaltrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=397-413&issue=4&author=H.-Y.+Linauthor=C.-S.+Chenauthor=S.-P.+Linauthor=J.-R.+Wengauthor=C.-S.+Chen&title=Targeting+Histone+Deacetylase+in+Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting histone deacetylase in cancer therapy</span></div><div class="casAuthors">Lin, Hsiang-Yu; Chen, Chang-Shi; Lin, Shuan-Pei; Weng, Jing-Ru; Chen, Ching-Shih</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">397-413</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Histone deacetylase (HDAC) is recognized as one of the promising targets for cancer treatment as many HDAC inhibitors have entered clin. trials for both solid and liq. tumors.  Nevertheless, the mechanisms underlying the antiproliferative effects of HDAC inhibitors remain elusive.  Although they have been shown to regulate the transcription of a defined set of genes through chromatin remodeling, increasing evidence suggests that modifications of the epigenetic histone code may not be the primary mechanism for HDAC inhibitor-mediated growth inhibition and apoptosis in cancer cells.  While histones still represent a primary target for the physiol. function of HDACs, the antitumor effect of HDAC inhibitors might also be attributed to transcription-independent mechanisms by modulating the acetylation status of a series of nonhistone targets.  Also noteworthy is the effect of HDAC inhibitors on Akt downregulation through the alteration of protein phosphatase 1 (PP1) complex formation.  To provide an overview of the use of HDAC inhibitors in cancer treatment, this review addresses the following subjects: (1) the physiol. relevance of HDAC-mediated acetylation of histone and nonhistone substrates, (2) the chem. biol. of HDACs and development of a novel class of HDAC inhibitors, and (3) the protein acetylation-independent effect of HDAC inhibitors on the activation status of signaling kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsa6h2NkYnN7Vg90H21EOLACvtfcHk0ljDOtthU2zqeA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntFaltrc%253D&md5=4d663196ac8258cd0e079b47761f3128</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fmed.20056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20056%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DH.-Y.%26aulast%3DChen%26aufirst%3DC.-S.%26aulast%3DLin%26aufirst%3DS.-P.%26aulast%3DWeng%26aufirst%3DJ.-R.%26aulast%3DChen%26aufirst%3DC.-S.%26atitle%3DTargeting%2520Histone%2520Deacetylase%2520in%2520Cancer%2520Therapy%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2006%26volume%3D26%26issue%3D4%26spage%3D397%26epage%3D413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Minucci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelicci, P. G.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">38</span><span class="NLM_x">â</span> <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm100665z&amp;key=10.1038%2Fnrc1779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm100665z&amp;key=16397526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm100665z&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1GgsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=38-51&issue=1&author=S.+Minucciauthor=P.+G.+Pelicci&title=Histone+deacetylase+inhibitors+and+the+promise+of+epigenetic+%28and+more%29+treatments+for+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer</span></div><div class="casAuthors">Minucci, Saverio; Pelicci, Pier Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-51</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Histone deacetylases (HDACs) are considered to be among the most promising targets in drug development for cancer therapy, and first-generation histone deacetylase inhibitors (HDACi) are currently being tested in phase I/II clin. trials.  A wide-ranging knowledge of the role of HDACs in tumorigenesis, and of the action of HDACi, has been achieved.  However, several basic aspects are not yet fully understood.  Investigating these aspects in the context of what we now understand about HDACi action both in vitro and in vivo will further improve the design of optimized clin. protocols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxXiACZV1sK7Vg90H21EOLACvtfcHk0ljnoD08BVCFsQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1GgsA%253D%253D&md5=384e1f8d676d61531e46843c060a9380</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrc1779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1779%26sid%3Dliteratum%253Aachs%26aulast%3DMinucci%26aufirst%3DS.%26aulast%3DPelicci%26aufirst%3DP.%2BG.%26atitle%3DHistone%2520deacetylase%2520inhibitors%2520and%2520the%2520promise%2520of%2520epigenetic%2520%2528and%2520more%2529%2520treatments%2520for%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26issue%3D1%26spage%3D38%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Jiahuai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrillo, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span> </span><span class="NLM_article-title">Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents</span> <span class="citation_source-journal">J. Hematol. Onco.l</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm100665z&amp;key=10.1186%2F1756-8722-3-5" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=5&author=T.+Jiahuaiauthor=S.+Cangauthor=Y.+Maauthor=R.+L.+Petrilloauthor=D.+Liu&title=Novel+histone+deacetylase+inhibitors+in+clinical+trials+as+anti-cancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1186%2F1756-8722-3-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-8722-3-5%26sid%3Dliteratum%253Aachs%26aulast%3DJiahuai%26aufirst%3DT.%26aulast%3DCang%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DPetrillo%26aufirst%3DR.%2BL.%26aulast%3DLiu%26aufirst%3DD.%26atitle%3DNovel%2520histone%2520deacetylase%2520inhibitors%2520in%2520clinical%2520trials%2520as%2520anti-cancer%2520agents%26jtitle%3DJ.%2520Hematol.%2520Onco.l%26date%3D2010%26volume%3D3%26spage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Prince, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishton, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, S. J.</span><span> </span><span class="NLM_article-title">Clinical Studies of Histone Deacetylase Inhibitors</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3958</span><span class="NLM_x">â</span> <span class="NLM_lpage">3969</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm100665z&amp;key=10.1158%2F1078-0432.CCR-08-2785" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm100665z&amp;key=19509172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm100665z&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntlOis78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=3958-3969&issue=12&author=H.+M.+Princeauthor=M.+J.+Bishtonauthor=S.+J.+Harrison&title=Clinical+Studies+of+Histone+Deacetylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical Studies of Histone Deacetylase Inhibitors</span></div><div class="casAuthors">Prince, H. Miles; Bishton, Mark J.; Harrison, Simon J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3958-3969</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Over the last 5 years, a plethora of histone deacetylase inhibitors (HDACi) have been evaluated in clin. trials.  These drugs have in common the ability to hyperacetylate both histone and nonhistone targets, resulting in a variety of effects on cancer cells, their microenvironment, and immune responses.  To date, responses with single agent HDACi have been predominantly obsd. in advanced hematol. malignancies including T-cell lymphoma, Hodgkin lymphoma, and myeloid malignancies.  Therefore, in this review we focus upon hematol. malignancies.  Generally HDACi are well tolerated with the most common acute toxicities being fatigue, gastrointestinal, and transient cytopenias.  Of note, few patients have been treated for prolonged periods of time and little is known about long-term toxicities.  The use of the biomarker of histone hyperacetylation has been useful as a guide to target specificity, but generally does not predict for response and the search for more clin. relevant biomarkers must continue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAT5q1xpNusLVg90H21EOLACvtfcHk0ljnoD08BVCFsQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntlOis78%253D&md5=776c9249c30fb91d6083445c545bd932</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-2785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-2785%26sid%3Dliteratum%253Aachs%26aulast%3DPrince%26aufirst%3DH.%2BM.%26aulast%3DBishton%26aufirst%3DM.%2BJ.%26aulast%3DHarrison%26aufirst%3DS.%2BJ.%26atitle%3DClinical%2520Studies%2520of%2520Histone%2520Deacetylase%2520Inhibitors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D15%26issue%3D12%26spage%3D3958%26epage%3D3969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Bots, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, R. W.</span><span> </span><span class="NLM_article-title">Rational Combinations Using HDAC Inhibitors</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3970</span><span class="NLM_x">â</span> <span class="NLM_lpage">3977</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm100665z&amp;key=10.1158%2F1078-0432.CCR-08-2786" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm100665z&amp;key=19509171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm100665z&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntlOis7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=3970-3977&issue=12&author=M.+Botsauthor=R.+W.+Johnstone&title=Rational+Combinations+Using+HDAC+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Combinations Using HDAC Inhibitors</span></div><div class="casAuthors">Bots, Michael; Johnstone, Ricky W.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3970-3977</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  In addn. to well-characterized genetic abnormalities that lead to cancer onset and progression, it is now recognized that alterations to the epigenome may also play a significant role in oncogenesis.  As a result, epigenetic-modulating agents such as histone deacetylase inhibitors (HDACi) have attracted enormous attention as anticancer drugs.  In numerous in vitro and preclin. settings, these compds. have shown their vast potential as single agent anticancer therapies, but unfortunately equiv. responses have not always been obsd. in patients.  Given the pleiotropic effects HDACi have on malignant cells, their true therapeutic potential most likely lies in combination with other anticancer drugs.  In this review we will focus on the anticancer effects of HDACi when combined with other cancer therapeutics with an emphasis on those combinations based on a strong mol. rationale.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhLnwCXjHtPbVg90H21EOLACvtfcHk0ljnoD08BVCFsQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntlOis7w%253D&md5=117c52a204aa45615eb04c8600e51c10</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-2786&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-2786%26sid%3Dliteratum%253Aachs%26aulast%3DBots%26aufirst%3DM.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26atitle%3DRational%2520Combinations%2520Using%2520HDAC%2520Inhibitors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D15%26issue%3D12%26spage%3D3970%26epage%3D3977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Mercurio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minucci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelicci, P. G.</span><span> </span><span class="NLM_article-title">Histone deacetylases and epigenetic therapies of hematological malignancies</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">18</span><span class="NLM_x">â</span> <span class="NLM_lpage">34</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=18-34&issue=1&author=C.+Mercurioauthor=S.+Minucciauthor=P.+G.+Pelicci&title=Histone+deacetylases+and+epigenetic+therapies+of+hematological+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMercurio%26aufirst%3DC.%26aulast%3DMinucci%26aufirst%3DS.%26aulast%3DPelicci%26aufirst%3DP.%2BG.%26atitle%3DHistone%2520deacetylases%2520and%2520epigenetic%2520therapies%2520of%2520hematological%2520malignancies%26jtitle%3DPharm.%2520Res.%26date%3D2010%26volume%3D62%26issue%3D1%26spage%3D18%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Morgan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, C. W.</span><span> </span><span class="NLM_article-title">Molecularly targeted therapies in myelodysplastic syndromes and acute myeloid leukemias</span> <span class="citation_source-journal">Ann. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">139</span><span class="NLM_x">â</span> <span class="NLM_lpage">163</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm100665z&amp;key=10.1007%2Fs00277-005-0051-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm100665z&amp;key=16391911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm100665z&amp;key=1%3ACAS%3A528%3ADC%252BD28XovVeltA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2006&pages=139-163&issue=3&author=M.+A.+Morganauthor=C.+W.+Reuter&title=Molecularly+targeted+therapies+in+myelodysplastic+syndromes+and+acute+myeloid+leukemias"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Molecularly targeted therapies in myelodysplastic syndromes and acute myeloid leukemias</span></div><div class="casAuthors">Morgan, Michael A.; Reuter, Christoph W. M.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Hematology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">139-163</span>CODEN:
                <span class="NLM_cas:coden">ANHEE8</span>;
        ISSN:<span class="NLM_cas:issn">0939-5555</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Although there has been significant progress in acute myeloid leukemia (AML) treatment in younger adults during the last decade, std. induction therapy still fails to induce remission in up to 40% of AML patients.  Addnl., relapses are common in 50-70% of patients who achieve a complete remission, and only 20-30% of patients enjoy long-term disease-free survival.  The natural history of myelodysplastic syndrome (MDS) is variable, with about half of the patients dying from cytopenic complications, and an addnl. 20-30% transforming to AML.  The advanced age of the majority of MDS patients limits the therapeutic strategies often to supportive care.  To address these shortcomings, much effort has been directed toward the development of novel treatment strategies that target the evolution and proliferation of malignant clones.  Presented here is an overview of molecularly targeted therapies currently being tested in AML and MDS patients, with a focus on FMS-like tyrosine kinase 3 inhibitors, farnesyltransferase inhibitors, antiangiogenesis agents, DNA hypomethylation agents, and histone deacetylase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC2IIKBnuoErVg90H21EOLACvtfcHk0lhALCk5x3OkEA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovVeltA%253D%253D&md5=a342517549182dc988ceec4af1de73c1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2Fs00277-005-0051-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00277-005-0051-7%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DM.%2BA.%26aulast%3DReuter%26aufirst%3DC.%2BW.%26atitle%3DMolecularly%2520targeted%2520therapies%2520in%2520myelodysplastic%2520syndromes%2520and%2520acute%2520myeloid%2520leukemias%26jtitle%3DAnn.%2520Hematol.%26date%3D2006%26volume%3D85%26issue%3D3%26spage%3D139%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Johnstone, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Licht, J. D.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitors in cancer therapy: is transcription the primary target?</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">13</span><span class="NLM_x">â</span> <span class="NLM_lpage">18</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=13-18&issue=1&author=R.+W.+Johnstoneauthor=J.+D.+Licht&title=Histone+deacetylase+inhibitors+in+cancer+therapy%3A+is+transcription+the+primary+target%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26aulast%3DLicht%26aufirst%3DJ.%2BD.%26atitle%3DHistone%2520deacetylase%2520inhibitors%2520in%2520cancer%2520therapy%253A%2520is%2520transcription%2520the%2520primary%2520target%253F%26jtitle%3DCancer%2520Cell%26date%3D2003%26volume%3D4%26issue%3D1%26spage%3D13%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Sorbera, L. A.</span><span> </span><span class="NLM_article-title">Epigenetic target as an approach to cancer therapy and chemoprevention</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">335</span><span class="NLM_x">â</span> <span class="NLM_lpage">344</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm100665z&amp;key=10.1358%2Fdof.2006.031.04.985053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm100665z&amp;key=1%3ACAS%3A528%3ADC%252BD28XntVylsbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=335-344&issue=4&author=L.+A.+Sorbera&title=Epigenetic+target+as+an+approach+to+cancer+therapy+and+chemoprevention"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic target as an approach to cancer therapy and chemoprevention</span></div><div class="casAuthors">Sorbera, Lisa A.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">335-344</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Carcinogenesis and tumor progression are controlled by both genetic and epigenetic events.  Unlike genetic aberrations, epigenetic aberrations such as DNA methylation and histone deacetylation evident in cancer cells can usually be reversed to reactivate epigenetically silenced tumor suppressor genes and possibly normalize a malignant cell population.  Thus, researchers have focused on epigenetic events as targets for effective cancer therapy and chemoprevention.  At the 97th American Assocn. for Cancer Research Annual Meeting in Washington, D.C., the preclin. and clin. activity of several histone deacetylase (HDAC) and DNA methyltransferase (DNMT) inhibitors was described, indicating promising anticancer effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCi1AxorTZnrVg90H21EOLACvtfcHk0lhALCk5x3OkEA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntVylsbc%253D&md5=32b4c23f6b9735485eb3fe411e919a96</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1358%2Fdof.2006.031.04.985053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2006.031.04.985053%26sid%3Dliteratum%253Aachs%26aulast%3DSorbera%26aufirst%3DL.%2BA.%26atitle%3DEpigenetic%2520target%2520as%2520an%2520approach%2520to%2520cancer%2520therapy%2520and%2520chemoprevention%26jtitle%3DDrugs%2520Future%26date%3D2006%26volume%3D31%26issue%3D4%26spage%3D335%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Ma, B. B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poon, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lui, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, A. T. C.</span><span> </span><span class="NLM_article-title">The preclinical activity of the histone deacetylase inhibitor PXD101 (belinostat) in hepatocellular carcinoma cell lines</span> <span class="citation_source-journal">Investigational New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">107</span><span class="NLM_x">â</span> <span class="NLM_lpage">114</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=107-114&issue=2&author=B.+B.+Y.+Maauthor=F.+Sungauthor=Q.+Taoauthor=F.+F.+Poonauthor=V.+W.+Luiauthor=W.+Yeoauthor=S.+L.+Chanauthor=A.+T.+C.+Chan&title=The+preclinical+activity+of+the+histone+deacetylase+inhibitor+PXD101+%28belinostat%29+in+hepatocellular+carcinoma+cell+lines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DB.%2BB.%2BY.%26aulast%3DSung%26aufirst%3DF.%26aulast%3DTao%26aufirst%3DQ.%26aulast%3DPoon%26aufirst%3DF.%2BF.%26aulast%3DLui%26aufirst%3DV.%2BW.%26aulast%3DYeo%26aufirst%3DW.%26aulast%3DChan%26aufirst%3DS.%2BL.%26aulast%3DChan%26aufirst%3DA.%2BT.%2BC.%26atitle%3DThe%2520preclinical%2520activity%2520of%2520the%2520histone%2520deacetylase%2520inhibitor%2520PXD101%2520%2528belinostat%2529%2520in%2520hepatocellular%2520carcinoma%2520cell%2520lines%26jtitle%3DInvestigational%2520New%2520Drugs%26date%3D2010%26volume%3D28%26issue%3D2%26spage%3D107%26epage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Buggy, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bass, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalrymple, S. A.</span><span> </span><span class="NLM_article-title">CRA-024781: a novel synthetic inhibitor of histone deacetylase enzymes with antitumor activity in vitro and in vivo</span> <span class="citation_source-journal">Mol Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1309</span><span class="NLM_x">â</span> <span class="NLM_lpage">1317</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm100665z&amp;key=10.1158%2F1535-7163.MCT-05-0442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm100665z&amp;key=16731764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm100665z&amp;key=1%3ACAS%3A528%3ADC%252BD28XltVWms7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=1309-1317&issue=5&author=J.+J.+Buggyauthor=Z.+A.+Caoauthor=K.+E.+Bassauthor=E.+Vernerauthor=S.+Balasubramanianauthor=L.+Liuauthor=B.+E.+Schultzauthor=P.+R.+Youngauthor=S.+A.+Dalrymple&title=CRA-024781%3A+a+novel+synthetic+inhibitor+of+histone+deacetylase+enzymes+with+antitumor+activity+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">CRA-024781: a novel synthetic inhibitor of histone deacetylase enzymes with antitumor activity in vitro and in vivo</span></div><div class="casAuthors">Buggy, Joseph J.; Cao, Z. Alexander; Bass, Kathryn E.; Verner, Erik; Balasubramanian, Sriram; Liu, Liang; Schultz, Brian E.; Young, Peter R.; Dalrymple, Stacie A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1309-1317</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">CRA-024781 is a novel, broad spectrum hydroxamic acid-based inhibitor of histone deacetylase (HDAC) that shows antitumor activity in vitro and in vivo preclinically and is under evaluation in phase I clin. trials for cancer.  CRA-024781 inhibited pure recombinant HDAC1 with a Ki of 0.007 Î¼mol/L, and also inhibited the other HDAC isoenzymes HDAC2, HDAC3/SMRT, HDAC6, HDAC8, and HDAC10 in the nanomolar range.  Treatment of cultured tumor cell lines grown in vitro with CRA-024781 resulted in the accumulation of acetylated histone and acetylated tubulin, resulting in an inhibition of tumor cell growth and the induction of apoptosis.  CRA-024781 parenterally administered to mice harboring HCT116 or DLD-1 colon tumor xenografts resulted in a statistically significant redn. in tumor growth at doses that were well tolerated as measured by body wt.  Inhibition of tumor growth was accompanied by an increase in the acetylation of Î±-tubulin in peripheral blood mononuclear cells, and an alteration in the expression of many genes in the tumors, including several involved in apoptosis and cell growth.  These results reveal CRA-024781 to be a novel HDAC inhibitor with potent antitumor activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8uJX28obQWrVg90H21EOLACvtfcHk0lhXca92X1gEXA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltVWms7Y%253D&md5=fa761c94dd4f3a031493476dd75af602</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-05-0442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-05-0442%26sid%3Dliteratum%253Aachs%26aulast%3DBuggy%26aufirst%3DJ.%2BJ.%26aulast%3DCao%26aufirst%3DZ.%2BA.%26aulast%3DBass%26aufirst%3DK.%2BE.%26aulast%3DVerner%26aufirst%3DE.%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DSchultz%26aufirst%3DB.%2BE.%26aulast%3DYoung%26aufirst%3DP.%2BR.%26aulast%3DDalrymple%26aufirst%3DS.%2BA.%26atitle%3DCRA-024781%253A%2520a%2520novel%2520synthetic%2520inhibitor%2520of%2520histone%2520deacetylase%2520enzymes%2520with%2520antitumor%2520activity%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DMol%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26issue%3D5%26spage%3D1309%26epage%3D1317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Atadja, P. W.</span><span> </span><span class="NLM_article-title">Use of HDAC inhibitors for the treatment of acute myeloid leukemia and/or myelodysplastic syndrome</span>. PCT Int. Appl.<span class="NLM_x"> (</span><span class="NLM_year">2010</span><span class="NLM_x">) </span>WO 2010009285 A1.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=P.+W.+Atadja&title=Use+of+HDAC+inhibitors+for+the+treatment+of+acute+myeloid+leukemia+and%2For+myelodysplastic+syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAtadja%26aufirst%3DP.%2BW.%26atitle%3DUse%2520of%2520HDAC%2520inhibitors%2520for%2520the%2520treatment%2520of%2520acute%2520myeloid%2520leukemia%2520and%252For%2520myelodysplastic%2520syndrome%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Geyer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forster, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindquist, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romieu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pienkowski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagiello-Gruszfeld, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skarlos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliva, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, D.</span><span> </span><span class="NLM_article-title">Lapatinib plus capecitabine for HER2-positive advanced breast cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">2733</span><span class="NLM_x">â</span> <span class="NLM_lpage">2743</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm100665z&amp;key=10.1056%2FNEJMoa064320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm100665z&amp;key=17192538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm100665z&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhslSqsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=2733-2743&issue=26&author=C.+Geyerauthor=J.+Forsterauthor=D.+Lindquistauthor=S.+Chanauthor=C.+Romieuauthor=T.+Pienkowskiauthor=A.+Jagiello-Gruszfeldauthor=J.+Crownauthor=A.+Chanauthor=B.+Kaufmanauthor=D.+Skarlosauthor=M.+Camponeauthor=N.+Davidsonauthor=M.+Bergerauthor=C.+Olivaauthor=S.+Rubinauthor=S.+Steinauthor=D.+Cameron&title=Lapatinib+plus+capecitabine+for+HER2-positive+advanced+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Lapatinib plus capecitabine for HER2-positive advanced breast cancer</span></div><div class="casAuthors">Geyer, Charles E.; Forster, John; Lindquist, Deborah; Chan, Stephen; Romieu, C. Gilles; Pienkowski, Tadeusz; Jagiello-Gruszfeld, Agnieszka; Crown, John; Chan, Arlene; Kaufman, Bella; Skarlos, Dimosthenis; Campone, Mario; Davidson, Neville; Berger, Mark; Oliva, Cristina; Rubin, Stephen D.; Stein, Steven; Cameron, David</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2733-2743</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Lapatinib, a tyrosine kinase inhibitor of human epidermal growth factor receptor type 2 (HER2, also referred to as HER2/neu) and epidermal growth factor receptor (EGFR), is active in combination with capecitabine in women with HER2-pos. metastatic breast cancer that has progressed after trastuzumab-based therapy.  In this trial, we compared lapatinib plus capecitabine with capecitabine alone in such patients.  Women with HER2-pos., locally advanced or metastatic breast cancer that had progressed after treatment with regimens that included an anthracycline, a taxane, and trastuzumab were randomly assigned to receive either combination therapy (lapatinib at a dose of 1250 mg per day continuously plus capecitabine at a dose of 2000 mg per square meter of body-surface area on days 1 through 14 of a 21-day cycle) or monotherapy (capecitabine alone at a dose of 2500 mg per square meter on days 1 through 14 of a 21-day cycle).  The primary end point was time to progression, based on an evaluation by independent reviewers under blinded conditions.  The interim anal. of time to progression met specified criteria for early reporting on the basis of superiority in the combination-therapy group.  The hazard ratio for the independently assessed time to progression was 0.49 (95% confidence interval, 0.34 to 0.71; P < 0.001), with 49 events in the combination-therapy group and 72 events in the monotherapy group.  The median time to progression was 8.4 mo in the combination-therapy group as compared with 4.4 mo in the monotherapy group.  This improvement was achieved without an increase in serious toxic effects or symptomatic cardiac events.  Lapatinib plus capecitabine is superior to capecitabine alone in women with HER2-pos. advanced breast cancer that has progressed after treatment with regimens that included an anthracycline, a taxane, and trastuzumab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxyRt3cMvZIbVg90H21EOLACvtfcHk0lhXca92X1gEXA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhslSqsA%253D%253D&md5=be0104abe2ca297bdfdd30717de84d8a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa064320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa064320%26sid%3Dliteratum%253Aachs%26aulast%3DGeyer%26aufirst%3DC.%26aulast%3DForster%26aufirst%3DJ.%26aulast%3DLindquist%26aufirst%3DD.%26aulast%3DChan%26aufirst%3DS.%26aulast%3DRomieu%26aufirst%3DC.%26aulast%3DPienkowski%26aufirst%3DT.%26aulast%3DJagiello-Gruszfeld%26aufirst%3DA.%26aulast%3DCrown%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DA.%26aulast%3DKaufman%26aufirst%3DB.%26aulast%3DSkarlos%26aufirst%3DD.%26aulast%3DCampone%26aufirst%3DM.%26aulast%3DDavidson%26aufirst%3DN.%26aulast%3DBerger%26aufirst%3DM.%26aulast%3DOliva%26aufirst%3DC.%26aulast%3DRubin%26aufirst%3DS.%26aulast%3DStein%26aufirst%3DS.%26aulast%3DCameron%26aufirst%3DD.%26atitle%3DLapatinib%2520plus%2520capecitabine%2520for%2520HER2-positive%2520advanced%2520breast%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D355%26issue%3D26%26spage%3D2733%26epage%3D2743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Nishino, S.; Hirotsu, K.; Shima, H.; Harada, T.; Oda, H.; Takahashi, T.; Suzuki, S.</span><span> </span><span class="NLM_article-title">Process for producing 3,4-dihydroquinazolin-4-one derivatives</span>. PCT Int. Appl. WO2003064399 A1,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=S.+Nishino&author=K.+Hirotsu&author=H.+Shima&author=T.+Harada&author=H.+Oda&author=T.+Takahashi&author=S.+Suzuki&title=Process+for+producing+3%2C4-dihydroquinazolin-4-one+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNishino%26aufirst%3DS.%26atitle%3DProcess%2520for%2520producing%25203%252C4-dihydroquinazolin-4-one%2520derivatives%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Nishino, S.; Hirotsu, K.; Shima, H.; Harada, T.; Oda, H.</span><span> </span><span class="NLM_article-title">Process for producing 4-aminoquinazoline compound by chlorination of quinazolin-4-one or its derivative and amination</span>. PCT Int. Appl. WO 2003066602,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=S.+Nishino&author=K.+Hirotsu&author=H.+Shima&author=T.+Harada&author=H.+Oda&title=Process+for+producing+4-aminoquinazoline+compound+by+chlorination+of+quinazolin-4-one+or+its+derivative+and+amination"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNishino%26aufirst%3DS.%26atitle%3DProcess%2520for%2520producing%25204-aminoquinazoline%2520compound%2520by%2520chlorination%2520of%2520quinazolin-4-one%2520or%2520its%2520derivative%2520and%2520amination%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Wallace, E.; Topolov, G.; Zhao, Q.; Lyssikatos, J. P.</span><span> </span><span class="NLM_article-title">Preparation of cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors</span>. US 2005101617,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=E.+Wallace&author=G.+Topolov&author=Q.+Zhao&author=J.+P.+Lyssikatos&title=Preparation+of+cyanoguanidines+and+cyanoamidines+as+ErbB2+and+EGFR+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWallace%26aufirst%3DE.%26atitle%3DPreparation%2520of%2520cyanoguanidines%2520and%2520cyanoamidines%2520as%2520ErbB2%2520and%2520EGFR%2520inhibitors%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Hosoya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikemoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiramatsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span> </span><span class="NLM_article-title">Danthrone Analogues Revisted: General Synthesis and Specific Functions Capable of Discriminating Two Kinds of Ca<sup>2+</sup> Release from Sarcoplasmic Rerticulum of Mouse Skeletal Muscle</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">663</span><span class="NLM_x">â</span> <span class="NLM_lpage">673</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=663-673&author=T.+Hosoyaauthor=H.+Aoyamaauthor=T.+Ikemotoauthor=Y.+Kiharaauthor=T.+Hiramatsuauthor=M.+Endoauthor=M.+Suzuki&title=Danthrone+Analogues+Revisted%3A+General+Synthesis+and+Specific+Functions+Capable+of+Discriminating+Two+Kinds+of+Ca2%2B+Release+from+Sarcoplasmic+Rerticulum+of+Mouse+Skeletal+Muscle"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DAoyama%26aufirst%3DH.%26aulast%3DIkemoto%26aufirst%3DT.%26aulast%3DKihara%26aufirst%3DY.%26aulast%3DHiramatsu%26aufirst%3DT.%26aulast%3DEndo%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DM.%26atitle%3DDanthrone%2520Analogues%2520Revisted%253A%2520General%2520Synthesis%2520and%2520Specific%2520Functions%2520Capable%2520of%2520Discriminating%2520Two%2520Kinds%2520of%2520Ca2%252B%2520Release%2520from%2520Sarcoplasmic%2520Rerticulum%2520of%2520Mouse%2520Skeletal%2520Muscle%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D663%26epage%3D673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ying, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hruby, V. J.</span><span> </span><span class="NLM_article-title">Stereoselective Synthesis of Novel Dipeptide Î²-Turn Mimetics Targeting Melanocortin Peptide Receptors</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">3115</span><span class="NLM_x">â</span> <span class="NLM_lpage">3118</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol0351347" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=3115-3118&issue=17&author=J.+Zhangauthor=C.+Xiongauthor=J.+Yingauthor=W.+Wangauthor=V.+J.+Hruby&title=Stereoselective+Synthesis+of+Novel+Dipeptide+%CE%B2-Turn+Mimetics+Targeting+Melanocortin+Peptide+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fol0351347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0351347%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DXiong%26aufirst%3DC.%26aulast%3DYing%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DStereoselective%2520Synthesis%2520of%2520Novel%2520Dipeptide%2520%25CE%25B2-Turn%2520Mimetics%2520Targeting%2520Melanocortin%2520Peptide%2520Receptors%26jtitle%3DOrg.%2520Lett.%26date%3D2003%26volume%3D5%26issue%3D17%26spage%3D3115%26epage%3D3118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Castro, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dormoy, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selve, C.</span><span> </span><span class="NLM_article-title">Peptide coupling reagents. IV. N-[Oxytris(dimethylamino)phosphonium]benzotriazole hexafluorophosphate</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1219</span><span class="NLM_x">â</span> <span class="NLM_lpage">1222</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1975&pages=1219-1222&author=B.+Castroauthor=J.+R.+Dormoyauthor=G.+Evinauthor=C.+Selve&title=Peptide+coupling+reagents.+IV.+N-%5BOxytris%28dimethylamino%29phosphonium%5Dbenzotriazole+hexafluorophosphate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCastro%26aufirst%3DB.%26aulast%3DDormoy%26aufirst%3DJ.%2BR.%26aulast%3DEvin%26aufirst%3DG.%26aulast%3DSelve%26aufirst%3DC.%26atitle%3DPeptide%2520coupling%2520reagents.%2520IV.%2520N-%255BOxytris%2528dimethylamino%2529phosphonium%255Dbenzotriazole%2520hexafluorophosphate%26jtitle%3DTetrahedron%2520Lett.%26date%3D1975%26volume%3D14%26spage%3D1219%26epage%3D1222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Petasis, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, Z. D.</span><span> </span><span class="NLM_article-title">Synthesis of piperazinones and benzopiperazinones from 1,2-diamines and organoboronic acids</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">9607</span><span class="NLM_x">â</span> <span class="NLM_lpage">9611</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2000&pages=9607-9611&author=N.+A.+Petasisauthor=Z.+D.+Patel&title=Synthesis+of+piperazinones+and+benzopiperazinones+from+1%2C2-diamines+and+organoboronic+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetasis%26aufirst%3DN.%2BA.%26aulast%3DPatel%26aufirst%3DZ.%2BD.%26atitle%3DSynthesis%2520of%2520piperazinones%2520and%2520benzopiperazinones%2520from%25201%252C2-diamines%2520and%2520organoboronic%2520acids%26jtitle%3DTetrahedron%2520Lett.%26date%3D2000%26volume%3D41%26spage%3D9607%26epage%3D9611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Mahboobi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellmer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eichhorn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pongratz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciossek, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">T., M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckers, T.</span><span> </span><span class="NLM_article-title">Novel designed chimeric HDAC- and tyrosine kinase inhibitors: A series of Imatinib hybrides as potent inhibitors of wild-type and mutant BCR-ABL, PDGF-RÎ² and histone deacetylases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2265</span><span class="NLM_x">â</span> <span class="NLM_lpage">2279</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800988r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2265-2279&issue=8&author=S.+Mahboobiauthor=A.+Sellmerauthor=M.+Winklerauthor=E.+Eichhornauthor=H.+Pongratzauthor=T.+Ciossekauthor=T.+Baerauthor=M.+T.author=T.+Beckers&title=Novel+designed+chimeric+HDAC-+and+tyrosine+kinase+inhibitors%3A+A+series+of+Imatinib+hybrides+as+potent+inhibitors+of+wild-type+and+mutant+BCR-ABL%2C+PDGF-R%CE%B2+and+histone+deacetylases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm800988r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800988r%26sid%3Dliteratum%253Aachs%26aulast%3DMahboobi%26aufirst%3DS.%26aulast%3DSellmer%26aufirst%3DA.%26aulast%3DWinkler%26aufirst%3DM.%26aulast%3DEichhorn%26aufirst%3DE.%26aulast%3DPongratz%26aufirst%3DH.%26aulast%3DCiossek%26aufirst%3DT.%26aulast%3DBaer%26aufirst%3DT.%26aulast%3DT.%26aufirst%3DM.%26aulast%3DBeckers%26aufirst%3DT.%26atitle%3DNovel%2520designed%2520chimeric%2520HDAC-%2520and%2520tyrosine%2520kinase%2520inhibitors%253A%2520A%2520series%2520of%2520Imatinib%2520hybrides%2520as%2520potent%2520inhibitors%2520of%2520wild-type%2520and%2520mutant%2520BCR-ABL%252C%2520PDGF-R%25CE%25B2%2520and%2520histone%2520deacetylases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D8%26spage%3D2265%26epage%3D2279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Beckers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkhardt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieland, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gimmnich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciossek, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, K.</span><span> </span><span class="NLM_article-title">Distinct pharmacological properties of 2nd generation HDAC inhibitors with the benzamide or hydroxamate head group</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">1138</span><span class="NLM_x">â</span> <span class="NLM_lpage">1148</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm100665z&amp;key=10.1002%2Fijc.22751" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm100665z&amp;key=17455259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm100665z&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFGhu7nN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2007&pages=1138-1148&author=T.+Beckersauthor=C.+Burkhardtauthor=H.+Wielandauthor=P.+Gimmnichauthor=T.+Ciossekauthor=T.+Maierauthor=K.+Sanders&title=Distinct+pharmacological+properties+of+2nd+generation+HDAC+inhibitors+with+the+benzamide+or+hydroxamate+head+group"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct pharmacological properties of second generation HDAC inhibitors with the benzamide or hydroxamate head group</span></div><div class="casAuthors">Beckers, Thomas; Burkhardt, Carmen; Wieland, Heike; Gimmnich, Petra; Ciossek, Thomas; Maier, Thomas; Sanders, Karl</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1138-1148</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Advanced second generation inhibitors of histone deacetylases (HDAC) are currently used in clin. development.  This study aimed at comparing the pharmacol. properties of selected second generation HDAC inhibitors with the hydroxamate and benzamide head group, namely SAHA, LAQ824/LBH589, CI994, MS275 and MGCD0103.  In biochem. assays using recombinant HDAC1, 3, 6 and 8 isoenzymes, SAHA and LAQ824/LBH589 behave as quite unselective HDAC inhibitors.  In contrast, the benzamides CI994, MS275 and MGCD0103 are more selective, potent inhibitors of at least HDAC1 and HDAC3.  All HDAC inhibitors induce histone H3 hyperacetylation, correlating with inhibition of proliferation, induction of cell differentiation and apoptosis.  A broad cytotoxicity is seen across cell lines from different tumor entities with LAQ824/LBH589 being the most potent agents.  The apoptosis inducing activity is evident in arrested and proliferating RKO colon cancer cells with inducible, heterologous p21waf1 expression, indicative for a cell-cycle independent mode-of-action.  Differentiation of MDA-MB468 breast cancer cells is induced by benzamide and hydroxamate analogs.  The reversibility of drug action was evaluated by pulse treatment of A549 lung cancer cells.  Whereas paclitaxel induced irreversible cell cycle alterations already after 6 h treatment, HDAC inhibitor action was retarded and irreversible after >16 h treatment.  Interestingly, pulse treatment was equally effective as continous treatment.  Finally, the efficacy of LAQ824, SAHA and MS275 in A549 nude mice xenografts was comparable to that of paclitaxel at well tolerated doses.  We conclude that despite a different HDAC isoenzyme inhibition profile, hydroxamate and benzamide analogs as studied display similar cellular profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiDHz24Jk1RLVg90H21EOLACvtfcHk0liT9aXc2tpaJw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFGhu7nN&md5=b022385076ee75290c2b6f8d3cdf4bbe</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fijc.22751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.22751%26sid%3Dliteratum%253Aachs%26aulast%3DBeckers%26aufirst%3DT.%26aulast%3DBurkhardt%26aufirst%3DC.%26aulast%3DWieland%26aufirst%3DH.%26aulast%3DGimmnich%26aufirst%3DP.%26aulast%3DCiossek%26aufirst%3DT.%26aulast%3DMaier%26aufirst%3DT.%26aulast%3DSanders%26aufirst%3DK.%26atitle%3DDistinct%2520pharmacological%2520properties%2520of%25202nd%2520generation%2520HDAC%2520inhibitors%2520with%2520the%2520benzamide%2520or%2520hydroxamate%2520head%2520group%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2007%26volume%3D121%26spage%3D1138%26epage%3D1148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Wegener, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirsching, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riester, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwienhorst, A.</span><span> </span><span class="NLM_article-title">A fluorogenic histone deacetylase assay well suited for high-throughput activity screening</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">61</span><span class="NLM_x">â</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm100665z&amp;key=10.1016%2FS1074-5521%2802%2900305-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm100665z&amp;key=12573699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm100665z&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps1Skuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=61-68&issue=1&author=D.+Wegenerauthor=F.+Wirschingauthor=D.+Riesterauthor=A.+Schwienhorst&title=A+fluorogenic+histone+deacetylase+assay+well+suited+for+high-throughput+activity+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A Fluorogenic Histone Deacetylase Assay Well Suited for High-Throughput Activity Screening</span></div><div class="casAuthors">Wegener, Dennis; Wirsching, Frank; Riester, Daniel; Schwienhorst, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-68</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) are important enzymes for the transcriptional regulation of gene expression in eukaryotic cells.  Recent findings suggest that HDACs could be key targets for chemotherapeutic intervention in malignant diseases.  A convenient and sensitive fluorogenic assay for HDAC activity would therefore expedite studies of HDAC in transcriptional regulation and in vitro screening for drug discovery.  In this study, novel fluorogenic substrates of HDACs were synthesized with an Îµ-acetylated lysyl moiety and an adjacent MCA moiety at the C terminus of the peptide chain.  Upon deacetylation of the acetylated lysyl moiety, mols. became substrates for trypsin, which released highly fluorescent AMC mols. in a subsequent step of the assay.  The fluorescence increased in direct proportion to the amt. of deacetylated substrate mols., i.e., HDAC activity.  The nonisotopic, homogeneous assay is well suited for high-throughput HDAC inhibitor screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5ogyqEBSC3bVg90H21EOLACvtfcHk0lgdjjTRuLC4Ng"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps1Skuw%253D%253D&md5=eea350d8066f6ebd773ba50cc0211fdc</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2802%2900305-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252802%252900305-8%26sid%3Dliteratum%253Aachs%26aulast%3DWegener%26aufirst%3DD.%26aulast%3DWirsching%26aufirst%3DF.%26aulast%3DRiester%26aufirst%3DD.%26aulast%3DSchwienhorst%26aufirst%3DA.%26atitle%3DA%2520fluorogenic%2520histone%2520deacetylase%2520assay%2520well%2520suited%2520for%2520high-throughput%2520activity%2520screening%26jtitle%3DChem.%2520Biol.%26date%3D2003%26volume%3D10%26issue%3D1%26spage%3D61%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Braunger, J.; Zoche, M.; Schmidt; Wiesbacher, M.; Burkhardt, C.; Gekeler, V.; Beckers, T.</span><i>AACR Annual Conference</i><span class="NLM_x"> </span><span class="NLM_year">2003</span><span class="NLM_x">, </span>Abstract 4556.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Braunger%2C+J.%3B+Zoche%2C+M.%3B+Schmidt%3B+Wiesbacher%2C+M.%3B+Burkhardt%2C+C.%3B+Gekeler%2C+V.%3B+Beckers%2C+T.AACR+Annual+Conference+2003%2C+Abstract+4556."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DBraunger%26aufirst%3DJ.%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">OâBrian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pognan, F.</span><span> </span><span class="NLM_article-title">Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell toxicity</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">5421</span><span class="NLM_x">â</span> <span class="NLM_lpage">5426</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm100665z&amp;key=10.1046%2Fj.1432-1327.2000.01606.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm100665z&amp;key=10951200" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=2000&pages=5421-5426&issue=17&author=J.+O%E2%80%99Brianauthor=I.+Wilsonauthor=T.+Ortonauthor=F.+Pognan&title=Investigation+of+the+Alamar+Blue+%28resazurin%29+fluorescent+dye+for+the+assessment+of+mammalian+cell+toxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.2000.01606.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.2000.01606.x%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Brian%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DI.%26aulast%3DOrton%26aufirst%3DT.%26aulast%3DPognan%26aufirst%3DF.%26atitle%3DInvestigation%2520of%2520the%2520Alamar%2520Blue%2520%2528resazurin%2529%2520fluorescent%2520dye%2520for%2520the%2520assessment%2520of%2520mammalian%2520cell%2520toxicity%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2000%26volume%3D267%26issue%3D17%26spage%3D5421%26epage%3D5426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Roschangar, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooley, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, R. T.</span><span> </span><span class="NLM_article-title">Use of lithium N,O-dimethylhydroxylamide as an efficient in situ protecting agent for aromatic aldehydes</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1657</span><span class="NLM_x">â</span> <span class="NLM_lpage">1666</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=1657-1666&issue=9&author=F.+Roschangarauthor=J.+C.+Brownauthor=B.+E.+Cooleyauthor=M.+J.+Sharpauthor=R.+T.+Matsuoka&title=Use+of+lithium+N%2CO-dimethylhydroxylamide+as+an+efficient+in+situ+protecting+agent+for+aromatic+aldehydes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoschangar%26aufirst%3DF.%26aulast%3DBrown%26aufirst%3DJ.%2BC.%26aulast%3DCooley%26aufirst%3DB.%2BE.%26aulast%3DSharp%26aufirst%3DM.%2BJ.%26aulast%3DMatsuoka%26aufirst%3DR.%2BT.%26atitle%3DUse%2520of%2520lithium%2520N%252CO-dimethylhydroxylamide%2520as%2520an%2520efficient%2520in%2520situ%2520protecting%2520agent%2520for%2520aromatic%2520aldehydes%26jtitle%3DTetrahedron%26date%3D2002%26volume%3D58%26issue%3D9%26spage%3D1657%26epage%3D1666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 65 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Xuewu Liang, Shuai Tang, Xuyi Liu, Yingluo Liu, Qifu Xu, Xiaomin Wang, Abdusaid Saidahmatov, Chunpu Li, Jiang Wang, Yu Zhou, Yingjie Zhang, Meiyu Geng, Min Huang, <span class="NLM_string-name hlFld-ContribAuthor">Hong Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Pyrrolo[2,3-d]pyrimidine-based Derivatives as Potent JAK/HDAC Dual Inhibitors for the Treatment of Refractory Solid Tumors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02111%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BPyrrolo%25255B2%25252C3-d%25255Dpyrimidine-based%252BDerivatives%252Bas%252BPotent%252BJAK%25252FHDAC%252BDual%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BRefractory%252BSolid%252BTumors%26aulast%3DLiang%26aufirst%3DXuewu%26date%3D2021%26date%3D2020%26date%3D07122020%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yepeng Luan, Jerry Li, Jean A. Bernatchez, <span class="NLM_string-name hlFld-ContribAuthor">Rongshi Li</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase and Histone Deacetylase Hybrid Inhibitors for Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (7)
                                     , 3171-3183. <a href="https://doi.org/10.1021/acs.jmedchem.8b00189" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00189</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00189%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DKinase%252Band%252BHistone%252BDeacetylase%252BHybrid%252BInhibitors%252Bfor%252BCancer%252BTherapy%26aulast%3DLuan%26aufirst%3DYepeng%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D05022018%26date%3D16112018%26date%3D12112018%26volume%3D62%26issue%3D7%26spage%3D3171%26epage%3D3183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nanyi  Wang</span>, <span class="hlFld-ContribAuthor ">Lirong  Wang</span>, and <span class="hlFld-ContribAuthor ">Xiang-Qun  Xie</span>  . </span><span class="cited-content_cbyCitation_article-title">ProSelection: A Novel Algorithm to Select Proper Protein Structure Subsets for in Silico Target Identification and Drug Discovery Research. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2017,</strong> <em>57 </em>
                                    (11)
                                     , 2686-2698. <a href="https://doi.org/10.1021/acs.jcim.7b00277" title="DOI URL">https://doi.org/10.1021/acs.jcim.7b00277</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.7b00277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.7b00277%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DProSelection%25253A%252BA%252BNovel%252BAlgorithm%252Bto%252BSelect%252BProper%252BProtein%252BStructure%252BSubsets%252Bfor%252Bin%252BSilico%252BTarget%252BIdentification%252Band%252BDrug%252BDiscovery%252BResearch%26aulast%3DWang%26aufirst%3DNanyi%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D17052017%26date%3D26102017%26date%3D27112017%26date%3D10102017%26volume%3D57%26issue%3D11%26spage%3D2686%26epage%3D2698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kaifan  Zhang</span>, <span class="hlFld-ContribAuthor ">Chi  Yang</span>, <span class="hlFld-ContribAuthor ">Hequan  Yao</span>, and <span class="hlFld-ContribAuthor ">Aijun  Lin</span>  . </span><span class="cited-content_cbyCitation_article-title">[3 + 2] Cycloaddition Reaction of in Situ Formed Azaoxyallyl Cations with Aldehydes: An Approach to Oxazolidin-4-ones. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2016,</strong> <em>18 </em>
                                    (18)
                                     , 4618-4621. <a href="https://doi.org/10.1021/acs.orglett.6b02254" title="DOI URL">https://doi.org/10.1021/acs.orglett.6b02254</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.6b02254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.6b02254%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3D%25255B3%252B%25252B%252B2%25255D%252BCycloaddition%252BReaction%252Bof%252Bin%252BSitu%252BFormed%252BAzaoxyallyl%252BCations%252Bwith%252BAldehydes%25253A%252BAn%252BApproach%252Bto%252BOxazolidin-4-ones%26aulast%3DZhang%26aufirst%3DKaifan%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D30072016%26date%3D29082016%26date%3D16092016%26volume%3D18%26issue%3D18%26spage%3D4618%26epage%3D4621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiang  Wang</span>, <span class="hlFld-ContribAuthor ">MarÃ­a  SÃ¡nchez-RosellÃ³</span>, <span class="hlFld-ContribAuthor ">JosÃ© Luis  AceÃ±a</span>, <span class="hlFld-ContribAuthor ">Carlos  del Pozo</span>, <span class="hlFld-ContribAuthor ">Alexander E.  Sorochinsky</span>, <span class="hlFld-ContribAuthor ">Santos  Fustero</span>, <span class="hlFld-ContribAuthor ">Vadim A.  Soloshonok</span>, and <span class="hlFld-ContribAuthor ">Hong  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001â2011). </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2014,</strong> <em>114 </em>
                                    (4)
                                     , 2432-2506. <a href="https://doi.org/10.1021/cr4002879" title="DOI URL">https://doi.org/10.1021/cr4002879</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr4002879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr4002879%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DFluorine%252Bin%252BPharmaceutical%252BIndustry%25253A%252BFluorine-Containing%252BDrugs%252BIntroduced%252Bto%252Bthe%252BMarket%252Bin%252Bthe%252BLast%252BDecade%252B%2525282001%2525E2%252580%2525932011%252529%26aulast%3DWang%26aufirst%3DJiang%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D27052013%26date%3D03122013%26date%3D26022014%26volume%3D114%26issue%3D4%26spage%3D2432%26epage%3D2506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhongyan  Chen</span>, <span class="hlFld-ContribAuthor ">Jiuxi  Chen</span>, <span class="hlFld-ContribAuthor ">Miaochang  Liu</span>, <span class="hlFld-ContribAuthor ">Jinchang  Ding</span>, <span class="hlFld-ContribAuthor ">Wenxia  Gao</span>, <span class="hlFld-ContribAuthor ">Xiaobo  Huang</span>, and <span class="hlFld-ContribAuthor ">Huayue  Wu</span>  . </span><span class="cited-content_cbyCitation_article-title">Unexpected Copper-Catalyzed Cascade Synthesis of Quinazoline Derivatives. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2013,</strong> <em>78 </em>
                                    (22)
                                     , 11342-11348. <a href="https://doi.org/10.1021/jo401908g" title="DOI URL">https://doi.org/10.1021/jo401908g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo401908g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo401908g%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DUnexpected%252BCopper-Catalyzed%252BCascade%252BSynthesis%252Bof%252BQuinazoline%252BDerivatives%26aulast%3DChen%26aufirst%3DZhongyan%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D28082013%26date%3D30102013%26date%3D15112013%26date%3D17102013%26volume%3D78%26issue%3D22%26spage%3D11342%26epage%3D11348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kristin S.  Ko</span>, <span class="hlFld-ContribAuthor ">Michael E.  Steffey</span>, <span class="hlFld-ContribAuthor ">Kristoffer R.  Brandvold</span>, and <span class="hlFld-ContribAuthor ">Matthew B.  Soellner</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of a Chimeric c-Src Kinase and HDAC Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>4 </em>
                                    (8)
                                     , 779-783. <a href="https://doi.org/10.1021/ml400175d" title="DOI URL">https://doi.org/10.1021/ml400175d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml400175d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml400175d%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDevelopment%252Bof%252Ba%252BChimeric%252Bc-Src%252BKinase%252Band%252BHDAC%252BInhibitor%26aulast%3DKo%26aufirst%3DKristin%2BS.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D10052013%26date%3D03072013%26date%3D11072013%26date%3D08082013%26date%3D03072013%26volume%3D4%26issue%3D8%26spage%3D779%26epage%3D783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gautam  Patel</span>, <span class="hlFld-ContribAuthor ">Caitlin E.  Karver</span>, <span class="hlFld-ContribAuthor ">Ranjan  Behera</span>, <span class="hlFld-ContribAuthor ">Paul J.  Guyett</span>, <span class="hlFld-ContribAuthor ">Catherine  Sullenberger</span>, <span class="hlFld-ContribAuthor ">Peter  Edwards</span>, <span class="hlFld-ContribAuthor ">Norma E.  Roncal</span>, <span class="hlFld-ContribAuthor ">Kojo  Mensa-Wilmot</span>, and <span class="hlFld-ContribAuthor ">Michael P.  Pollastri</span>  . </span><span class="cited-content_cbyCitation_article-title">Kinase Scaffold Repurposing for Neglected Disease Drug Discovery: Discovery of an Efficacious, Lapatanib-Derived Lead Compound for Trypanosomiasis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (10)
                                     , 3820-3832. <a href="https://doi.org/10.1021/jm400349k" title="DOI URL">https://doi.org/10.1021/jm400349k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400349k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400349k%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DKinase%252BScaffold%252BRepurposing%252Bfor%252BNeglected%252BDisease%252BDrug%252BDiscovery%25253A%252BDiscovery%252Bof%252Ban%252BEfficacious%25252C%252BLapatanib-Derived%252BLead%252BCompound%252Bfor%252BTrypanosomiasis%26aulast%3DPatel%26aufirst%3DGautam%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D27112012%26date%3D03052013%26date%3D23052013%26date%3D18042013%26volume%3D56%26issue%3D10%26spage%3D3820%26epage%3D3832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed  Elkamhawy</span>, <span class="hlFld-ContribAuthor ">Sora  Paik</span>, <span class="hlFld-ContribAuthor ">Jong-Hyun  Park</span>, <span class="hlFld-ContribAuthor ">Hyeon  Jeong Kim</span>, <span class="hlFld-ContribAuthor ">Ahmed H.E.  Hassan</span>, <span class="hlFld-ContribAuthor ">Kyeong  Lee</span>, <span class="hlFld-ContribAuthor ">Ki  Duk Park</span>, <span class="hlFld-ContribAuthor ">Eun  Joo Roh</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel and potent safinamide-based derivatives as highly selective hMAO-B inhibitors for treatment of Parkinson's disease (PD): Design, synthesis, in vitro, in vivo and in silico biological studies. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>539 </em>, 105233. <a href="https://doi.org/10.1016/j.bioorg.2021.105233" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105233</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105233%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Band%252Bpotent%252Bsafinamide-based%252Bderivatives%252Bas%252Bhighly%252Bselective%252BhMAO-B%252Binhibitors%252Bfor%252Btreatment%252Bof%252BParkinson%252527s%252Bdisease%252B%252528PD%252529%25253A%252BDesign%25252C%252Bsynthesis%25252C%252Bin%252Bvitro%25252C%252Bin%252Bvivo%252Band%252Bin%252Bsilico%252Bbiological%252Bstudies%26aulast%3DElkamhawy%26aufirst%3DAhmed%26date%3D2021%26volume%3D539%26spage%3D105233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin-Tian  Ma</span>, <span class="hlFld-ContribAuthor ">Li-Sheng  Wang</span>, <span class="hlFld-ContribAuthor ">Zhi  Chai</span>, <span class="hlFld-ContribAuthor ">Xin-Feng  Chen</span>, <span class="hlFld-ContribAuthor ">Bo-Cheng  Tang</span>, <span class="hlFld-ContribAuthor ">Xiang-Long  Chen</span>, <span class="hlFld-ContribAuthor ">Cai  He</span>, <span class="hlFld-ContribAuthor ">Yan-Dong  Wu</span>, <span class="hlFld-ContribAuthor ">An-Xin  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Access to 2-arylquinazolines
              via
              catabolism/reconstruction of amino acids with the insertion of dimethyl sulfoxide. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2021,</strong> <em>57 </em>
                                    (44)
                                     , 5414-5417. <a href="https://doi.org/10.1039/D1CC00623A" title="DOI URL">https://doi.org/10.1039/D1CC00623A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1CC00623A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1CC00623A%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DAccess%252Bto%252B2-arylquinazolines%252Bvia%252Bcatabolism%25252Freconstruction%252Bof%252Bamino%252Bacids%252Bwith%252Bthe%252Binsertion%252Bof%252Bdimethyl%252Bsulfoxide%26aulast%3DMa%26aufirst%3DJin-Tian%26date%3D2021%26date%3D2021%26volume%3D57%26issue%3D44%26spage%3D5414%26epage%3D5417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta  Szumilak</span>, <span class="hlFld-ContribAuthor ">Anna  Wiktorowska-Owczarek</span>, <span class="hlFld-ContribAuthor ">Andrzej  Stanczak</span>. </span><span class="cited-content_cbyCitation_article-title">Hybrid DrugsâA Strategy for Overcoming Anticancer Drug Resistance?. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (9)
                                     , 2601. <a href="https://doi.org/10.3390/molecules26092601" title="DOI URL">https://doi.org/10.3390/molecules26092601</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26092601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26092601%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DHybrid%252BDrugs%2525E2%252580%252594A%252BStrategy%252Bfor%252BOvercoming%252BAnticancer%252BDrug%252BResistance%25253F%26aulast%3DSzumilak%26aufirst%3DMarta%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D9%26spage%3D2601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gargi Nikhil  Vaidya</span>, <span class="hlFld-ContribAuthor ">Pooja  Rana</span>, <span class="hlFld-ContribAuthor ">Ashwini  Venkatesh</span>, <span class="hlFld-ContribAuthor ">Deep Rohan  Chatterjee</span>, <span class="hlFld-ContribAuthor ">Darshan  Contractor</span>, <span class="hlFld-ContribAuthor ">Dinesh Parshuram  Satpute</span>, <span class="hlFld-ContribAuthor ">Mithilesh  Nagpure</span>, <span class="hlFld-ContribAuthor ">Alok  Jain</span>, <span class="hlFld-ContribAuthor ">Dinesh  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Paradigm shift of âclassicalâ HDAC inhibitors to âhybridâ HDAC inhibitors in therapeutic interventions. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>209 </em>, 112844. <a href="https://doi.org/10.1016/j.ejmech.2020.112844" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112844</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112844%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DParadigm%252Bshift%252Bof%252B%2525E2%252580%25259Cclassical%2525E2%252580%25259D%252BHDAC%252Binhibitors%252Bto%252B%2525E2%252580%25259Chybrid%2525E2%252580%25259D%252BHDAC%252Binhibitors%252Bin%252Btherapeutic%252Binterventions%26aulast%3DVaidya%26aufirst%3DGargi%2BNikhil%26date%3D2021%26volume%3D209%26spage%3D112844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amr K.A.  Bass</span>, <span class="hlFld-ContribAuthor ">Mona S.  El-Zoghbi</span>, <span class="hlFld-ContribAuthor ">El-Shimaa M.  Nageeb</span>, <span class="hlFld-ContribAuthor ">Mamdouh F.A.  Mohamed</span>, <span class="hlFld-ContribAuthor ">Mohamed  Badr</span>, <span class="hlFld-ContribAuthor ">Gamal El-Din A.  Abuo-Rahma</span>. </span><span class="cited-content_cbyCitation_article-title">Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>209 </em>, 112904. <a href="https://doi.org/10.1016/j.ejmech.2020.112904" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112904</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112904%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DComprehensive%252Breview%252Bfor%252Banticancer%252Bhybridized%252Bmultitargeting%252BHDAC%252Binhibitors%26aulast%3DBass%26aufirst%3DAmr%2BK.A.%26date%3D2021%26volume%3D209%26spage%3D112904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajkumar Romeshkumar  Singh</span>, <span class="hlFld-ContribAuthor ">Thokchom Prasanta  Singh</span>, <span class="hlFld-ContribAuthor ">Thangjam Linda  Devi</span>, <span class="hlFld-ContribAuthor ">Thokchom Jeeta  Devi</span>, <span class="hlFld-ContribAuthor ">Okram Mukherjee  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2,4-disubstituted quinazolines promoted by deep eutectic solvent. </span><span class="cited-content_cbyCitation_journal-name">Current Research in Green and Sustainable Chemistry</span><span> <strong>2021,</strong> <em>4 </em>, 100130. <a href="https://doi.org/10.1016/j.crgsc.2021.100130" title="DOI URL">https://doi.org/10.1016/j.crgsc.2021.100130</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.crgsc.2021.100130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.crgsc.2021.100130%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Research%2520in%2520Green%2520and%2520Sustainable%2520Chemistry%26atitle%3DSynthesis%252Bof%252B2%25252C4-disubstituted%252Bquinazolines%252Bpromoted%252Bby%252Bdeep%252Beutectic%252Bsolvent%26aulast%3DSingh%26aufirst%3DRajkumar%2BRomeshkumar%26date%3D2021%26volume%3D4%26spage%3D100130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaopeng  Peng</span>, <span class="hlFld-ContribAuthor ">Zhiqiang  Sun</span>, <span class="hlFld-ContribAuthor ">Peihua  Kuang</span>, <span class="hlFld-ContribAuthor ">Jianjun  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress on HDAC inhibitors with dual targeting capabilities for cancer treatment. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>208 </em>, 112831. <a href="https://doi.org/10.1016/j.ejmech.2020.112831" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112831</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112831%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bprogress%252Bon%252BHDAC%252Binhibitors%252Bwith%252Bdual%252Btargeting%252Bcapabilities%252Bfor%252Bcancer%252Btreatment%26aulast%3DPeng%26aufirst%3DXiaopeng%26date%3D2020%26volume%3D208%26spage%3D112831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bernhard  Biersack</span>, <span class="hlFld-ContribAuthor ">Sibel  Polat</span>, <span class="hlFld-ContribAuthor ">Michael  HÃ¶pfner</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer properties of chimeric HDAC and kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Cancer Biology</span><span> <strong>2020,</strong> <em>184 </em><a href="https://doi.org/10.1016/j.semcancer.2020.11.005" title="DOI URL">https://doi.org/10.1016/j.semcancer.2020.11.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.semcancer.2020.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.semcancer.2020.11.005%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Cancer%2520Biology%26atitle%3DAnticancer%252Bproperties%252Bof%252Bchimeric%252BHDAC%252Band%252Bkinase%252Binhibitors%26aulast%3DBiersack%26aufirst%3DBernhard%26date%3D2020%26volume%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Imann  Mosleh</span>, <span class="hlFld-ContribAuthor ">Hamid R.  Shahsavari</span>, <span class="hlFld-ContribAuthor ">Robert  Beitle</span>, <span class="hlFld-ContribAuthor ">M. Hassan  Beyzavi</span>. </span><span class="cited-content_cbyCitation_article-title">Recombinant Peptide Fusion ProteinâTemplated Palladium Nanoparticles for SuzukiâMiyaura and Stille Coupling Reactions. </span><span class="cited-content_cbyCitation_journal-name">ChemCatChem</span><span> <strong>2020,</strong> <em>12 </em>
                                    (11)
                                     , 2942-2946. <a href="https://doi.org/10.1002/cctc.201902099" title="DOI URL">https://doi.org/10.1002/cctc.201902099</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cctc.201902099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcctc.201902099%26sid%3Dliteratum%253Aachs%26jtitle%3DChemCatChem%26atitle%3DRecombinant%252BPeptide%252BFusion%252BProtein%2525E2%252580%252590Templated%252BPalladium%252BNanoparticles%252Bfor%252BSuzuki%2525E2%252580%252590Miyaura%252Band%252BStille%252BCoupling%252BReactions%26aulast%3DMosleh%26aufirst%3DImann%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D11%26spage%3D2942%26epage%3D2946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adileh  Ayati</span>, <span class="hlFld-ContribAuthor ">Setareh  Moghimi</span>, <span class="hlFld-ContribAuthor ">Somayeh  Salarinejad</span>, <span class="hlFld-ContribAuthor ">Maliheh  Safavi</span>, <span class="hlFld-ContribAuthor ">Behjat  Pouramiri</span>, <span class="hlFld-ContribAuthor ">Alireza  Foroumadi</span>. </span><span class="cited-content_cbyCitation_article-title">A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>99 </em>, 103811. <a href="https://doi.org/10.1016/j.bioorg.2020.103811" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103811</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103811%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DA%252Breview%252Bon%252Bprogression%252Bof%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor%252B%252528EGFR%252529%252Binhibitors%252Bas%252Ban%252Befficient%252Bapproach%252Bin%252Bcancer%252Btargeted%252Btherapy%26aulast%3DAyati%26aufirst%3DAdileh%26date%3D2020%26volume%3D99%26spage%3D103811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manvendra  Kumar</span>, <span class="hlFld-ContribAuthor ">Gaurav  Joshi</span>, <span class="hlFld-ContribAuthor ">Joydeep  Chatterjee</span>, <span class="hlFld-ContribAuthor ">Raj  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Epidermal Growth Factor Receptor and its Trafficking Regulation by Acetylation: Implication in Resistance and Exploring the Newer Therapeutic Avenues in Cancer. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (12)
                                     , 1105-1123. <a href="https://doi.org/10.2174/1568026620666200207100227" title="DOI URL">https://doi.org/10.2174/1568026620666200207100227</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026620666200207100227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026620666200207100227%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DEpidermal%252BGrowth%252BFactor%252BReceptor%252Band%252Bits%252BTrafficking%252BRegulation%252Bby%252BAcetylation%25253A%252BImplication%252Bin%252BResistance%252Band%252BExploring%252Bthe%252BNewer%252BTherapeutic%252BAvenues%252Bin%252BCancer%26aulast%3DKumar%26aufirst%3DManvendra%26date%3D2020%26volume%3D20%26issue%3D12%26spage%3D1105%26epage%3D1123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vasily N.  Osipov</span>, <span class="hlFld-ContribAuthor ">Derenik S.  Khachatryan</span>, <span class="hlFld-ContribAuthor ">Alexandr N.  Balaev</span>. </span><span class="cited-content_cbyCitation_article-title">Biologically active quinazoline-based hydroxamic acids. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2020,</strong> <em>29 </em>
                                    (5)
                                     , 831-845. <a href="https://doi.org/10.1007/s00044-020-02530-7" title="DOI URL">https://doi.org/10.1007/s00044-020-02530-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02530-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02530-7%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DBiologically%252Bactive%252Bquinazoline-based%252Bhydroxamic%252Bacids%26aulast%3DOsipov%26aufirst%3DVasily%2BN.%26date%3D2020%26date%3D2020%26volume%3D29%26issue%3D5%26spage%3D831%26epage%3D845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anton V.  Kolotaev</span>, <span class="hlFld-ContribAuthor ">Karine R.  Matevosyan</span>, <span class="hlFld-ContribAuthor ">Vasiliy N.  Osipov</span>, <span class="hlFld-ContribAuthor ">Derenik S.  Khachatryan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of new quinazoline-containing hydroxamic acids as potential HDAC/VEGFR inhibitors. Unusual rearrangements with pyrrolidone ring opening and dehydration of 3-N-hydroxyquinazoline fragment containing tetracycles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2019,</strong> <em>60 </em>
                                    (51)
                                     , 151315. <a href="https://doi.org/10.1016/j.tetlet.2019.151315" title="DOI URL">https://doi.org/10.1016/j.tetlet.2019.151315</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2019.151315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2019.151315%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSynthesis%252Bof%252Bnew%252Bquinazoline-containing%252Bhydroxamic%252Bacids%252Bas%252Bpotential%252BHDAC%25252FVEGFR%252Binhibitors.%252BUnusual%252Brearrangements%252Bwith%252Bpyrrolidone%252Bring%252Bopening%252Band%252Bdehydration%252Bof%252B3-N-hydroxyquinazoline%252Bfragment%252Bcontaining%252Btetracycles%26aulast%3DKolotaev%26aufirst%3DAnton%2BV.%26date%3D2019%26volume%3D60%26issue%3D51%26spage%3D151315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Supaphorn  Seetaha</span>, <span class="hlFld-ContribAuthor ">Siriluk  Ratanabanyong</span>, <span class="hlFld-ContribAuthor ">Kiattawee  Choowongkomon</span>. </span><span class="cited-content_cbyCitation_article-title">Expression, purification, and characterization of the native intracellular domain of human epidermal growth factor receptors 1 and 2 in Escherichia coli. </span><span class="cited-content_cbyCitation_journal-name">Applied Microbiology and Biotechnology</span><span> <strong>2019,</strong> <em>103 </em>
                                    (20)
                                     , 8427-8438. <a href="https://doi.org/10.1007/s00253-019-10116-6" title="DOI URL">https://doi.org/10.1007/s00253-019-10116-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00253-019-10116-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00253-019-10116-6%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Microbiology%2520and%2520Biotechnology%26atitle%3DExpression%25252C%252Bpurification%25252C%252Band%252Bcharacterization%252Bof%252Bthe%252Bnative%252Bintracellular%252Bdomain%252Bof%252Bhuman%252Bepidermal%252Bgrowth%252Bfactor%252Breceptors%252B1%252Band%252B2%252Bin%252BEscherichia%252Bcoli%26aulast%3DSeetaha%26aufirst%3DSupaphorn%26date%3D2019%26date%3D2019%26volume%3D103%26issue%3D20%26spage%3D8427%26epage%3D8438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mengying  Wang</span>, <span class="hlFld-ContribAuthor ">Yusheng  Wu</span>, <span class="hlFld-ContribAuthor ">Cuifang  Xu</span>, <span class="hlFld-ContribAuthor ">Rucheng  Zhao</span>, <span class="hlFld-ContribAuthor ">Yanyu  Huang</span>, <span class="hlFld-ContribAuthor ">Xiangchao  Zeng</span>, <span class="hlFld-ContribAuthor ">Tianfeng  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of 2â(5âPhenylindolâ3âyl)benzimidazole Derivatives with Antiproliferative Effects towards TripleâNegative Breast Cancer Cells by Activation of ROSâMediated Mitochondria Dysfunction. </span><span class="cited-content_cbyCitation_journal-name">Chemistry â An Asian Journal</span><span> <strong>2019,</strong> <em>14 </em>
                                    (15)
                                     , 2648-2655. <a href="https://doi.org/10.1002/asia.201900468" title="DOI URL">https://doi.org/10.1002/asia.201900468</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/asia.201900468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fasia.201900468%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520An%2520Asian%2520Journal%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252B2%2525E2%252580%252590%2525285%2525E2%252580%252590Phenylindol%2525E2%252580%2525903%2525E2%252580%252590yl%252529benzimidazole%252BDerivatives%252Bwith%252BAntiproliferative%252BEffects%252Btowards%252BTriple%2525E2%252580%252590Negative%252BBreast%252BCancer%252BCells%252Bby%252BActivation%252Bof%252BROS%2525E2%252580%252590Mediated%252BMitochondria%252BDysfunction%26aulast%3DWang%26aufirst%3DMengying%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D15%26spage%3D2648%26epage%3D2655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammad A.  Alam</span>. </span><span class="cited-content_cbyCitation_article-title">Methods for Hydroxamic Acid Synthesis. </span><span class="cited-content_cbyCitation_journal-name">Current Organic Chemistry</span><span> <strong>2019,</strong> <em>23 </em>
                                    (9)
                                     , 978-993. <a href="https://doi.org/10.2174/1385272823666190424142821" title="DOI URL">https://doi.org/10.2174/1385272823666190424142821</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1385272823666190424142821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1385272823666190424142821%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Organic%2520Chemistry%26atitle%3DMethods%252Bfor%252BHydroxamic%252BAcid%252BSynthesis%26aulast%3DAlam%26aufirst%3DMohammad%2BA.%26date%3D2019%26volume%3D23%26issue%3D9%26spage%3D978%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gandhesiri  Satish</span>, <span class="hlFld-ContribAuthor ">Ashok  Polu</span>, <span class="hlFld-ContribAuthor ">Laxman  Kota</span>, <span class="hlFld-ContribAuthor ">Andivelu  Ilangovan</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-catalyzed oxidative amination of methanol to access quinazolines. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (19)
                                     , 4774-4782. <a href="https://doi.org/10.1039/C9OB00392D" title="DOI URL">https://doi.org/10.1039/C9OB00392D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB00392D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB00392D%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DCopper-catalyzed%252Boxidative%252Bamination%252Bof%252Bmethanol%252Bto%252Baccess%252Bquinazolines%26aulast%3DSatish%26aufirst%3DGandhesiri%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D19%26spage%3D4774%26epage%3D4782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frida S.  Herrera-VÃ¡zquez</span>, <span class="hlFld-ContribAuthor ">Francisco  HernÃ¡ndez-Luis</span>, <span class="hlFld-ContribAuthor ">JosÃ© L.  Medina Franco</span>. </span><span class="cited-content_cbyCitation_article-title">Quinazolines as inhibitors of chromatin-associated proteins in histones. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2019,</strong> <em>28 </em>
                                    (4)
                                     , 395-416. <a href="https://doi.org/10.1007/s00044-019-02300-0" title="DOI URL">https://doi.org/10.1007/s00044-019-02300-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-019-02300-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-019-02300-0%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DQuinazolines%252Bas%252Binhibitors%252Bof%252Bchromatin-associated%252Bproteins%252Bin%252Bhistones%26aulast%3DHerrera-V%25C3%25A1zquez%26aufirst%3DFrida%2BS.%26date%3D2019%26date%3D2019%26volume%3D28%26issue%3D4%26spage%3D395%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K  Radhakrishnan</span>, <span class="hlFld-ContribAuthor ">Soumi  Das</span>, <span class="hlFld-ContribAuthor ">Lal Mohan  Kundu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of SizeâExpanded Nucleobase Analogues for Artificial BaseâPairing Using a LigandâFree, MicrowaveâAssisted Copper(I)âCatalyzed Reaction. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2018,</strong> <em>3 </em>
                                    (46)
                                     , 13098-13102. <a href="https://doi.org/10.1002/slct.201802455" title="DOI URL">https://doi.org/10.1002/slct.201802455</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201802455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201802455%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DSynthesis%252Bof%252BSize%2525E2%252580%252590Expanded%252BNucleobase%252BAnalogues%252Bfor%252BArtificial%252BBase%2525E2%252580%252590Pairing%252BUsing%252Ba%252BLigand%2525E2%252580%252590Free%25252C%252BMicrowave%2525E2%252580%252590Assisted%252BCopper%252528I%252529%2525E2%252580%252590Catalyzed%252BReaction%26aulast%3DRadhakrishnan%26aufirst%3DK%26date%3D2018%26date%3D2018%26volume%3D3%26issue%3D46%26spage%3D13098%26epage%3D13102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rekha  Sangwan</span>, <span class="hlFld-ContribAuthor ">Remya  Rajan</span>, <span class="hlFld-ContribAuthor ">Pintu Kumar  Mandal</span>. </span><span class="cited-content_cbyCitation_article-title">HDAC as onco target: Reviewing the synthetic approaches with SAR study of their inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>158 </em>, 620-706. <a href="https://doi.org/10.1016/j.ejmech.2018.08.073" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.08.073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.08.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.08.073%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHDAC%252Bas%252Bonco%252Btarget%25253A%252BReviewing%252Bthe%252Bsynthetic%252Bapproaches%252Bwith%252BSAR%252Bstudy%252Bof%252Btheir%252Binhibitors%26aulast%3DSangwan%26aufirst%3DRekha%26date%3D2018%26volume%3D158%26spage%3D620%26epage%3D706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mahmud  Hasan</span>, <span class="hlFld-ContribAuthor ">Rehana K.  Leak</span>, <span class="hlFld-ContribAuthor ">Robert E.  Stratford</span>, <span class="hlFld-ContribAuthor ">Darius P.  Zlotos</span>, <span class="hlFld-ContribAuthor ">Paula A.  Witt-Enderby</span>. </span><span class="cited-content_cbyCitation_article-title">Drug conjugates-an emerging approach to treat breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology Research & Perspectives</span><span> <strong>2018,</strong> <em>6 </em>
                                    (4)
                                     , e00417. <a href="https://doi.org/10.1002/prp2.417" title="DOI URL">https://doi.org/10.1002/prp2.417</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/prp2.417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fprp2.417%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520Research%2520%2526%2520Perspectives%26atitle%3DDrug%252Bconjugates-an%252Bemerging%252Bapproach%252Bto%252Btreat%252Bbreast%252Bcancer%26aulast%3DHasan%26aufirst%3DMahmud%26date%3D2018%26date%3D2018%26volume%3D6%26issue%3D4%26spage%3De00417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ludan  Hu</span>, <span class="hlFld-ContribAuthor ">Huifen  Xu</span>, <span class="hlFld-ContribAuthor ">Qin  Yang</span>, <span class="hlFld-ContribAuthor ">Zhihong  Deng</span>, <span class="hlFld-ContribAuthor ">Chu-Yi  Yu</span>, <span class="hlFld-ContribAuthor ">Yiyuan  Peng</span>. </span><span class="cited-content_cbyCitation_article-title">Quinazoline-directed selective ortho-iodination for the synthesis of 2-(2-iodoaryl)-4-arylquinazolines. </span><span class="cited-content_cbyCitation_journal-name">Journal of Organometallic Chemistry</span><span> <strong>2017,</strong> <em>843 </em>, 20-25. <a href="https://doi.org/10.1016/j.jorganchem.2017.05.025" title="DOI URL">https://doi.org/10.1016/j.jorganchem.2017.05.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jorganchem.2017.05.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jorganchem.2017.05.025%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Organometallic%2520Chemistry%26atitle%3DQuinazoline-directed%252Bselective%252Bortho-iodination%252Bfor%252Bthe%252Bsynthesis%252Bof%252B2-%2525282-iodoaryl%252529-4-arylquinazolines%26aulast%3DHu%26aufirst%3DLudan%26date%3D2017%26volume%3D843%26spage%3D20%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Ding</span>, <span class="hlFld-ContribAuthor ">Dan  Li</span>, <span class="hlFld-ContribAuthor ">Yan-Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Sai-Sai  Han</span>, <span class="hlFld-ContribAuthor ">Chun-Mei  Gao</span>, <span class="hlFld-ContribAuthor ">Chun-Yan  Tan</span>, <span class="hlFld-ContribAuthor ">Yu-Yang  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of ErbB/HDAC inhibitors by combining the core pharmacophores of HDAC inhibitor vorinostat and kinase inhibitors vandetanib, BMS-690514, neratinib, and TAK-285. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2017,</strong> <em>28 </em>
                                    (6)
                                     , 1220-1227. <a href="https://doi.org/10.1016/j.cclet.2017.01.003" title="DOI URL">https://doi.org/10.1016/j.cclet.2017.01.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2017.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2017.01.003%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DDiscovery%252Bof%252BErbB%25252FHDAC%252Binhibitors%252Bby%252Bcombining%252Bthe%252Bcore%252Bpharmacophores%252Bof%252BHDAC%252Binhibitor%252Bvorinostat%252Band%252Bkinase%252Binhibitors%252Bvandetanib%25252C%252BBMS-690514%25252C%252Bneratinib%25252C%252Band%252BTAK-285%26aulast%3DDing%26aufirst%3DChao%26date%3D2017%26volume%3D28%26issue%3D6%26spage%3D1220%26epage%3D1227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Moumita  Saha</span>, <span class="hlFld-ContribAuthor ">Prasun  Mukherjee</span>, <span class="hlFld-ContribAuthor ">Asish R.  Das</span>. </span><span class="cited-content_cbyCitation_article-title">Practical application of PhI(OAc)2/I2 combination to synthesize benzimidazoles from 2-aminobenzylamine through ring distortion strategy. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2017,</strong> <em>58 </em>
                                    (11)
                                     , 1046-1049. <a href="https://doi.org/10.1016/j.tetlet.2017.01.099" title="DOI URL">https://doi.org/10.1016/j.tetlet.2017.01.099</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2017.01.099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2017.01.099%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DPractical%252Bapplication%252Bof%252BPhI%252528OAc%2525292%25252FI2%252Bcombination%252Bto%252Bsynthesize%252Bbenzimidazoles%252Bfrom%252B2-aminobenzylamine%252Bthrough%252Bring%252Bdistortion%252Bstrategy%26aulast%3DSaha%26aufirst%3DMoumita%26date%3D2017%26volume%3D58%26issue%3D11%26spage%3D1046%26epage%3D1049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D.  Qu</span>, <span class="hlFld-ContribAuthor ">A.  Yan</span>, <span class="hlFld-ContribAuthor ">J. S.  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">SAR and QSAR study on the bioactivities of human epidermal growth factor receptor-2 (HER2) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">SAR and QSAR in Environmental Research</span><span> <strong>2017,</strong> <em>28 </em>
                                    (2)
                                     , 111-132. <a href="https://doi.org/10.1080/1062936X.2017.1284898" title="DOI URL">https://doi.org/10.1080/1062936X.2017.1284898</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1062936X.2017.1284898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1062936X.2017.1284898%26sid%3Dliteratum%253Aachs%26jtitle%3DSAR%2520and%2520QSAR%2520in%2520Environmental%2520Research%26atitle%3DSAR%252Band%252BQSAR%252Bstudy%252Bon%252Bthe%252Bbioactivities%252Bof%252Bhuman%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor-2%252B%252528HER2%252529%252Binhibitors%26aulast%3DQu%26aufirst%3DD.%26date%3D2017%26date%3D2017%26volume%3D28%26issue%3D2%26spage%3D111%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Ding</span>, <span class="hlFld-ContribAuthor ">Shaopeng  Chen</span>, <span class="hlFld-ContribAuthor ">Cunlong  Zhang</span>, <span class="hlFld-ContribAuthor ">Guangnan  Hu</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Lulu  Li</span>, <span class="hlFld-ContribAuthor ">Yu Zong  Chen</span>, <span class="hlFld-ContribAuthor ">Chunyan  Tan</span>, <span class="hlFld-ContribAuthor ">Yuyang  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and investigation of novel 6-(1,2,3-triazol-4-yl)-4-aminoquinazolin derivatives possessing hydroxamic acid moiety for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (1)
                                     , 27-37. <a href="https://doi.org/10.1016/j.bmc.2016.10.006" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.10.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.10.006%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Binvestigation%252Bof%252Bnovel%252B6-%2525281%25252C2%25252C3-triazol-4-yl%252529-4-aminoquinazolin%252Bderivatives%252Bpossessing%252Bhydroxamic%252Bacid%252Bmoiety%252Bfor%252Bcancer%252Btherapy%26aulast%3DDing%26aufirst%3DChao%26date%3D2017%26volume%3D25%26issue%3D1%26spage%3D27%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angel R.  de Lera</span>, <span class="hlFld-ContribAuthor ">A.  Ganesan</span>. </span><span class="cited-content_cbyCitation_article-title">Epigenetic polypharmacology: from combination therapy to multitargeted drugs. </span><span class="cited-content_cbyCitation_journal-name">Clinical Epigenetics</span><span> <strong>2016,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13148-016-0271-9" title="DOI URL">https://doi.org/10.1186/s13148-016-0271-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13148-016-0271-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13148-016-0271-9%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Epigenetics%26atitle%3DEpigenetic%252Bpolypharmacology%25253A%252Bfrom%252Bcombination%252Btherapy%252Bto%252Bmultitargeted%252Bdrugs%26aulast%3Dde%2BLera%26aufirst%3DAngel%2BR.%26date%3D2016%26date%3D2016%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">JoÃ«lle  Roche</span>, <span class="hlFld-ContribAuthor ">Philippe  Bertrand</span>. </span><span class="cited-content_cbyCitation_article-title">Inside HDACs with more selective HDAC inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>121 </em>, 451-483. <a href="https://doi.org/10.1016/j.ejmech.2016.05.047" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.05.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.05.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.05.047%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInside%252BHDACs%252Bwith%252Bmore%252Bselective%252BHDAC%252Binhibitors%26aulast%3DRoche%26aufirst%3DJo%25C3%25ABlle%26date%3D2016%26volume%3D121%26spage%3D451%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Ganesan</span>. </span><span class="cited-content_cbyCitation_article-title">Multitarget Drugs: an Epigenetic Epiphany. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2016,</strong> <em>11 </em>
                                    (12)
                                     , 1227-1241. <a href="https://doi.org/10.1002/cmdc.201500394" title="DOI URL">https://doi.org/10.1002/cmdc.201500394</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201500394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201500394%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DMultitarget%252BDrugs%25253A%252Ban%252BEpigenetic%252BEpiphany%26aulast%3DGanesan%26aufirst%3DA.%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D12%26spage%3D1227%26epage%3D1241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong-Gang  Ma</span>, <span class="hlFld-ContribAuthor ">Yan  Zhang</span>, <span class="hlFld-ContribAuthor ">Bin-Bin  Feng</span>, <span class="hlFld-ContribAuthor ">Xiang-Shan  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 6-aryl-5H-quinazolino[4,3-b]quinazolin-8(6H)-one derivatives in ionic liquids catalyzed by iodine. </span><span class="cited-content_cbyCitation_journal-name">Research on Chemical Intermediates</span><span> <strong>2016,</strong> <em>42 </em>
                                    (2)
                                     , 1045-1055. <a href="https://doi.org/10.1007/s11164-015-2072-8" title="DOI URL">https://doi.org/10.1007/s11164-015-2072-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11164-015-2072-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11164-015-2072-8%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520on%2520Chemical%2520Intermediates%26atitle%3DSynthesis%252Bof%252B6-aryl-5H-quinazolino%25255B4%25252C3-b%25255Dquinazolin-8%2525286H%252529-one%252Bderivatives%252Bin%252Bionic%252Bliquids%252Bcatalyzed%252Bby%252Biodine%26aulast%3DMa%26aufirst%3DYong-Gang%26date%3D2016%26date%3D2015%26volume%3D42%26issue%3D2%26spage%3D1045%26epage%3D1055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fan-Wei  Peng</span>, <span class="hlFld-ContribAuthor ">Ji  Xuan</span>, <span class="hlFld-ContribAuthor ">Ting-Ting  Wu</span>, <span class="hlFld-ContribAuthor ">Jia-Yu  Xue</span>, <span class="hlFld-ContribAuthor ">Zi-Wei  Ren</span>, <span class="hlFld-ContribAuthor ">Da-Ke  Liu</span>, <span class="hlFld-ContribAuthor ">Xiu-Qi  Wang</span>, <span class="hlFld-ContribAuthor ">Xin-Hang  Chen</span>, <span class="hlFld-ContribAuthor ">Jia-Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Yun-Gen  Xu</span>, <span class="hlFld-ContribAuthor ">Lei  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of N-phenylquinazolin-4-amine hybrids as dual inhibitors of VEGFR-2 and HDAC. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>109 </em>, 1-12. <a href="https://doi.org/10.1016/j.ejmech.2015.12.033" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.12.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.12.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.12.033%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252BN-phenylquinazolin-4-amine%252Bhybrids%252Bas%252Bdual%252Binhibitors%252Bof%252BVEGFR-2%252Band%252BHDAC%26aulast%3DPeng%26aufirst%3DFan-Wei%26date%3D2016%26volume%3D109%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steffen  Bugge</span>, <span class="hlFld-ContribAuthor ">Audun Formo  Buene</span>, <span class="hlFld-ContribAuthor ">Nathalie  Jurisch-Yaksi</span>, <span class="hlFld-ContribAuthor ">Ingri Ullestad  Moen</span>, <span class="hlFld-ContribAuthor ">Ellen Martine  SkjÃ¸nsfjell</span>, <span class="hlFld-ContribAuthor ">Eirik  Sundby</span>, <span class="hlFld-ContribAuthor ">BÃ¥rd Helge  Hoff</span>. </span><span class="cited-content_cbyCitation_article-title">Extended structureâactivity study of thienopyrimidine-based EGFR inhibitors with evaluation of drug-like properties. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>107 </em>, 255-274. <a href="https://doi.org/10.1016/j.ejmech.2015.11.012" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.11.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.11.012%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExtended%252Bstructure%2525E2%252580%252593activity%252Bstudy%252Bof%252Bthienopyrimidine-based%252BEGFR%252Binhibitors%252Bwith%252Bevaluation%252Bof%252Bdrug-like%252Bproperties%26aulast%3DBugge%26aufirst%3DSteffen%26date%3D2016%26volume%3D107%26spage%3D255%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zainab  Noor</span>, <span class="hlFld-ContribAuthor ">Noreen  Afzal</span>, <span class="hlFld-ContribAuthor ">Sajid  Rashid</span>, . </span><span class="cited-content_cbyCitation_article-title">Exploration of Novel Inhibitors for Class I Histone Deacetylase Isoforms by QSAR Modeling and Molecular Dynamics Simulation Assays. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2015,</strong> <em>10 </em>
                                    (10)
                                     , e0139588. <a href="https://doi.org/10.1371/journal.pone.0139588" title="DOI URL">https://doi.org/10.1371/journal.pone.0139588</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0139588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0139588%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DExploration%252Bof%252BNovel%252BInhibitors%252Bfor%252BClass%252BI%252BHistone%252BDeacetylase%252BIsoforms%252Bby%252BQSAR%252BModeling%252Band%252BMolecular%252BDynamics%252BSimulation%252BAssays%26aulast%3DNoor%26aufirst%3DZainab%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D10%26spage%3De0139588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Loana  Musso</span>, <span class="hlFld-ContribAuthor ">Sabrina  Dallavalle</span>, <span class="hlFld-ContribAuthor ">Franco  Zunino</span>. </span><span class="cited-content_cbyCitation_article-title">Perspectives in the development of hybrid bifunctional antitumour agents. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2015,</strong> <em>96 </em>
                                    (4)
                                     , 297-305. <a href="https://doi.org/10.1016/j.bcp.2015.06.006" title="DOI URL">https://doi.org/10.1016/j.bcp.2015.06.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2015.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2015.06.006%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DPerspectives%252Bin%252Bthe%252Bdevelopment%252Bof%252Bhybrid%252Bbifunctional%252Bantitumour%252Bagents%26aulast%3DMusso%26aufirst%3DLoana%26date%3D2015%26volume%3D96%26issue%3D4%26spage%3D297%26epage%3D305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Zhang</span>, <span class="hlFld-ContribAuthor ">Kai  Zhang</span>, <span class="hlFld-ContribAuthor ">Meng  Zhao</span>, <span class="hlFld-ContribAuthor ">Lixia  Zhang</span>, <span class="hlFld-ContribAuthor ">Mingze  Qin</span>, <span class="hlFld-ContribAuthor ">Shuchun  Guo</span>, <span class="hlFld-ContribAuthor ">Yanfang  Zhao</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a novel class anti-proliferative agents and potential inhibitors of EGFR tyrosine kinases based on 4-anilinotetrahydropyrido[4,3-d]pyrimidine scaffold: Design, synthesis and biological evaluations. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (15)
                                     , 4591-4607. <a href="https://doi.org/10.1016/j.bmc.2015.05.059" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.05.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.05.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.05.059%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252Bnovel%252Bclass%252Banti-proliferative%252Bagents%252Band%252Bpotential%252Binhibitors%252Bof%252BEGFR%252Btyrosine%252Bkinases%252Bbased%252Bon%252B4-anilinotetrahydropyrido%25255B4%25252C3-d%25255Dpyrimidine%252Bscaffold%25253A%252BDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluations%26aulast%3DZhang%26aufirst%3DYong%26date%3D2015%26volume%3D23%26issue%3D15%26spage%3D4591%26epage%3D4607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Ling</span>, <span class="hlFld-ContribAuthor ">Xuemin  Wang</span>, <span class="hlFld-ContribAuthor ">Chenniu  Wang</span>, <span class="hlFld-ContribAuthor ">Chenjun  Xu</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Yihua  Zhang</span>, <span class="hlFld-ContribAuthor ">Yanan  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Hybrids from Farnesylthiosalicylic Acid and Hydroxamic Acid as Dual Ras-Related Signaling and Histone Deacetylase (HDAC) Inhibitors: Design, Synthesis and Biological Evaluation. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2015,</strong> <em>10 </em>
                                    (6)
                                     , 971-976. <a href="https://doi.org/10.1002/cmdc.201500019" title="DOI URL">https://doi.org/10.1002/cmdc.201500019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201500019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201500019%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DHybrids%252Bfrom%252BFarnesylthiosalicylic%252BAcid%252Band%252BHydroxamic%252BAcid%252Bas%252BDual%252BRas-Related%252BSignaling%252Band%252BHistone%252BDeacetylase%252B%252528HDAC%252529%252BInhibitors%25253A%252BDesign%25252C%252BSynthesis%252Band%252BBiological%252BEvaluation%26aulast%3DLing%26aufirst%3DYong%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D6%26spage%3D971%26epage%3D976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Yannan  Kong</span>, <span class="hlFld-ContribAuthor ">Jie  Zhang</span>, <span class="hlFld-ContribAuthor ">Mingbo  Su</span>, <span class="hlFld-ContribAuthor ">Yubo  Zhou</span>, <span class="hlFld-ContribAuthor ">Yi  Zang</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Yanfen  Fang</span>, <span class="hlFld-ContribAuthor ">Xiongwen  Zhang</span>, <span class="hlFld-ContribAuthor ">Wei  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>95 </em>, 127-135. <a href="https://doi.org/10.1016/j.ejmech.2015.03.035" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.03.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.03.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.03.035%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bcolchicine%252Bderivatives%252Bas%252Bnovel%252Btubulin%252Band%252Bhistone%252Bdeacetylase%252Bdual%252Binhibitors%26aulast%3DZhang%26aufirst%3DXuan%26date%3D2015%26volume%3D95%26spage%3D127%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steffen  Bugge</span>, <span class="hlFld-ContribAuthor ">Ingri Ullestad  Moen</span>, <span class="hlFld-ContribAuthor ">Kent-Ove  Kragseth Sylte</span>, <span class="hlFld-ContribAuthor ">Eirik  Sundby</span>, <span class="hlFld-ContribAuthor ">BÃ¥rd Helge  Hoff</span>. </span><span class="cited-content_cbyCitation_article-title">Truncated structures used in search for new lead compounds and in a retrospective analysis of thienopyrimidine-based EGFR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>94 </em>, 175-194. <a href="https://doi.org/10.1016/j.ejmech.2015.03.004" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.03.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.03.004%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTruncated%252Bstructures%252Bused%252Bin%252Bsearch%252Bfor%252Bnew%252Blead%252Bcompounds%252Band%252Bin%252Ba%252Bretrospective%252Banalysis%252Bof%252Bthienopyrimidine-based%252BEGFR%252Binhibitors%26aulast%3DBugge%26aufirst%3DSteffen%26date%3D2015%26volume%3D94%26spage%3D175%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anil  Rana</span>, <span class="hlFld-ContribAuthor ">Jimi Marin  Alex</span>, <span class="hlFld-ContribAuthor ">Monika  Chauhan</span>, <span class="hlFld-ContribAuthor ">Gaurav  Joshi</span>, <span class="hlFld-ContribAuthor ">Raj  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">A review on pharmacophoric designs of antiproliferative agents. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2015,</strong> <em>24 </em>
                                    (3)
                                     , 903-920. <a href="https://doi.org/10.1007/s00044-014-1196-5" title="DOI URL">https://doi.org/10.1007/s00044-014-1196-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-014-1196-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-014-1196-5%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DA%252Breview%252Bon%252Bpharmacophoric%252Bdesigns%252Bof%252Bantiproliferative%252Bagents%26aulast%3DRana%26aufirst%3DAnil%26date%3D2015%26date%3D2014%26volume%3D24%26issue%3D3%26spage%3D903%26epage%3D920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Yantao  Han</span>, <span class="hlFld-ContribAuthor ">Qixiao  Jiang</span>, <span class="hlFld-ContribAuthor ">Chunbo  Wang</span>, <span class="hlFld-ContribAuthor ">Xuehong  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaoguang  Li</span>, <span class="hlFld-ContribAuthor ">Fuming  Xu</span>, <span class="hlFld-ContribAuthor ">Yuqi  Jiang</span>, <span class="hlFld-ContribAuthor ">Qiang  Wang</span>, <span class="hlFld-ContribAuthor ">Wenfang  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Trend of Histone Deacetylase Inhibitors in Cancer Therapy: Isoform Selectivity or Multitargeted Strategy. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2015,</strong> <em>35 </em>
                                    (1)
                                     , 63-84. <a href="https://doi.org/10.1002/med.21320" title="DOI URL">https://doi.org/10.1002/med.21320</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21320%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DTrend%252Bof%252BHistone%252BDeacetylase%252BInhibitors%252Bin%252BCancer%252BTherapy%25253A%252BIsoform%252BSelectivity%252Bor%252BMultitargeted%252BStrategy%26aulast%3DZhang%26aufirst%3DLei%26date%3D2015%26date%3D2014%26volume%3D35%26issue%3D1%26spage%3D63%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nan  Zhou</span>, <span class="hlFld-ContribAuthor ">Wenfang  Xu</span>, <span class="hlFld-ContribAuthor ">Yingjie  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Histone deacetylase inhibitors merged with protein tyrosine kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Drug Discoveries & Therapeutics</span><span> <strong>2015,</strong> <em>9 </em>
                                    (3)
                                     , 147-155. <a href="https://doi.org/10.5582/ddt.2015.01001" title="DOI URL">https://doi.org/10.5582/ddt.2015.01001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5582/ddt.2015.01001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5582%2Fddt.2015.01001%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discoveries%2520%2526%2520Therapeutics%26atitle%3DHistone%252Bdeacetylase%252Binhibitors%252Bmerged%252Bwith%252Bprotein%252Btyrosine%252Bkinase%252Binhibitors%26aulast%3DZhou%26aufirst%3DNan%26date%3D2015%26volume%3D9%26issue%3D3%26spage%3D147%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C.T.  Chan</span>, <span class="hlFld-ContribAuthor ">J.  Qi</span>, <span class="hlFld-ContribAuthor ">W.  Smith</span>, <span class="hlFld-ContribAuthor ">R.  Paranol</span>, <span class="hlFld-ContribAuthor ">R.  Mazitschek</span>, <span class="hlFld-ContribAuthor ">N.  West</span>, <span class="hlFld-ContribAuthor ">R.  Reeves</span>, <span class="hlFld-ContribAuthor ">G.  Chiosis</span>, <span class="hlFld-ContribAuthor ">S.L.  Schreiber</span>, <span class="hlFld-ContribAuthor ">J.E.  Bradner</span>, <span class="hlFld-ContribAuthor ">R.  Paulmurugan</span>, <span class="hlFld-ContribAuthor ">S.S.  Gambhir</span>. </span><span class="cited-content_cbyCitation_article-title">Syntheses and Discovery of a Novel Class of Cinnamic Hydroxamates as Histone Deacetylase Inhibitors by Multimodality Molecular Imaging in Living Subjects. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2014,</strong> <em>74 </em>
                                    (24)
                                     , 7475-7486. <a href="https://doi.org/10.1158/0008-5472.CAN-14-0197" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-14-0197</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-14-0197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-14-0197%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DSyntheses%252Band%252BDiscovery%252Bof%252Ba%252BNovel%252BClass%252Bof%252BCinnamic%252BHydroxamates%252Bas%252BHistone%252BDeacetylase%252BInhibitors%252Bby%252BMultimodality%252BMolecular%252BImaging%252Bin%252BLiving%252BSubjects%26aulast%3DChan%26aufirst%3DC.T.%26date%3D2014%26date%3D2014%26volume%3D74%26issue%3D24%26spage%3D7475%26epage%3D7486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hiren  Patel</span>, <span class="hlFld-ContribAuthor ">Irina  Chuckowree</span>, <span class="hlFld-ContribAuthor ">Peter  Coxhead</span>, <span class="hlFld-ContribAuthor ">Matthew  Guille</span>, <span class="hlFld-ContribAuthor ">Minghua  Wang</span>, <span class="hlFld-ContribAuthor ">Alexandra  Zuckermann</span>, <span class="hlFld-ContribAuthor ">Robin S. B.  Williams</span>, <span class="hlFld-ContribAuthor ">Mariangela  Librizzi</span>, <span class="hlFld-ContribAuthor ">Ronald M.  Paranal</span>, <span class="hlFld-ContribAuthor ">James E.  Bradner</span>, <span class="hlFld-ContribAuthor ">John  Spencer</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of hybrid anticancer agents based on kinase and histone deacetylase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2014,</strong> <em>5 </em>
                                    (12)
                                     , 1829-1833. <a href="https://doi.org/10.1039/C4MD00211C" title="DOI URL">https://doi.org/10.1039/C4MD00211C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4MD00211C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4MD00211C%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DSynthesis%252Bof%252Bhybrid%252Banticancer%252Bagents%252Bbased%252Bon%252Bkinase%252Band%252Bhistone%252Bdeacetylase%252Binhibitors%26aulast%3DPatel%26aufirst%3DHiren%26date%3D2014%26date%3D2014%26volume%3D5%26issue%3D12%26spage%3D1829%26epage%3D1833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hitisha K.  Patel</span>, <span class="hlFld-ContribAuthor ">Marton I.  Siklos</span>, <span class="hlFld-ContribAuthor ">Hazem  Abdelkarim</span>, <span class="hlFld-ContribAuthor ">Emma L.  Mendonca</span>, <span class="hlFld-ContribAuthor ">Aditya  Vaidya</span>, <span class="hlFld-ContribAuthor ">Pavel A.  Petukhov</span>, <span class="hlFld-ContribAuthor ">Gregory R. J.  Thatcher</span>. </span><span class="cited-content_cbyCitation_article-title">A Chimeric SERM-Histone Deacetylase Inhibitor Approach to Breast Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2014,</strong> <em>9 </em>
                                    (3)
                                     , 602-613. <a href="https://doi.org/10.1002/cmdc.201300270" title="DOI URL">https://doi.org/10.1002/cmdc.201300270</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201300270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201300270%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DA%252BChimeric%252BSERM-Histone%252BDeacetylase%252BInhibitor%252BApproach%252Bto%252BBreast%252BCancer%252BTherapy%26aulast%3DPatel%26aufirst%3DHitisha%2BK.%26date%3D2014%26date%3D2013%26volume%3D9%26issue%3D3%26spage%3D602%26epage%3D613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Si-Ning  Li</span>, <span class="hlFld-ContribAuthor ">Huan-Qiu  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Epidermal growth factor receptor inhibitors: a patent review (2010 â present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2014,</strong> <em>24 </em>
                                    (3)
                                     , 309-321. <a href="https://doi.org/10.1517/13543776.2014.871527" title="DOI URL">https://doi.org/10.1517/13543776.2014.871527</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2014.871527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2014.871527%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DEpidermal%252Bgrowth%252Bfactor%252Breceptor%252Binhibitors%25253A%252Ba%252Bpatent%252Breview%252B%2525282010%252B%2525E2%252580%252593%252Bpresent%252529%26aulast%3DLi%26aufirst%3DSi-Ning%26date%3D2014%26date%3D2014%26volume%3D24%26issue%3D3%26spage%3D309%26epage%3D321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Jie  Zhang</span>, <span class="hlFld-ContribAuthor ">Mingbo  Su</span>, <span class="hlFld-ContribAuthor ">Yubo  Zhou</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Wei  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of 4â²-demethyl-4-deoxypodophyllotoxin derivatives as novel tubulin and histone deacetylase dual inhibitors. </span><span class="cited-content_cbyCitation_journal-name">RSC Adv.</span><span> <strong>2014,</strong> <em>4 </em>
                                    (76)
                                     , 40444-40448. <a href="https://doi.org/10.1039/C4RA05508J" title="DOI URL">https://doi.org/10.1039/C4RA05508J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4RA05508J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4RA05508J%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Adv.%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B4%2525E2%252580%2525B2-demethyl-4-deoxypodophyllotoxin%252Bderivatives%252Bas%252Bnovel%252Btubulin%252Band%252Bhistone%252Bdeacetylase%252Bdual%252Binhibitors%26aulast%3DZhang%26aufirst%3DXuan%26date%3D2014%26date%3D2014%26volume%3D4%26issue%3D76%26spage%3D40444%26epage%3D40448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Radhey Mohan  Singh</span>, <span class="hlFld-ContribAuthor ">Kishor Chandra  Bharadwaj</span>, <span class="hlFld-ContribAuthor ">Dharmendra Kumar  Tiwari</span>. </span><span class="cited-content_cbyCitation_article-title">MoritaâBaylisâHillman reaction of acrylamide with isatin derivatives. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>10 </em>, 2975-2980. <a href="https://doi.org/10.3762/bjoc.10.315" title="DOI URL">https://doi.org/10.3762/bjoc.10.315</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.10.315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.10.315%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DMorita%2525E2%252580%252593Baylis%2525E2%252580%252593Hillman%252Breaction%252Bof%252Bacrylamide%252Bwith%252Bisatin%252Bderivatives%26aulast%3DSingh%26aufirst%3DRadhey%2BMohan%26date%3D2014%26date%3D2014%26volume%3D10%26spage%3D2975%26epage%3D2980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Bin  Bao</span>, <span class="hlFld-ContribAuthor ">Xiuhua  Yu</span>, <span class="hlFld-ContribAuthor ">Linjiang  Tong</span>, <span class="hlFld-ContribAuthor ">Yu  Luo</span>, <span class="hlFld-ContribAuthor ">Qingqing  Huang</span>, <span class="hlFld-ContribAuthor ">Mingbo  Su</span>, <span class="hlFld-ContribAuthor ">Li  Sheng</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Hong  Zhu</span>, <span class="hlFld-ContribAuthor ">Bo  Yang</span>, <span class="hlFld-ContribAuthor ">Xiongwen  Zhang</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Wei  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery and optimization of novel dual inhibitors of topoisomerase ii and histone deacetylase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (22)
                                     , 6981-6995. <a href="https://doi.org/10.1016/j.bmc.2013.09.023" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.09.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.09.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.09.023%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bdiscovery%252Band%252Boptimization%252Bof%252Bnovel%252Bdual%252Binhibitors%252Bof%252Btopoisomerase%252Bii%252Band%252Bhistone%252Bdeacetylase%26aulast%3DZhang%26aufirst%3DXuan%26date%3D2013%26volume%3D21%26issue%3D22%26spage%3D6981%26epage%3D6995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Jie  Zhang</span>, <span class="hlFld-ContribAuthor ">Linjiang  Tong</span>, <span class="hlFld-ContribAuthor ">Yu  Luo</span>, <span class="hlFld-ContribAuthor ">Mingbo  Su</span>, <span class="hlFld-ContribAuthor ">Yi  Zang</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Wei  Lu</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery of colchicine-SAHA hybrids as a new class of antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (11)
                                     , 3240-3244. <a href="https://doi.org/10.1016/j.bmc.2013.03.049" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.03.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.03.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.03.049%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bdiscovery%252Bof%252Bcolchicine-SAHA%252Bhybrids%252Bas%252Ba%252Bnew%252Bclass%252Bof%252Bantitumor%252Bagents%26aulast%3DZhang%26aufirst%3DXuan%26date%3D2013%26volume%3D21%26issue%3D11%26spage%3D3240%26epage%3D3244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Mingbo  Su</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Wei  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">The Design and Synthesis of a New Class of RTK/HDAC  Dual-Targeted Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2013,</strong> <em>18 </em>
                                    (6)
                                     , 6491-6503. <a href="https://doi.org/10.3390/molecules18066491" title="DOI URL">https://doi.org/10.3390/molecules18066491</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules18066491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules18066491%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DThe%252BDesign%252Band%252BSynthesis%252Bof%252Ba%252BNew%252BClass%252Bof%252BRTK%25252FHDAC%252BDual-Targeted%252BInhibitors%26aulast%3DZhang%26aufirst%3DXuan%26date%3D2013%26date%3D2013%26volume%3D18%26issue%3D6%26spage%3D6491%26epage%3D6503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miao  Zuo</span>, <span class="hlFld-ContribAuthor ">Yue-Wen  Zheng</span>, <span class="hlFld-ContribAuthor ">She-Min  Lu</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">San-Qi  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of N-aryl salicylamides with a hydroxamic acid moiety at 5-position as novel HDACâEGFR dual inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2012,</strong> <em>20 </em>
                                    (14)
                                     , 4405-4412. <a href="https://doi.org/10.1016/j.bmc.2012.05.034" title="DOI URL">https://doi.org/10.1016/j.bmc.2012.05.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2012.05.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2012.05.034%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252BN-aryl%252Bsalicylamides%252Bwith%252Ba%252Bhydroxamic%252Bacid%252Bmoiety%252Bat%252B5-position%252Bas%252Bnovel%252BHDAC%2525E2%252580%252593EGFR%252Bdual%252Binhibitors%26aulast%3DZuo%26aufirst%3DMiao%26date%3D2012%26volume%3D20%26issue%3D14%26spage%3D4405%26epage%3D4412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seung-Yong  Seo</span>. </span><span class="cited-content_cbyCitation_article-title">Multi-targeted hybrids based on HDAC inhibitors for anti-cancer drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Archives of Pharmacal Research</span><span> <strong>2012,</strong> <em>35 </em>
                                    (2)
                                     , 197-200. <a href="https://doi.org/10.1007/s12272-012-0221-9" title="DOI URL">https://doi.org/10.1007/s12272-012-0221-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12272-012-0221-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12272-012-0221-9%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Pharmacal%2520Research%26atitle%3DMulti-targeted%252Bhybrids%252Bbased%252Bon%252BHDAC%252Binhibitors%252Bfor%252Banti-cancer%252Bdrug%252Bdiscovery%26aulast%3DSeo%26aufirst%3DSeung-Yong%26date%3D2012%26date%3D2012%26volume%3D35%26issue%3D2%26spage%3D197%26epage%3D200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas  Beckers</span>, <span class="hlFld-ContribAuthor ">Andreas  Sellmer</span>, <span class="hlFld-ContribAuthor ">Emerich  Eichhorn</span>, <span class="hlFld-ContribAuthor ">Herwig  Pongratz</span>, <span class="hlFld-ContribAuthor ">Christoph  SchÃ¤chtele</span>, <span class="hlFld-ContribAuthor ">Frank  Totzke</span>, <span class="hlFld-ContribAuthor ">Gerhard  Kelter</span>, <span class="hlFld-ContribAuthor ">Rebekka  Krumbach</span>, <span class="hlFld-ContribAuthor ">Heinz-Herbert  Fiebig</span>, <span class="hlFld-ContribAuthor ">Frank-D.  BÃ¶hmer</span>, <span class="hlFld-ContribAuthor ">Siavosh  Mahboobi</span>. </span><span class="cited-content_cbyCitation_article-title">Novel inhibitors of epidermal growth factor receptor: (4-(Arylamino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl)(1H-indol-2-yl)methanones and (1H-indol-2-yl)(4-(phenylamino)thieno[2,3-d]pyrimidin-6-yl)methanones. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2012,</strong> <em>20 </em>
                                    (1)
                                     , 125-136. <a href="https://doi.org/10.1016/j.bmc.2011.11.023" title="DOI URL">https://doi.org/10.1016/j.bmc.2011.11.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2011.11.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2011.11.023%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Binhibitors%252Bof%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor%25253A%252B%2525284-%252528Arylamino%252529-7H-pyrrolo%25255B2%25252C3-d%25255Dpyrimidin-6-yl%252529%2525281H-indol-2-yl%252529methanones%252Band%252B%2525281H-indol-2-yl%252529%2525284-%252528phenylamino%252529thieno%25255B2%25252C3-d%25255Dpyrimidin-6-yl%252529methanones%26aulast%3DBeckers%26aufirst%3DThomas%26date%3D2012%26volume%3D20%26issue%3D1%26spage%3D125%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Siyuan  Li</span>, <span class="hlFld-ContribAuthor ">Chunying  Guo</span>, <span class="hlFld-ContribAuthor ">Hongli  Zhao</span>, <span class="hlFld-ContribAuthor ">Yun  Tang</span>, <span class="hlFld-ContribAuthor ">Minbo  Lan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 4-[3-chloro-4-(3-fluorobenzyloxy)anilino]-6-(3-substituted-phenoxy)pyrimidines as dual EGFR/ErbB-2 kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2012,</strong> <em>20 </em>
                                    (2)
                                     , 877-885. <a href="https://doi.org/10.1016/j.bmc.2011.11.056" title="DOI URL">https://doi.org/10.1016/j.bmc.2011.11.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2011.11.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2011.11.056%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B4-%25255B3-chloro-4-%2525283-fluorobenzyloxy%252529anilino%25255D-6-%2525283-substituted-phenoxy%252529pyrimidines%252Bas%252Bdual%252BEGFR%25252FErbB-2%252Bkinase%252Binhibitors%26aulast%3DLi%26aufirst%3DSiyuan%26date%3D2012%26volume%3D20%26issue%3D2%26spage%3D877%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas  Beckers</span>, <span class="hlFld-ContribAuthor ">Siavosh  Mahboobi</span>, <span class="hlFld-ContribAuthor ">Andreas  Sellmer</span>, <span class="hlFld-ContribAuthor ">Matthias  Winkler</span>, <span class="hlFld-ContribAuthor ">Emerich  Eichhorn</span>, <span class="hlFld-ContribAuthor ">Herwig  Pongratz</span>, <span class="hlFld-ContribAuthor ">Thomas  Maier</span>, <span class="hlFld-ContribAuthor ">Thomas  Ciossek</span>, <span class="hlFld-ContribAuthor ">Thomas  Baer</span>, <span class="hlFld-ContribAuthor ">Gerhard  Kelter</span>, <span class="hlFld-ContribAuthor ">Heinz-Herbert  Fiebig</span>, <span class="hlFld-ContribAuthor ">Mathias  Schmidt</span>. </span><span class="cited-content_cbyCitation_article-title">Chimerically designed HDAC- and tyrosine kinase inhibitors. A series of erlotinib hybrids as dual-selective inhibitors of EGFR, HER2 and histone deacetylases. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2012,</strong> <em>3 </em>
                                    (7)
                                     , 829. <a href="https://doi.org/10.1039/c2md00317a" title="DOI URL">https://doi.org/10.1039/c2md00317a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c2md00317a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc2md00317a%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DChimerically%252Bdesigned%252BHDAC-%252Band%252Btyrosine%252Bkinase%252Binhibitors.%252BA%252Bseries%252Bof%252Berlotinib%252Bhybrids%252Bas%252Bdual-selective%252Binhibitors%252Bof%252BEGFR%25252C%252BHER2%252Band%252Bhistone%252Bdeacetylases%26aulast%3DBeckers%26aufirst%3DThomas%26date%3D2012%26volume%3D3%26issue%3D7%26spage%3D829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mukesh K.  Sharma</span>, <span class="hlFld-ContribAuthor ">Martin G.  Banwell</span>. </span><span class="cited-content_cbyCitation_article-title">5-Formyl-2-furanylboronic Acid. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,<a href="https://doi.org/10.1002/047084289X.rn01372" title="DOI URL">https://doi.org/10.1002/047084289X.rn01372</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/047084289X.rn01372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F047084289X.rn01372%26sid%3Dliteratum%253Aachs%26atitle%3D5-Formyl-2-furanylboronic%252BAcid%26aulast%3DSharma%26aufirst%3DMukesh%2BK.%26date%3D2011%26date%3D2011%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26atitle%3DEncyclopedia%252Bof%252BReagents%252Bfor%252BOrganic%252BSynthesis%26date%3D2001%26date%3D2001%26volume%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael M.  Miller</span>, <span class="hlFld-ContribAuthor ">Albert J.  DelMonte</span>. </span><span class="cited-content_cbyCitation_article-title">Six-Membered Ring Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 371-402. <a href="https://doi.org/10.1016/B978-0-08-096805-6.00013-9" title="DOI URL">https://doi.org/10.1016/B978-0-08-096805-6.00013-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-096805-6.00013-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-096805-6.00013-9%26sid%3Dliteratum%253Aachs%26atitle%3DSix-Membered%252BRing%252BSystems%26aulast%3DMiller%26aufirst%3DMichael%2BM.%26date%3D2011%26spage%3D371%26epage%3D402%26pub%3DElsevier%26date%3D2011%26volume%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/medium/jm-2010-00665z_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/large/jm-2010-00665z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100665z&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/medium/jm-2010-00665z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/large/jm-2010-00665z_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of selected HDACiâs in preclinical and clinical developments (<b>1</b>â<b>4</b>), <b>5</b>, and novel chimerically designed compounds (<b>6</b>â<b>8</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/large/jm-2010-00665z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100665z&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/medium/jm-2010-00665z_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/large/jm-2010-00665z_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of [3-Chloro-4-(3-fluorobenzyloxy)phenyl]-(6-iodoquinazolin-4-yl)amine (<b>16</b>) As a Central Intermediate</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/large/jm-2010-00665z_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100665z&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/medium/jm-2010-00665z_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/large/jm-2010-00665z_0010.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <i>N</i>-Hydroxyacrylamides <b>6a</b>â<b>6d</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/large/jm-2010-00665z_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100665z&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/medium/jm-2010-00665z_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/large/jm-2010-00665z_0011.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Carboxylic Acid (2-Aminophenyl)amides (<b>7a</b>, <b>7b</b>) and Carboxylic Acid Hydroxyamides (<b>8a</b>, <b>8b</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/large/jm-2010-00665z_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100665z&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/medium/jm-2010-00665z_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/large/jm-2010-00665z_0001.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Phenylaminoacrylamides (<b>7c</b>â<b>7e</b>) and of <i>N</i>-(2-Aminophenyl)-3-(4-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-yl)phenyl)propanamide (<b>7f</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/large/jm-2010-00665z_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100665z&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/medium/jm-2010-00665z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/large/jm-2010-00665z_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Western blot analysis of Cal27 head and neck cancer cells treated for 16 h with compounds <b>5</b> (A) and <b>6c</b> or <b>6a</b> (B). As a control, cells treated with 1 Î¼M <b>5</b>, <b>6a</b>, or <b>6c</b> were documented by phase contrast microscopy in (C).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/large/jm-2010-00665z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100665z&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i46">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24572" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24572" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 26 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Lin, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weng, J.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.-S.</span><span> </span><span class="NLM_article-title">Targeting Histone Deacetylase in Cancer Therapy</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">397</span><span class="NLM_x">â</span> <span class="NLM_lpage">413</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm100665z&amp;key=10.1002%2Fmed.20056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm100665z&amp;key=16450343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm100665z&amp;key=1%3ACAS%3A528%3ADC%252BD28XntFaltrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=397-413&issue=4&author=H.-Y.+Linauthor=C.-S.+Chenauthor=S.-P.+Linauthor=J.-R.+Wengauthor=C.-S.+Chen&title=Targeting+Histone+Deacetylase+in+Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting histone deacetylase in cancer therapy</span></div><div class="casAuthors">Lin, Hsiang-Yu; Chen, Chang-Shi; Lin, Shuan-Pei; Weng, Jing-Ru; Chen, Ching-Shih</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">397-413</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Histone deacetylase (HDAC) is recognized as one of the promising targets for cancer treatment as many HDAC inhibitors have entered clin. trials for both solid and liq. tumors.  Nevertheless, the mechanisms underlying the antiproliferative effects of HDAC inhibitors remain elusive.  Although they have been shown to regulate the transcription of a defined set of genes through chromatin remodeling, increasing evidence suggests that modifications of the epigenetic histone code may not be the primary mechanism for HDAC inhibitor-mediated growth inhibition and apoptosis in cancer cells.  While histones still represent a primary target for the physiol. function of HDACs, the antitumor effect of HDAC inhibitors might also be attributed to transcription-independent mechanisms by modulating the acetylation status of a series of nonhistone targets.  Also noteworthy is the effect of HDAC inhibitors on Akt downregulation through the alteration of protein phosphatase 1 (PP1) complex formation.  To provide an overview of the use of HDAC inhibitors in cancer treatment, this review addresses the following subjects: (1) the physiol. relevance of HDAC-mediated acetylation of histone and nonhistone substrates, (2) the chem. biol. of HDACs and development of a novel class of HDAC inhibitors, and (3) the protein acetylation-independent effect of HDAC inhibitors on the activation status of signaling kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsa6h2NkYnN7Vg90H21EOLACvtfcHk0lg6Nc4fGYLjWA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntFaltrc%253D&md5=4d663196ac8258cd0e079b47761f3128</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fmed.20056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20056%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DH.-Y.%26aulast%3DChen%26aufirst%3DC.-S.%26aulast%3DLin%26aufirst%3DS.-P.%26aulast%3DWeng%26aufirst%3DJ.-R.%26aulast%3DChen%26aufirst%3DC.-S.%26atitle%3DTargeting%2520Histone%2520Deacetylase%2520in%2520Cancer%2520Therapy%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2006%26volume%3D26%26issue%3D4%26spage%3D397%26epage%3D413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Minucci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelicci, P. G.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">38</span><span class="NLM_x">â</span> <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm100665z&amp;key=10.1038%2Fnrc1779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm100665z&amp;key=16397526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm100665z&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1GgsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=38-51&issue=1&author=S.+Minucciauthor=P.+G.+Pelicci&title=Histone+deacetylase+inhibitors+and+the+promise+of+epigenetic+%28and+more%29+treatments+for+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer</span></div><div class="casAuthors">Minucci, Saverio; Pelicci, Pier Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-51</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Histone deacetylases (HDACs) are considered to be among the most promising targets in drug development for cancer therapy, and first-generation histone deacetylase inhibitors (HDACi) are currently being tested in phase I/II clin. trials.  A wide-ranging knowledge of the role of HDACs in tumorigenesis, and of the action of HDACi, has been achieved.  However, several basic aspects are not yet fully understood.  Investigating these aspects in the context of what we now understand about HDACi action both in vitro and in vivo will further improve the design of optimized clin. protocols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxXiACZV1sK7Vg90H21EOLACvtfcHk0liqiz2nIlWFxQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1GgsA%253D%253D&md5=384e1f8d676d61531e46843c060a9380</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrc1779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1779%26sid%3Dliteratum%253Aachs%26aulast%3DMinucci%26aufirst%3DS.%26aulast%3DPelicci%26aufirst%3DP.%2BG.%26atitle%3DHistone%2520deacetylase%2520inhibitors%2520and%2520the%2520promise%2520of%2520epigenetic%2520%2528and%2520more%2529%2520treatments%2520for%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26issue%3D1%26spage%3D38%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Jiahuai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrillo, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span> </span><span class="NLM_article-title">Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents</span> <span class="citation_source-journal">J. Hematol. Onco.l</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm100665z&amp;key=10.1186%2F1756-8722-3-5" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=5&author=T.+Jiahuaiauthor=S.+Cangauthor=Y.+Maauthor=R.+L.+Petrilloauthor=D.+Liu&title=Novel+histone+deacetylase+inhibitors+in+clinical+trials+as+anti-cancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1186%2F1756-8722-3-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-8722-3-5%26sid%3Dliteratum%253Aachs%26aulast%3DJiahuai%26aufirst%3DT.%26aulast%3DCang%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DPetrillo%26aufirst%3DR.%2BL.%26aulast%3DLiu%26aufirst%3DD.%26atitle%3DNovel%2520histone%2520deacetylase%2520inhibitors%2520in%2520clinical%2520trials%2520as%2520anti-cancer%2520agents%26jtitle%3DJ.%2520Hematol.%2520Onco.l%26date%3D2010%26volume%3D3%26spage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Prince, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishton, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, S. J.</span><span> </span><span class="NLM_article-title">Clinical Studies of Histone Deacetylase Inhibitors</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3958</span><span class="NLM_x">â</span> <span class="NLM_lpage">3969</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm100665z&amp;key=10.1158%2F1078-0432.CCR-08-2785" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm100665z&amp;key=19509172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm100665z&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntlOis78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=3958-3969&issue=12&author=H.+M.+Princeauthor=M.+J.+Bishtonauthor=S.+J.+Harrison&title=Clinical+Studies+of+Histone+Deacetylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical Studies of Histone Deacetylase Inhibitors</span></div><div class="casAuthors">Prince, H. Miles; Bishton, Mark J.; Harrison, Simon J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3958-3969</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Over the last 5 years, a plethora of histone deacetylase inhibitors (HDACi) have been evaluated in clin. trials.  These drugs have in common the ability to hyperacetylate both histone and nonhistone targets, resulting in a variety of effects on cancer cells, their microenvironment, and immune responses.  To date, responses with single agent HDACi have been predominantly obsd. in advanced hematol. malignancies including T-cell lymphoma, Hodgkin lymphoma, and myeloid malignancies.  Therefore, in this review we focus upon hematol. malignancies.  Generally HDACi are well tolerated with the most common acute toxicities being fatigue, gastrointestinal, and transient cytopenias.  Of note, few patients have been treated for prolonged periods of time and little is known about long-term toxicities.  The use of the biomarker of histone hyperacetylation has been useful as a guide to target specificity, but generally does not predict for response and the search for more clin. relevant biomarkers must continue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAT5q1xpNusLVg90H21EOLACvtfcHk0liqiz2nIlWFxQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntlOis78%253D&md5=776c9249c30fb91d6083445c545bd932</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-2785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-2785%26sid%3Dliteratum%253Aachs%26aulast%3DPrince%26aufirst%3DH.%2BM.%26aulast%3DBishton%26aufirst%3DM.%2BJ.%26aulast%3DHarrison%26aufirst%3DS.%2BJ.%26atitle%3DClinical%2520Studies%2520of%2520Histone%2520Deacetylase%2520Inhibitors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D15%26issue%3D12%26spage%3D3958%26epage%3D3969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Bots, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, R. W.</span><span> </span><span class="NLM_article-title">Rational Combinations Using HDAC Inhibitors</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3970</span><span class="NLM_x">â</span> <span class="NLM_lpage">3977</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm100665z&amp;key=10.1158%2F1078-0432.CCR-08-2786" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm100665z&amp;key=19509171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm100665z&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntlOis7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=3970-3977&issue=12&author=M.+Botsauthor=R.+W.+Johnstone&title=Rational+Combinations+Using+HDAC+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Combinations Using HDAC Inhibitors</span></div><div class="casAuthors">Bots, Michael; Johnstone, Ricky W.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3970-3977</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  In addn. to well-characterized genetic abnormalities that lead to cancer onset and progression, it is now recognized that alterations to the epigenome may also play a significant role in oncogenesis.  As a result, epigenetic-modulating agents such as histone deacetylase inhibitors (HDACi) have attracted enormous attention as anticancer drugs.  In numerous in vitro and preclin. settings, these compds. have shown their vast potential as single agent anticancer therapies, but unfortunately equiv. responses have not always been obsd. in patients.  Given the pleiotropic effects HDACi have on malignant cells, their true therapeutic potential most likely lies in combination with other anticancer drugs.  In this review we will focus on the anticancer effects of HDACi when combined with other cancer therapeutics with an emphasis on those combinations based on a strong mol. rationale.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhLnwCXjHtPbVg90H21EOLACvtfcHk0liqiz2nIlWFxQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntlOis7w%253D&md5=117c52a204aa45615eb04c8600e51c10</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-2786&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-2786%26sid%3Dliteratum%253Aachs%26aulast%3DBots%26aufirst%3DM.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26atitle%3DRational%2520Combinations%2520Using%2520HDAC%2520Inhibitors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D15%26issue%3D12%26spage%3D3970%26epage%3D3977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Mercurio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minucci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelicci, P. G.</span><span> </span><span class="NLM_article-title">Histone deacetylases and epigenetic therapies of hematological malignancies</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">18</span><span class="NLM_x">â</span> <span class="NLM_lpage">34</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=18-34&issue=1&author=C.+Mercurioauthor=S.+Minucciauthor=P.+G.+Pelicci&title=Histone+deacetylases+and+epigenetic+therapies+of+hematological+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMercurio%26aufirst%3DC.%26aulast%3DMinucci%26aufirst%3DS.%26aulast%3DPelicci%26aufirst%3DP.%2BG.%26atitle%3DHistone%2520deacetylases%2520and%2520epigenetic%2520therapies%2520of%2520hematological%2520malignancies%26jtitle%3DPharm.%2520Res.%26date%3D2010%26volume%3D62%26issue%3D1%26spage%3D18%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Morgan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, C. W.</span><span> </span><span class="NLM_article-title">Molecularly targeted therapies in myelodysplastic syndromes and acute myeloid leukemias</span> <span class="citation_source-journal">Ann. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">139</span><span class="NLM_x">â</span> <span class="NLM_lpage">163</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm100665z&amp;key=10.1007%2Fs00277-005-0051-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm100665z&amp;key=16391911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm100665z&amp;key=1%3ACAS%3A528%3ADC%252BD28XovVeltA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2006&pages=139-163&issue=3&author=M.+A.+Morganauthor=C.+W.+Reuter&title=Molecularly+targeted+therapies+in+myelodysplastic+syndromes+and+acute+myeloid+leukemias"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Molecularly targeted therapies in myelodysplastic syndromes and acute myeloid leukemias</span></div><div class="casAuthors">Morgan, Michael A.; Reuter, Christoph W. M.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Hematology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">139-163</span>CODEN:
                <span class="NLM_cas:coden">ANHEE8</span>;
        ISSN:<span class="NLM_cas:issn">0939-5555</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Although there has been significant progress in acute myeloid leukemia (AML) treatment in younger adults during the last decade, std. induction therapy still fails to induce remission in up to 40% of AML patients.  Addnl., relapses are common in 50-70% of patients who achieve a complete remission, and only 20-30% of patients enjoy long-term disease-free survival.  The natural history of myelodysplastic syndrome (MDS) is variable, with about half of the patients dying from cytopenic complications, and an addnl. 20-30% transforming to AML.  The advanced age of the majority of MDS patients limits the therapeutic strategies often to supportive care.  To address these shortcomings, much effort has been directed toward the development of novel treatment strategies that target the evolution and proliferation of malignant clones.  Presented here is an overview of molecularly targeted therapies currently being tested in AML and MDS patients, with a focus on FMS-like tyrosine kinase 3 inhibitors, farnesyltransferase inhibitors, antiangiogenesis agents, DNA hypomethylation agents, and histone deacetylase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC2IIKBnuoErVg90H21EOLACvtfcHk0linjSsM1_4J5Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovVeltA%253D%253D&md5=a342517549182dc988ceec4af1de73c1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2Fs00277-005-0051-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00277-005-0051-7%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DM.%2BA.%26aulast%3DReuter%26aufirst%3DC.%2BW.%26atitle%3DMolecularly%2520targeted%2520therapies%2520in%2520myelodysplastic%2520syndromes%2520and%2520acute%2520myeloid%2520leukemias%26jtitle%3DAnn.%2520Hematol.%26date%3D2006%26volume%3D85%26issue%3D3%26spage%3D139%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Johnstone, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Licht, J. D.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitors in cancer therapy: is transcription the primary target?</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">13</span><span class="NLM_x">â</span> <span class="NLM_lpage">18</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=13-18&issue=1&author=R.+W.+Johnstoneauthor=J.+D.+Licht&title=Histone+deacetylase+inhibitors+in+cancer+therapy%3A+is+transcription+the+primary+target%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26aulast%3DLicht%26aufirst%3DJ.%2BD.%26atitle%3DHistone%2520deacetylase%2520inhibitors%2520in%2520cancer%2520therapy%253A%2520is%2520transcription%2520the%2520primary%2520target%253F%26jtitle%3DCancer%2520Cell%26date%3D2003%26volume%3D4%26issue%3D1%26spage%3D13%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Sorbera, L. A.</span><span> </span><span class="NLM_article-title">Epigenetic target as an approach to cancer therapy and chemoprevention</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">335</span><span class="NLM_x">â</span> <span class="NLM_lpage">344</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm100665z&amp;key=10.1358%2Fdof.2006.031.04.985053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm100665z&amp;key=1%3ACAS%3A528%3ADC%252BD28XntVylsbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=335-344&issue=4&author=L.+A.+Sorbera&title=Epigenetic+target+as+an+approach+to+cancer+therapy+and+chemoprevention"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic target as an approach to cancer therapy and chemoprevention</span></div><div class="casAuthors">Sorbera, Lisa A.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">335-344</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Carcinogenesis and tumor progression are controlled by both genetic and epigenetic events.  Unlike genetic aberrations, epigenetic aberrations such as DNA methylation and histone deacetylation evident in cancer cells can usually be reversed to reactivate epigenetically silenced tumor suppressor genes and possibly normalize a malignant cell population.  Thus, researchers have focused on epigenetic events as targets for effective cancer therapy and chemoprevention.  At the 97th American Assocn. for Cancer Research Annual Meeting in Washington, D.C., the preclin. and clin. activity of several histone deacetylase (HDAC) and DNA methyltransferase (DNMT) inhibitors was described, indicating promising anticancer effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCi1AxorTZnrVg90H21EOLACvtfcHk0linjSsM1_4J5Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntVylsbc%253D&md5=32b4c23f6b9735485eb3fe411e919a96</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1358%2Fdof.2006.031.04.985053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2006.031.04.985053%26sid%3Dliteratum%253Aachs%26aulast%3DSorbera%26aufirst%3DL.%2BA.%26atitle%3DEpigenetic%2520target%2520as%2520an%2520approach%2520to%2520cancer%2520therapy%2520and%2520chemoprevention%26jtitle%3DDrugs%2520Future%26date%3D2006%26volume%3D31%26issue%3D4%26spage%3D335%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Ma, B. B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poon, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lui, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, A. T. C.</span><span> </span><span class="NLM_article-title">The preclinical activity of the histone deacetylase inhibitor PXD101 (belinostat) in hepatocellular carcinoma cell lines</span> <span class="citation_source-journal">Investigational New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">107</span><span class="NLM_x">â</span> <span class="NLM_lpage">114</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=107-114&issue=2&author=B.+B.+Y.+Maauthor=F.+Sungauthor=Q.+Taoauthor=F.+F.+Poonauthor=V.+W.+Luiauthor=W.+Yeoauthor=S.+L.+Chanauthor=A.+T.+C.+Chan&title=The+preclinical+activity+of+the+histone+deacetylase+inhibitor+PXD101+%28belinostat%29+in+hepatocellular+carcinoma+cell+lines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DB.%2BB.%2BY.%26aulast%3DSung%26aufirst%3DF.%26aulast%3DTao%26aufirst%3DQ.%26aulast%3DPoon%26aufirst%3DF.%2BF.%26aulast%3DLui%26aufirst%3DV.%2BW.%26aulast%3DYeo%26aufirst%3DW.%26aulast%3DChan%26aufirst%3DS.%2BL.%26aulast%3DChan%26aufirst%3DA.%2BT.%2BC.%26atitle%3DThe%2520preclinical%2520activity%2520of%2520the%2520histone%2520deacetylase%2520inhibitor%2520PXD101%2520%2528belinostat%2529%2520in%2520hepatocellular%2520carcinoma%2520cell%2520lines%26jtitle%3DInvestigational%2520New%2520Drugs%26date%3D2010%26volume%3D28%26issue%3D2%26spage%3D107%26epage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Buggy, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bass, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalrymple, S. A.</span><span> </span><span class="NLM_article-title">CRA-024781: a novel synthetic inhibitor of histone deacetylase enzymes with antitumor activity in vitro and in vivo</span> <span class="citation_source-journal">Mol Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1309</span><span class="NLM_x">â</span> <span class="NLM_lpage">1317</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm100665z&amp;key=10.1158%2F1535-7163.MCT-05-0442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm100665z&amp;key=16731764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm100665z&amp;key=1%3ACAS%3A528%3ADC%252BD28XltVWms7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=1309-1317&issue=5&author=J.+J.+Buggyauthor=Z.+A.+Caoauthor=K.+E.+Bassauthor=E.+Vernerauthor=S.+Balasubramanianauthor=L.+Liuauthor=B.+E.+Schultzauthor=P.+R.+Youngauthor=S.+A.+Dalrymple&title=CRA-024781%3A+a+novel+synthetic+inhibitor+of+histone+deacetylase+enzymes+with+antitumor+activity+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">CRA-024781: a novel synthetic inhibitor of histone deacetylase enzymes with antitumor activity in vitro and in vivo</span></div><div class="casAuthors">Buggy, Joseph J.; Cao, Z. Alexander; Bass, Kathryn E.; Verner, Erik; Balasubramanian, Sriram; Liu, Liang; Schultz, Brian E.; Young, Peter R.; Dalrymple, Stacie A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1309-1317</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">CRA-024781 is a novel, broad spectrum hydroxamic acid-based inhibitor of histone deacetylase (HDAC) that shows antitumor activity in vitro and in vivo preclinically and is under evaluation in phase I clin. trials for cancer.  CRA-024781 inhibited pure recombinant HDAC1 with a Ki of 0.007 Î¼mol/L, and also inhibited the other HDAC isoenzymes HDAC2, HDAC3/SMRT, HDAC6, HDAC8, and HDAC10 in the nanomolar range.  Treatment of cultured tumor cell lines grown in vitro with CRA-024781 resulted in the accumulation of acetylated histone and acetylated tubulin, resulting in an inhibition of tumor cell growth and the induction of apoptosis.  CRA-024781 parenterally administered to mice harboring HCT116 or DLD-1 colon tumor xenografts resulted in a statistically significant redn. in tumor growth at doses that were well tolerated as measured by body wt.  Inhibition of tumor growth was accompanied by an increase in the acetylation of Î±-tubulin in peripheral blood mononuclear cells, and an alteration in the expression of many genes in the tumors, including several involved in apoptosis and cell growth.  These results reveal CRA-024781 to be a novel HDAC inhibitor with potent antitumor activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8uJX28obQWrVg90H21EOLACvtfcHk0ljZtF_R-eCHbQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltVWms7Y%253D&md5=fa761c94dd4f3a031493476dd75af602</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-05-0442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-05-0442%26sid%3Dliteratum%253Aachs%26aulast%3DBuggy%26aufirst%3DJ.%2BJ.%26aulast%3DCao%26aufirst%3DZ.%2BA.%26aulast%3DBass%26aufirst%3DK.%2BE.%26aulast%3DVerner%26aufirst%3DE.%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DSchultz%26aufirst%3DB.%2BE.%26aulast%3DYoung%26aufirst%3DP.%2BR.%26aulast%3DDalrymple%26aufirst%3DS.%2BA.%26atitle%3DCRA-024781%253A%2520a%2520novel%2520synthetic%2520inhibitor%2520of%2520histone%2520deacetylase%2520enzymes%2520with%2520antitumor%2520activity%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DMol%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26issue%3D5%26spage%3D1309%26epage%3D1317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Atadja, P. W.</span><span> </span><span class="NLM_article-title">Use of HDAC inhibitors for the treatment of acute myeloid leukemia and/or myelodysplastic syndrome</span>. PCT Int. Appl.<span class="NLM_x"> (</span><span class="NLM_year">2010</span><span class="NLM_x">) </span>WO 2010009285 A1.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=P.+W.+Atadja&title=Use+of+HDAC+inhibitors+for+the+treatment+of+acute+myeloid+leukemia+and%2For+myelodysplastic+syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAtadja%26aufirst%3DP.%2BW.%26atitle%3DUse%2520of%2520HDAC%2520inhibitors%2520for%2520the%2520treatment%2520of%2520acute%2520myeloid%2520leukemia%2520and%252For%2520myelodysplastic%2520syndrome%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Geyer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forster, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindquist, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romieu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pienkowski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagiello-Gruszfeld, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skarlos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliva, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, D.</span><span> </span><span class="NLM_article-title">Lapatinib plus capecitabine for HER2-positive advanced breast cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">2733</span><span class="NLM_x">â</span> <span class="NLM_lpage">2743</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm100665z&amp;key=10.1056%2FNEJMoa064320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm100665z&amp;key=17192538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm100665z&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhslSqsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=2733-2743&issue=26&author=C.+Geyerauthor=J.+Forsterauthor=D.+Lindquistauthor=S.+Chanauthor=C.+Romieuauthor=T.+Pienkowskiauthor=A.+Jagiello-Gruszfeldauthor=J.+Crownauthor=A.+Chanauthor=B.+Kaufmanauthor=D.+Skarlosauthor=M.+Camponeauthor=N.+Davidsonauthor=M.+Bergerauthor=C.+Olivaauthor=S.+Rubinauthor=S.+Steinauthor=D.+Cameron&title=Lapatinib+plus+capecitabine+for+HER2-positive+advanced+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Lapatinib plus capecitabine for HER2-positive advanced breast cancer</span></div><div class="casAuthors">Geyer, Charles E.; Forster, John; Lindquist, Deborah; Chan, Stephen; Romieu, C. Gilles; Pienkowski, Tadeusz; Jagiello-Gruszfeld, Agnieszka; Crown, John; Chan, Arlene; Kaufman, Bella; Skarlos, Dimosthenis; Campone, Mario; Davidson, Neville; Berger, Mark; Oliva, Cristina; Rubin, Stephen D.; Stein, Steven; Cameron, David</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2733-2743</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Lapatinib, a tyrosine kinase inhibitor of human epidermal growth factor receptor type 2 (HER2, also referred to as HER2/neu) and epidermal growth factor receptor (EGFR), is active in combination with capecitabine in women with HER2-pos. metastatic breast cancer that has progressed after trastuzumab-based therapy.  In this trial, we compared lapatinib plus capecitabine with capecitabine alone in such patients.  Women with HER2-pos., locally advanced or metastatic breast cancer that had progressed after treatment with regimens that included an anthracycline, a taxane, and trastuzumab were randomly assigned to receive either combination therapy (lapatinib at a dose of 1250 mg per day continuously plus capecitabine at a dose of 2000 mg per square meter of body-surface area on days 1 through 14 of a 21-day cycle) or monotherapy (capecitabine alone at a dose of 2500 mg per square meter on days 1 through 14 of a 21-day cycle).  The primary end point was time to progression, based on an evaluation by independent reviewers under blinded conditions.  The interim anal. of time to progression met specified criteria for early reporting on the basis of superiority in the combination-therapy group.  The hazard ratio for the independently assessed time to progression was 0.49 (95% confidence interval, 0.34 to 0.71; P < 0.001), with 49 events in the combination-therapy group and 72 events in the monotherapy group.  The median time to progression was 8.4 mo in the combination-therapy group as compared with 4.4 mo in the monotherapy group.  This improvement was achieved without an increase in serious toxic effects or symptomatic cardiac events.  Lapatinib plus capecitabine is superior to capecitabine alone in women with HER2-pos. advanced breast cancer that has progressed after treatment with regimens that included an anthracycline, a taxane, and trastuzumab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxyRt3cMvZIbVg90H21EOLACvtfcHk0ljZtF_R-eCHbQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhslSqsA%253D%253D&md5=be0104abe2ca297bdfdd30717de84d8a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa064320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa064320%26sid%3Dliteratum%253Aachs%26aulast%3DGeyer%26aufirst%3DC.%26aulast%3DForster%26aufirst%3DJ.%26aulast%3DLindquist%26aufirst%3DD.%26aulast%3DChan%26aufirst%3DS.%26aulast%3DRomieu%26aufirst%3DC.%26aulast%3DPienkowski%26aufirst%3DT.%26aulast%3DJagiello-Gruszfeld%26aufirst%3DA.%26aulast%3DCrown%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DA.%26aulast%3DKaufman%26aufirst%3DB.%26aulast%3DSkarlos%26aufirst%3DD.%26aulast%3DCampone%26aufirst%3DM.%26aulast%3DDavidson%26aufirst%3DN.%26aulast%3DBerger%26aufirst%3DM.%26aulast%3DOliva%26aufirst%3DC.%26aulast%3DRubin%26aufirst%3DS.%26aulast%3DStein%26aufirst%3DS.%26aulast%3DCameron%26aufirst%3DD.%26atitle%3DLapatinib%2520plus%2520capecitabine%2520for%2520HER2-positive%2520advanced%2520breast%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D355%26issue%3D26%26spage%3D2733%26epage%3D2743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Nishino, S.; Hirotsu, K.; Shima, H.; Harada, T.; Oda, H.; Takahashi, T.; Suzuki, S.</span><span> </span><span class="NLM_article-title">Process for producing 3,4-dihydroquinazolin-4-one derivatives</span>. PCT Int. Appl. WO2003064399 A1,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=S.+Nishino&author=K.+Hirotsu&author=H.+Shima&author=T.+Harada&author=H.+Oda&author=T.+Takahashi&author=S.+Suzuki&title=Process+for+producing+3%2C4-dihydroquinazolin-4-one+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNishino%26aufirst%3DS.%26atitle%3DProcess%2520for%2520producing%25203%252C4-dihydroquinazolin-4-one%2520derivatives%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Nishino, S.; Hirotsu, K.; Shima, H.; Harada, T.; Oda, H.</span><span> </span><span class="NLM_article-title">Process for producing 4-aminoquinazoline compound by chlorination of quinazolin-4-one or its derivative and amination</span>. PCT Int. Appl. WO 2003066602,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=S.+Nishino&author=K.+Hirotsu&author=H.+Shima&author=T.+Harada&author=H.+Oda&title=Process+for+producing+4-aminoquinazoline+compound+by+chlorination+of+quinazolin-4-one+or+its+derivative+and+amination"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNishino%26aufirst%3DS.%26atitle%3DProcess%2520for%2520producing%25204-aminoquinazoline%2520compound%2520by%2520chlorination%2520of%2520quinazolin-4-one%2520or%2520its%2520derivative%2520and%2520amination%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Wallace, E.; Topolov, G.; Zhao, Q.; Lyssikatos, J. P.</span><span> </span><span class="NLM_article-title">Preparation of cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors</span>. US 2005101617,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=E.+Wallace&author=G.+Topolov&author=Q.+Zhao&author=J.+P.+Lyssikatos&title=Preparation+of+cyanoguanidines+and+cyanoamidines+as+ErbB2+and+EGFR+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWallace%26aufirst%3DE.%26atitle%3DPreparation%2520of%2520cyanoguanidines%2520and%2520cyanoamidines%2520as%2520ErbB2%2520and%2520EGFR%2520inhibitors%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Hosoya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikemoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiramatsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span> </span><span class="NLM_article-title">Danthrone Analogues Revisted: General Synthesis and Specific Functions Capable of Discriminating Two Kinds of Ca<sup>2+</sup> Release from Sarcoplasmic Rerticulum of Mouse Skeletal Muscle</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">663</span><span class="NLM_x">â</span> <span class="NLM_lpage">673</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=663-673&author=T.+Hosoyaauthor=H.+Aoyamaauthor=T.+Ikemotoauthor=Y.+Kiharaauthor=T.+Hiramatsuauthor=M.+Endoauthor=M.+Suzuki&title=Danthrone+Analogues+Revisted%3A+General+Synthesis+and+Specific+Functions+Capable+of+Discriminating+Two+Kinds+of+Ca2%2B+Release+from+Sarcoplasmic+Rerticulum+of+Mouse+Skeletal+Muscle"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DAoyama%26aufirst%3DH.%26aulast%3DIkemoto%26aufirst%3DT.%26aulast%3DKihara%26aufirst%3DY.%26aulast%3DHiramatsu%26aufirst%3DT.%26aulast%3DEndo%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DM.%26atitle%3DDanthrone%2520Analogues%2520Revisted%253A%2520General%2520Synthesis%2520and%2520Specific%2520Functions%2520Capable%2520of%2520Discriminating%2520Two%2520Kinds%2520of%2520Ca2%252B%2520Release%2520from%2520Sarcoplasmic%2520Rerticulum%2520of%2520Mouse%2520Skeletal%2520Muscle%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D663%26epage%3D673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ying, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hruby, V. J.</span><span> </span><span class="NLM_article-title">Stereoselective Synthesis of Novel Dipeptide Î²-Turn Mimetics Targeting Melanocortin Peptide Receptors</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">3115</span><span class="NLM_x">â</span> <span class="NLM_lpage">3118</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol0351347" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=3115-3118&issue=17&author=J.+Zhangauthor=C.+Xiongauthor=J.+Yingauthor=W.+Wangauthor=V.+J.+Hruby&title=Stereoselective+Synthesis+of+Novel+Dipeptide+%CE%B2-Turn+Mimetics+Targeting+Melanocortin+Peptide+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fol0351347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0351347%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DXiong%26aufirst%3DC.%26aulast%3DYing%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DStereoselective%2520Synthesis%2520of%2520Novel%2520Dipeptide%2520%25CE%25B2-Turn%2520Mimetics%2520Targeting%2520Melanocortin%2520Peptide%2520Receptors%26jtitle%3DOrg.%2520Lett.%26date%3D2003%26volume%3D5%26issue%3D17%26spage%3D3115%26epage%3D3118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Castro, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dormoy, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selve, C.</span><span> </span><span class="NLM_article-title">Peptide coupling reagents. IV. N-[Oxytris(dimethylamino)phosphonium]benzotriazole hexafluorophosphate</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1219</span><span class="NLM_x">â</span> <span class="NLM_lpage">1222</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1975&pages=1219-1222&author=B.+Castroauthor=J.+R.+Dormoyauthor=G.+Evinauthor=C.+Selve&title=Peptide+coupling+reagents.+IV.+N-%5BOxytris%28dimethylamino%29phosphonium%5Dbenzotriazole+hexafluorophosphate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCastro%26aufirst%3DB.%26aulast%3DDormoy%26aufirst%3DJ.%2BR.%26aulast%3DEvin%26aufirst%3DG.%26aulast%3DSelve%26aufirst%3DC.%26atitle%3DPeptide%2520coupling%2520reagents.%2520IV.%2520N-%255BOxytris%2528dimethylamino%2529phosphonium%255Dbenzotriazole%2520hexafluorophosphate%26jtitle%3DTetrahedron%2520Lett.%26date%3D1975%26volume%3D14%26spage%3D1219%26epage%3D1222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Petasis, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, Z. D.</span><span> </span><span class="NLM_article-title">Synthesis of piperazinones and benzopiperazinones from 1,2-diamines and organoboronic acids</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">9607</span><span class="NLM_x">â</span> <span class="NLM_lpage">9611</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2000&pages=9607-9611&author=N.+A.+Petasisauthor=Z.+D.+Patel&title=Synthesis+of+piperazinones+and+benzopiperazinones+from+1%2C2-diamines+and+organoboronic+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetasis%26aufirst%3DN.%2BA.%26aulast%3DPatel%26aufirst%3DZ.%2BD.%26atitle%3DSynthesis%2520of%2520piperazinones%2520and%2520benzopiperazinones%2520from%25201%252C2-diamines%2520and%2520organoboronic%2520acids%26jtitle%3DTetrahedron%2520Lett.%26date%3D2000%26volume%3D41%26spage%3D9607%26epage%3D9611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Mahboobi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellmer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eichhorn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pongratz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciossek, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">T., M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckers, T.</span><span> </span><span class="NLM_article-title">Novel designed chimeric HDAC- and tyrosine kinase inhibitors: A series of Imatinib hybrides as potent inhibitors of wild-type and mutant BCR-ABL, PDGF-RÎ² and histone deacetylases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2265</span><span class="NLM_x">â</span> <span class="NLM_lpage">2279</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800988r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2265-2279&issue=8&author=S.+Mahboobiauthor=A.+Sellmerauthor=M.+Winklerauthor=E.+Eichhornauthor=H.+Pongratzauthor=T.+Ciossekauthor=T.+Baerauthor=M.+T.author=T.+Beckers&title=Novel+designed+chimeric+HDAC-+and+tyrosine+kinase+inhibitors%3A+A+series+of+Imatinib+hybrides+as+potent+inhibitors+of+wild-type+and+mutant+BCR-ABL%2C+PDGF-R%CE%B2+and+histone+deacetylases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm800988r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800988r%26sid%3Dliteratum%253Aachs%26aulast%3DMahboobi%26aufirst%3DS.%26aulast%3DSellmer%26aufirst%3DA.%26aulast%3DWinkler%26aufirst%3DM.%26aulast%3DEichhorn%26aufirst%3DE.%26aulast%3DPongratz%26aufirst%3DH.%26aulast%3DCiossek%26aufirst%3DT.%26aulast%3DBaer%26aufirst%3DT.%26aulast%3DT.%26aufirst%3DM.%26aulast%3DBeckers%26aufirst%3DT.%26atitle%3DNovel%2520designed%2520chimeric%2520HDAC-%2520and%2520tyrosine%2520kinase%2520inhibitors%253A%2520A%2520series%2520of%2520Imatinib%2520hybrides%2520as%2520potent%2520inhibitors%2520of%2520wild-type%2520and%2520mutant%2520BCR-ABL%252C%2520PDGF-R%25CE%25B2%2520and%2520histone%2520deacetylases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D8%26spage%3D2265%26epage%3D2279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Beckers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkhardt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieland, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gimmnich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciossek, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, K.</span><span> </span><span class="NLM_article-title">Distinct pharmacological properties of 2nd generation HDAC inhibitors with the benzamide or hydroxamate head group</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">1138</span><span class="NLM_x">â</span> <span class="NLM_lpage">1148</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm100665z&amp;key=10.1002%2Fijc.22751" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm100665z&amp;key=17455259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm100665z&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFGhu7nN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2007&pages=1138-1148&author=T.+Beckersauthor=C.+Burkhardtauthor=H.+Wielandauthor=P.+Gimmnichauthor=T.+Ciossekauthor=T.+Maierauthor=K.+Sanders&title=Distinct+pharmacological+properties+of+2nd+generation+HDAC+inhibitors+with+the+benzamide+or+hydroxamate+head+group"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct pharmacological properties of second generation HDAC inhibitors with the benzamide or hydroxamate head group</span></div><div class="casAuthors">Beckers, Thomas; Burkhardt, Carmen; Wieland, Heike; Gimmnich, Petra; Ciossek, Thomas; Maier, Thomas; Sanders, Karl</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1138-1148</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Advanced second generation inhibitors of histone deacetylases (HDAC) are currently used in clin. development.  This study aimed at comparing the pharmacol. properties of selected second generation HDAC inhibitors with the hydroxamate and benzamide head group, namely SAHA, LAQ824/LBH589, CI994, MS275 and MGCD0103.  In biochem. assays using recombinant HDAC1, 3, 6 and 8 isoenzymes, SAHA and LAQ824/LBH589 behave as quite unselective HDAC inhibitors.  In contrast, the benzamides CI994, MS275 and MGCD0103 are more selective, potent inhibitors of at least HDAC1 and HDAC3.  All HDAC inhibitors induce histone H3 hyperacetylation, correlating with inhibition of proliferation, induction of cell differentiation and apoptosis.  A broad cytotoxicity is seen across cell lines from different tumor entities with LAQ824/LBH589 being the most potent agents.  The apoptosis inducing activity is evident in arrested and proliferating RKO colon cancer cells with inducible, heterologous p21waf1 expression, indicative for a cell-cycle independent mode-of-action.  Differentiation of MDA-MB468 breast cancer cells is induced by benzamide and hydroxamate analogs.  The reversibility of drug action was evaluated by pulse treatment of A549 lung cancer cells.  Whereas paclitaxel induced irreversible cell cycle alterations already after 6 h treatment, HDAC inhibitor action was retarded and irreversible after >16 h treatment.  Interestingly, pulse treatment was equally effective as continous treatment.  Finally, the efficacy of LAQ824, SAHA and MS275 in A549 nude mice xenografts was comparable to that of paclitaxel at well tolerated doses.  We conclude that despite a different HDAC isoenzyme inhibition profile, hydroxamate and benzamide analogs as studied display similar cellular profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiDHz24Jk1RLVg90H21EOLACvtfcHk0lhkCKgmbqCPmQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFGhu7nN&md5=b022385076ee75290c2b6f8d3cdf4bbe</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fijc.22751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.22751%26sid%3Dliteratum%253Aachs%26aulast%3DBeckers%26aufirst%3DT.%26aulast%3DBurkhardt%26aufirst%3DC.%26aulast%3DWieland%26aufirst%3DH.%26aulast%3DGimmnich%26aufirst%3DP.%26aulast%3DCiossek%26aufirst%3DT.%26aulast%3DMaier%26aufirst%3DT.%26aulast%3DSanders%26aufirst%3DK.%26atitle%3DDistinct%2520pharmacological%2520properties%2520of%25202nd%2520generation%2520HDAC%2520inhibitors%2520with%2520the%2520benzamide%2520or%2520hydroxamate%2520head%2520group%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2007%26volume%3D121%26spage%3D1138%26epage%3D1148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Wegener, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirsching, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riester, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwienhorst, A.</span><span> </span><span class="NLM_article-title">A fluorogenic histone deacetylase assay well suited for high-throughput activity screening</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">61</span><span class="NLM_x">â</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm100665z&amp;key=10.1016%2FS1074-5521%2802%2900305-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm100665z&amp;key=12573699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm100665z&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps1Skuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=61-68&issue=1&author=D.+Wegenerauthor=F.+Wirschingauthor=D.+Riesterauthor=A.+Schwienhorst&title=A+fluorogenic+histone+deacetylase+assay+well+suited+for+high-throughput+activity+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A Fluorogenic Histone Deacetylase Assay Well Suited for High-Throughput Activity Screening</span></div><div class="casAuthors">Wegener, Dennis; Wirsching, Frank; Riester, Daniel; Schwienhorst, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-68</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) are important enzymes for the transcriptional regulation of gene expression in eukaryotic cells.  Recent findings suggest that HDACs could be key targets for chemotherapeutic intervention in malignant diseases.  A convenient and sensitive fluorogenic assay for HDAC activity would therefore expedite studies of HDAC in transcriptional regulation and in vitro screening for drug discovery.  In this study, novel fluorogenic substrates of HDACs were synthesized with an Îµ-acetylated lysyl moiety and an adjacent MCA moiety at the C terminus of the peptide chain.  Upon deacetylation of the acetylated lysyl moiety, mols. became substrates for trypsin, which released highly fluorescent AMC mols. in a subsequent step of the assay.  The fluorescence increased in direct proportion to the amt. of deacetylated substrate mols., i.e., HDAC activity.  The nonisotopic, homogeneous assay is well suited for high-throughput HDAC inhibitor screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5ogyqEBSC3bVg90H21EOLACvtfcHk0lhkCKgmbqCPmQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps1Skuw%253D%253D&md5=eea350d8066f6ebd773ba50cc0211fdc</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2802%2900305-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252802%252900305-8%26sid%3Dliteratum%253Aachs%26aulast%3DWegener%26aufirst%3DD.%26aulast%3DWirsching%26aufirst%3DF.%26aulast%3DRiester%26aufirst%3DD.%26aulast%3DSchwienhorst%26aufirst%3DA.%26atitle%3DA%2520fluorogenic%2520histone%2520deacetylase%2520assay%2520well%2520suited%2520for%2520high-throughput%2520activity%2520screening%26jtitle%3DChem.%2520Biol.%26date%3D2003%26volume%3D10%26issue%3D1%26spage%3D61%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Braunger, J.; Zoche, M.; Schmidt; Wiesbacher, M.; Burkhardt, C.; Gekeler, V.; Beckers, T.</span><i>AACR Annual Conference</i><span class="NLM_x"> </span><span class="NLM_year">2003</span><span class="NLM_x">, </span>Abstract 4556.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Braunger%2C+J.%3B+Zoche%2C+M.%3B+Schmidt%3B+Wiesbacher%2C+M.%3B+Burkhardt%2C+C.%3B+Gekeler%2C+V.%3B+Beckers%2C+T.AACR+Annual+Conference+2003%2C+Abstract+4556."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DBraunger%26aufirst%3DJ.%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">OâBrian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pognan, F.</span><span> </span><span class="NLM_article-title">Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell toxicity</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">5421</span><span class="NLM_x">â</span> <span class="NLM_lpage">5426</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm100665z&amp;key=10.1046%2Fj.1432-1327.2000.01606.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm100665z&amp;key=10951200" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=2000&pages=5421-5426&issue=17&author=J.+O%E2%80%99Brianauthor=I.+Wilsonauthor=T.+Ortonauthor=F.+Pognan&title=Investigation+of+the+Alamar+Blue+%28resazurin%29+fluorescent+dye+for+the+assessment+of+mammalian+cell+toxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.2000.01606.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.2000.01606.x%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Brian%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DI.%26aulast%3DOrton%26aufirst%3DT.%26aulast%3DPognan%26aufirst%3DF.%26atitle%3DInvestigation%2520of%2520the%2520Alamar%2520Blue%2520%2528resazurin%2529%2520fluorescent%2520dye%2520for%2520the%2520assessment%2520of%2520mammalian%2520cell%2520toxicity%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2000%26volume%3D267%26issue%3D17%26spage%3D5421%26epage%3D5426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Roschangar, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooley, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, R. T.</span><span> </span><span class="NLM_article-title">Use of lithium N,O-dimethylhydroxylamide as an efficient in situ protecting agent for aromatic aldehydes</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1657</span><span class="NLM_x">â</span> <span class="NLM_lpage">1666</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=1657-1666&issue=9&author=F.+Roschangarauthor=J.+C.+Brownauthor=B.+E.+Cooleyauthor=M.+J.+Sharpauthor=R.+T.+Matsuoka&title=Use+of+lithium+N%2CO-dimethylhydroxylamide+as+an+efficient+in+situ+protecting+agent+for+aromatic+aldehydes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoschangar%26aufirst%3DF.%26aulast%3DBrown%26aufirst%3DJ.%2BC.%26aulast%3DCooley%26aufirst%3DB.%2BE.%26aulast%3DSharp%26aufirst%3DM.%2BJ.%26aulast%3DMatsuoka%26aufirst%3DR.%2BT.%26atitle%3DUse%2520of%2520lithium%2520N%252CO-dimethylhydroxylamide%2520as%2520an%2520efficient%2520in%2520situ%2520protecting%2520agent%2520for%2520aromatic%2520aldehydes%26jtitle%3DTetrahedron%26date%3D2002%26volume%3D58%26issue%3D9%26spage%3D1657%26epage%3D1666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i45"><a href="/doi/suppl/10.1021/jm100665z">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_71836"></div></div></div></div></div><hr /></hr><p class="last">Full experimental details for synthetically preparations, analytical data, and biological test systems. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm100665z/suppl_file/jm100665z_si_001.pdf">jm100665z_si_001.pdf (129.36 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm100665z&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Fjm100665z%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-24" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm100665z" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6798fcfa5da22390","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
